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ABSTRACT 
 
 The influence of protein nutrition on endurance performance has received growing 
attention over the last several years. At present, there is no clear consensus as to whether 
protein feeding harnesses any ergogenic benefit for endurance athletes, due to 
methodological differences between the studies conducted to date. Whilst prior studies 
suggest that endurance capacity may be extended with additional protein, chapters in this 
thesis demonstrate no effect of protein on endurance performance. In addition to endurance 
capacity, protein ingestion during and following exercise has been advocated to enhance the 
recovery process. However, the impact of carbohydrate-protein co-ingestion on recovery 
from intense exercise is considered to be somewhat equivocal, due to the practical relevance 
of different tests of recovery and the lack of a clear physiological mechanism. Indeed, data 
presented herein indicates that protein co-ingestion does not enhance recovery at 24 hours 
post-exercise. Consequently, there is currently no basis on which to recommend protein 
feeding for endurance performance and recovery. 
 Nutrient strategies implemented in the post-exercise period can markedly alter the acute 
response of muscle protein synthesis. Thus, over an extended period of training appropriate 
post-exercise nutrient manipulations may modulate metabolic adaptations. Whereas the 
metabolic and molecular response to protein nutrition with resistance exercise has received 
increasing attention, protein feeding following endurance exercise has received considerably 
less. The combination of endurance exercise and protein ingestion increases the synthesis of 
mixed muscle protein via the phosphorylation of signalling intermediates implicated in 
mRNA translation initiation and elongation. Herein, we demonstrate that the response of 
mixed muscle proteins to post-endurance exercise protein feeding is due, in large part, to an 
increase in the synthesis of contractile proteins. Furthermore we provide evidence of altered 
signalling phosphorylation with protein feeding which may explain the protein synthetic 
response. 
 Insulin resistance that precedes Type II diabetes is characterized by blunted sensitivity 
of the pancreas to glucose and impaired glucose uptake in skeletal muscle. It is suggested that 
defective intracellular signalling, crucial for glucoregulation, may lead to hyperglycemia. 
However, lifestyle interventions including nutrient manipulations and exercise have the 
potential to improve glycemic control and can effectively restore glycemic control. Indeed, a 
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single bout of resistance exercise can improve insulin sensitivity and glycemic control for up 
to 48 hours post-exercise. In addition to resistance exercise, co-ingesting protein and/or 
amino acids with a carbohydrate load facilitates the release of insulin, thereby suppressing the 
prevailing plasma glucose response. The final experimental chapter in this thesis shows that 
the rate of glucose disposal from the circulation is elevated 24 hours after a single bout of 
resistance exercise in healthy normoglycemic males. It appears that prior exercise increased 
the basal and insulin-stimulated phosphorylation of proximal intracellular signalling 
intermediates regulating glucose uptake in skeletal muscle. Interestingly, protein ingestion 
did not augment the glucose-lowering effects of prior resistance exercise. 
 
KEYWORDS: Endurance cycling, muscle damage, muscle protein synthesis, resistance 
exercise, glucose metabolism, intracellular signalling.  
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“Achievement is not always success while reputed failure often is. It is honest endeavour, 
persistent effort to do the best possible under any and all circumstances”. 
   
 
Orison Swett Marden, writer and physician (1850 - 1924) 
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CHAPTER 1 
GENERAL INTRODUCTION 
 
1.1 Introduction 
The quality and quantity of nutritional intake harnesses many benefits for athletic 
populations. Nutritional strategies implemented prior to and during exercise can profoundly 
alter exercise performance and prolong endurance capacity. Further, effective post-exercise 
nutritional strategies can replenish depleted energy stores, attenuate indices of muscle 
damage and augment the recovery of endurance capacity and muscle function. In addition to 
exercise performance and recovery, dietary modifications can profoundly alter the adaptive 
response to exercise. Although the major perturbations to cellular homeostasis and muscle 
substrate stores occur during exercise, the activation of intracellular signalling pathways 
important for chronic training adaptations are thought to occur during the first few hours of 
recovery, (114, 209). This has led to suggestions that many chronic training adaptations are 
generated by the cumulative effects of the transient events that occur during recovery from 
each (acute) exercise bout. Evidence is accumulating to suggest that nutrient intake can serve 
as a potent modulator of many of the acute responses to exercise training.  
 
Protein, derived from the Greek word proteos, means primary or ‘most important’. In 
the sporting environment, protein nutrition was initially favoured by bodybuilders, but it now 
a common consideration for the majority of athletes. However, the effectiveness of protein 
nutrition for endurance athletes is yet to be fully elucidated. In combination with 
methodological limitations that cloud our understanding of how protein feeding can impact 
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endurance performance and recovery, very little is known regarding the influence of protein 
nutrition on the metabolic and molecular adaptations to endurance exercise. Thus, improving 
our understanding of how nutritional strategies can optimize the adaptive response to exercise 
could provide the knowledge necessary to allow athletes to successfully modify their training 
and dietary habits and achieve their competitive goals. In light of evidence to suggest that 
protein nutrition could be important for endurance athletes, chapters in this thesis detail 
studies that have focussed on determining the effects of protein nutrition on endurance 
performance, indices of recovery and metabolic and cellular adaptations to endurance 
exercise. 
 
Beyond athletic performance, lifestyle interventions such as exercise training and 
dietary manipulations have the potential to prevent or delay the incidence of metabolic 
disorders. Skeletal muscle mass accounts for ~50% of total body mass. Accordingly, skeletal 
muscle is a substantial contributor to basal metabolic rate (135). Furthermore, skeletal muscle 
represents the prime storage depot for body amino acids and is a critical metabolic tissue 
involved in glucose disposal and lipid oxidation, particularly during periods of exercise (2, 
176, 274). As such, maintaining a large and metabolically active skeletal muscle mass 
through exercise, has some influence on the risk for metabolic disorders (e.g., Type II 
diabetes) as well as all-cause mortality in a variety of diseased states (274). Indeed it is 
known that a single bout of resistance exercise can improve glucose tolerance and insulin 
sensitivity for up to 48 hours post-exercise in humans (176, 205). At the level of skeletal 
muscle, the mechanisms facilitating this response are not fully understood. 
 
In addition to contractile stimuli, nutritional modifications can be used to fulfil several 
distinct roles in the treatment of metabolic disorders, for example, by increasing weight-loss 
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and lowering glucose concentrations. Besides the application of energy restricted diets, it has 
been suggested that specific food components can be applied to directly modulate glycemic 
control. In this regard, cell culture and animal studies elegantly show that protein and/or 
branched chain amino acids can promote skeletal muscle glucose uptake (and removal from 
the circulation) via the activation of insulin-dependent and insulin-independent signalling 
pathways. In the absence of clear evidence in humans, that exercise and protein nutrition can 
improve metabolic health parameters, chapters in this thesis will also focus on examining the 
response of glucose metabolism to an acute bout of resistance exercise-alone or resistance 
exercise with protein feeding.  
 
1.1.1  Metabolic basis of exercise training adaptations 
Skeletal muscle is a malleable tissue capable of altering the type and amount of protein 
in response to disruptions to cellular homeostasis. The complex process of exercise-induced 
adaptation in skeletal muscle involves specific signalling mechanisms initiating replication of 
DNA genetic sequences (151) that enable subsequent translation of the genetic code into a 
series of amino acids to create new proteins (31). Skeletal muscles sense and distinguish 
contraction-specific signals to produce adaptations over time that are specific to the nature, 
intensity and duration of exercise (129, 167). However, it is thought that there is substantial 
overlap in the molecular response to different exercise modes (156). Contraction generates 
transient increases in the quantity of messenger RNA (mRNA) that for a multitude of genes 
typically peaks within 12 hours post-exercise and returns to basal levels within 24 hours (21, 
209, 275). This directional change in mRNA is generally the same as the encoded protein 
during adaptation to a new steady-state level (30). Thus, contractile stimuli acutely increase 
transcriptional activity and the subsequent synthesis of new proteins and may be potentiated 
when appropriate nutrient strategies are implemented post-exercise. In summary, chronic 
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adaptations to training are thought to represent the summation of each discrete exercise bout, 
with these perturbations leading to cumulative alterations in gene and protein expression and 
ultimately distinct phenotypic changes (112, 167). 
 
However, the ability to infer phenotypic changes in skeletal muscle from ‘snapshots’ of 
gene expression is complicated by the fact that multiple factors may be involved in the 
translation of mRNA species that can ultimately affect the expression of their protein 
products such as, for example, the post-transcriptional modification or stability (via action of 
chaperone proteins and RNAses) of mRNA transcripts and/or their translational regulation by 
other molecules such as microRNAs (271). In the absence of measured changes in protein 
abundance and/or the direct synthesis of their protein product it may be difficult to 
conclusively ascertain the functional outcome of changes in gene transcription.  
 
1.1.2 Protein metabolism in skeletal muscle tissue 
Skeletal muscle proteins are constantly and simultaneously synthesized and degraded. 
Net protein balance is defined as the difference between muscle protein synthesis and muscle 
protein breakdown. Thus, a significant rise in skeletal muscle protein synthesis (anabolism) 
and/or a reduction in muscle protein breakdown (catabolism), such that net protein balance 
remains positive can result in the accretion of skeletal muscle proteins. Conversely, a 
negative net protein balance, arising from a reduction in synthesis and/or increase in 
breakdown, will result in a loss of skeletal muscle proteins. Net protein balance is maintained 
by ingestion of protein-containing meals which results in systemic hyperaminoacidemia that 
is stimulatory for the synthesis of new proteins (18, 27, 28, 83). Therefore, in persons with 
consistent dietary habits who are not performing exercise, skeletal muscle protein mass 
remains relatively stable. However, the feeding-induced stimulation of muscle protein 
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synthesis is only transient and even in the face of available amino acids returns to basal levels 
(28). Exercise stimuli, aerobic and more so resistive, improve net protein balance. However, 
the ingestion of protein during post-exercise recovery is necessary to shift net protein balance 
in favour of muscle protein accumulation (23, 218). Thus, feeding and exercise must be 
utilized concurrently to manifest a positive net protein balance and increase protein mass 
when performed habitually. 
 
In healthy individuals, changes in the rate of muscle protein synthesis are thought to 
represent the primary locus of control for regulating overall muscle protein balance (218). 
Evidence to support this contention is based on the following observations: i) the transition 
from the fasted to the fed state is associated with a 60-80% stimulation of muscle protein 
synthesis with no measurable change in breakdown (23, 260, 262); ii) the acute (i.e. 3 hours) 
feeding and exercise-induced increase in net protein balance is due primarily to changes in 
muscle protein synthesis and is additive to the daily net protein balance (242); iii) the acute 
change in muscle protein synthesis is qualitatively predictive of long term changes in muscle 
mass in response to both hypertrophic (i.e., resistance training) (82, 110, 116, 157, 268) and 
atrophic (i.e., immobilization) stimuli (94). 
 
 
1.1.3 Intracellular signalling mechanisms regulating protein metabolism  
Acute changes in muscle protein synthesis are regulated at the level of mRNA 
translation of which the primary rate controlling step is the initiation and formation of a 
translation-competent ribosome (147). The first stage of mRNA translation involves charging 
of initiator methionyl-tRNA, which is catalyzed by the guanine nucleotide exchange activity 
of the ε-subunit of eukaryotic initiation factor (eIF) 2B (eIF2Bε) and its subsequent 
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association with eIF2. This ternary structure then binds to the 40S ribosomal subunit to form 
the 43S pre-initiation complex. Following this, hyperphosphorylation of the negative 
regulator 4E-binding protein 1 (4E-BP1) results in its release of eIF4E, which is then 
permitted to bind to the mRNA and form the heterotrimeric eIF4F-mRNA complex. The 
eIF4F-mRNA complex then combines with the 43S pre-initiation complex to form the 48S 
pre-initiation complex, which subsequently binds to the 60S ribosomal subunit to form a 
translationally competent ribosome. Although initiation is the primary regulated step in 
mRNA translation, peptide chain elongation consumes the vast majority of energy during 
protein synthesis and also represents another level of control for the synthesis of proteins in 
vivo (263). The translocation of the ribosome along mRNA is catalyzed by eukaryotic 
elongation factor 2 (eEF2), which is negatively regulated by phosphorylation that is catalyzed 
by eEF2 kinase. Of particular importance to the regulation of protein synthesis appears to be 
the mTOR-mediated activation of p70S6K, which phosphorylates both eIF4B, to enhance the 
helicase activity of eIF4F complex and eEF2 kinase. Furthermore, hyperphosphorylation of 
p70S6K and downstream target ribosomal protein (rp) S6 facilitates translation initiation by 
increasing the affinity of ribosomes for binding 5’terminal oligopyridimine (5’TOP) mRNAs 
(131). Thus, p70S6K plays a role in both the initiation and elongation stages of mRNA 
translation (213). The signalling mechanisms regulating skeletal muscle protein synthesis are 
presented in Figure 1.1. 
 
1.2 Influence of nutrition on muscle protein synthesis  
 
Skeletal muscle is a heterogeneous tissue, composed of a variety of different proteins 
with distinct functions. From the standpoint of overall muscle mass and quality, the most 
important protein fraction within skeletal muscle is myofibrillar, which is composed 
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primarily of the contractile proteins actin and myosin. However, skeletal muscle contains 
many non-myofibrillar proteins and organelles (e.g., mitochondria, sarco- and endoplasmic 
reticula, ribosomal proteins, etc.) that are found within the cytoplasm of the muscle cell and 
therefore are collectively referred to as sarcoplasmic proteins. Mitochondrial proteins are 
involved in energy production and sarcoplasmic proteins contribute to anaerobic energy 
production, intracellular transport and numerous other functions. In addition, the external 
support lattice of muscle cells is comprised primarily of both fibrillar and non-fibrillar 
collagen protein. The majority of studies investigating the effects of nutrients on muscle 
protein synthesis measure changes in a mixed muscle protein fraction. This practice has 
provided the framework for our basic knowledge of how muscle responds to feeding but has 
the obvious disadvantage of representing an average synthetic rate of all muscle proteins. 
Measurement of the mixed muscle protein synthetic rate could mask potentially important 
physiological differences within specific muscle protein fractions. Therefore, the following 
sections of this chapter will discuss the changes in the synthesis of mixed muscle and specific 
muscle fractions in response to feeding. 
 
1.2.1  Fate of dietary amino acids 
A substantial portion (up to ~80% for some) of dietary amino acids absorbed by the 
small intestines, are subsequently catabolized or utilized for the synthesis of constitutive 
hepatic and secreted proteins within gut tissues, with the balance being transported to the 
liver to encounter a similar metabolic fate (174, 216). In addition to the synthesis of 
constitutive hepatic and exported proteins (especially albumin (61)), dietary amino acids can 
also be converted into glucose by the liver to provide a source of energy for other body 
tissues such as, for example, the brain. Because of its high turnover rate and large metabolic 
capacity, this first-pass splanchnic extraction, which includes both gut and liver metabolism, 
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represents a means for contending with large fluctuations in peripheral blood amino acid 
concentrations following ingestion of large protein containing meals (174). However, in order 
to support the synthesis of other body proteins there must be a net efflux of amino acids from 
the liver into the peripheral circulation. These amino acids bypass first-pass extraction and 
provide the substrates for the synthesis of a wide variety of body proteins, arguably the most 
important of which, based on their role in locomotion and amino acid storage as well as their 
collective contribution to whole body substrate metabolism, are skeletal muscle proteins. 
Dietary amino acids transported from the circulation into the skeletal muscle enter the free 
pool of amino acids whereby they can stimulate and support the synthesis of new muscle 
proteins. In addition to their roles as substrates for muscle protein synthesis, amino acids can 
also be deaminated and converted into a source of metabolic fuel for muscle and other tissues 
of the body. This process occurs either directly via the production of tricarboxylic acid (TCA) 
cycle intermediates, or indirectly via the production of precursors for hepatic 
gluconeogenesis. Under conditions in which the delivery of dietary amino acids to the muscle 
and other body tissue exceeds their ability to be incorporated into new proteins there is a 
marked increase in amino acid catabolism (179). Therefore, it is apparent that, in addition to 
the well defined role of stimulating and supporting muscle protein synthesis, the disposal of 
dietary amino acids can also occur through other metabolic pathways within different tissues 
of the body.  
 
1.2.2  Muscle protein synthesis after feeding  
It has been well established that the transition from a fasted to fed state is characterized 
by the inward transport of amino acids into skeletal muscle and a marked increase in the 
synthesis of muscle proteins (22, 217). The feeding-induced stimulation of protein synthesis, 
which is consistent across different muscles and fibre types (41, 180), functions to restore the 
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obligatory losses of muscle protein that occur during the fasting so that on a day-to-day basis 
muscle mass is maintained. The primary stimulatory effect of feeding arises almost 
exclusively from the presence of the essential amino acids (236, 244, 261), in particular the 
branched chain amino acid leucine (235). There is evidence to indicate that insulin can 
enhance the synthesis of muscle proteins when administered alone (89) or in the presence of a 
sub-optimal level of amino acids (i.e., a level below which protein synthesis is maximally 
stimulated) (99). The mechanism by which insulin facilitates the protein synthetic response in 
this situation is not direct but likely occurs via the enhanced delivery of nutrients to the 
muscle, secondary to an insulin-induced vasodilation and capillary recruitment (51, 85). With 
the provision of an optimal level of exogenous amino acids it appears that only basal insulin 
concentrations are required to allow the full stimulation of muscle protein synthesis (95, 99). 
These data suggest the role of insulin in healthy individuals is permissive rather than 
stimulatory for the anabolic effect of amino acids. However, in the absence of amino acids 
the role of post-prandial insulin concentrations for muscle anabolism may be more important 
(89). Thus, the meal-induced stimulation of muscle protein synthesis is primarily regulated by 
the presence of dietary amino acids. 
 
Muscle protein synthesis is rapidly (i.e. within 30-90 min) increased in response to a 
physiological increase in plasma amino acids (10, 28, 83). Interestingly, the stimulation of 
muscle protein synthesis during a constant infusion of amino acids subsides after ~3 hours 
despite the presence of a persistent hyperaminoacidemia (28). The presence of a refractory 
period for protein synthesis (28) combined with the observation that the synthesis of mixed 
muscle proteins is regulated by the extracellular rather than intracellular concentration of 
amino acids (27), suggests that muscle protein synthesis may be stimulated primarily by the 
acute change in plasma amino acid concentration in response to amino acid ingestion. 
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Subsequent studies have established that mixed muscle protein synthesis is rapidly stimulated 
after the ingestion of dietary amino acids (83). Furthermore, recent studies have begun to 
describe the temporal changes in the synthesis of specific muscle protein fractions after the 
ingestion of physiological protein ingestion (10, 181) and intravenous infusion of mixed 
amino acids (28). 
 
1.2.3  Synthetic response of different protein fractions after feeding  
It is thought that myofibrillar proteins are the prime storage depot for amino acids in the 
body. This notion is supported by evidence that during periods of reduced amino acid 
availability, myofibrillar proteins are preferentially targeted for degradation (272). Thus, in 
order to maintain muscle mass, protein feeding must stimulate the synthesis of myofibrillar 
proteins to counteract fasted-state losses. In spite of the critical role myofibrillar proteins play 
in amino acid storage, few studies have examined the response of myofibrillar proteins to 
alterations in nutrient status. Work by Bohé and colleagues (27, 28) showed that myofibrillar 
proteins display similar sensitivity to a mixed muscle protein fraction during the provision of 
amino acids, with regard to the magnitude and duration of synthesis. This is not surprising 
considering that myofibrillar protein accounts for ~60-65% of all skeletal muscle protein and 
would contribute substantially to rates of mixed muscle protein synthesis. However, it should 
be noted that early studies examining the response of myofibrillar protein synthesis to protein 
feeding infused amino acids intravenously, an approach which may not adequately describe a 
physiological situation in which amino acids are ingested orally. More recent studies 
demonstrate a similar amplitude and duration of myofibrillar and sarcoplasmic protein 
synthesis in response to physiological whey protein ingestion (10, 181). These data are in 
contrast to previous studies reporting that sarcoplasmic proteins are less sensitive to nutrient 
availability than myofibrillar proteins (59, 180). Accepting that muscle protein synthesis is 
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regulated by acute changes in extracellular amino acid concentration (27), it is possible that a 
bolus ingestion of 25g (181) and 48g (10) of protein supplied in these studies, enhanced the 
sensitivity of sarcoplasmic proteins to nutrients, as a result of a greater physiological increase 
in extracellular amino acid concentration compared with oral ingestion of 10g of crystalline 
amino acids (59), or a sustained infusion of amino acids (180).  
 
Sarcoplasmic proteins, in which mitochondrial proteins are included, are thought to be 
less sensitive to nutrient availability than myofibrillar proteins (59, 180). Differences in the 
nutrient sensitivity of the two protein fractions has been hypothesized to represent a 
mechanism muscle composition to ensure that and the relative amount of myofibrillar and 
sarcoplasmic proteins are maintained, despite differences in the rates of turnover (14, 59, 
180). Due to technical limitations, changes in mitochondrial protein synthesis rates in 
response to the ingestion of a physiological dose of protein have not been well characterized. 
However, Bohé et al. (27, 28) showed the synthetic response of myofibrillar, sarcoplasmic 
and mitochondrial proteins were similar in magnitude and duration following an amino acid 
infusion. In union with the findings of Moore et al. (181), these data imply that an accelerated 
increase in plasma amino acid concentration, typically found after the ingestion of rapidly 
digested protein such as whey, might maximize the synthesis of sarcoplasmic and 
mitochondrial proteins to match that of the myofibrillar fraction. Thus, to advance our 
understanding of how non-myofibrillar proteins respond to nutrients it would be valuable to 
characterize changes in the synthesis of mitochondrial muscle proteins to physiological 
nutrient ingestion. Further to this suggestion, Moore et al. (181) recently showed the 
combined effect of resistance exercise and whey protein feeding potentiated the synthetic 
response of myofibrillar proteins. Thus, the synergistic effect of nutrient and contractile 
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Figure 1.1 A simplified schematic representation of the intracellular signalling mechanisms 
controlling skeletal muscle protein synthesis by amino acids and insulin. Proteins have been 
labelled to designate them as positive (green) or negative (red) regulators of mTOR and muscle 
protein synthesis.  
stimuli may be important for the synthesis of specific protein fractions and remains to be 
fully elucidated.  
 
 
 
1.2.4  Intracellular signalling response to feeding  
Considerable advances have been made toward improving our understanding of the 
intracellular signalling events that contribute to the activation and regulation of mRNA 
translation in skeletal muscle. Of critical importance to the activation of muscle protein 
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synthesis with nutrient ingestion appears to be proteins within the mTOR signalling cascade. 
For example, the feeding-induced increase in human skeletal muscle protein synthesis is 
accompanied by an increase in the phosphorylation of mTOR and its downstream effectors 
involved in mRNA translation initiation (p70S6K, 4E-BP1) and elongation (eEF2) (10, 60, 
83, 93, 103, 234). The association between these signals and muscle protein synthesis was 
recently brought to light by Atherton and colleagues (10), who demonstrated that the 
‘upswing’ in muscle protein synthesis following amino acid ingestion is echoed in the 
phosphorylation of several intermediates in the mTOR signalling pathway. 
 
Although studies investigating the effect of amino acid feeding on intracellular 
signalling in humans typically provide additional carbohydrates that would enhance insulin-
stimulated phosphorylation of mTOR by its upstream kinase Akt (83, 99), amino acids have 
been shown to activate mTOR in vivo directly with only a basal requirement for insulin (105, 
119, 263). It has recently been shown that during the constant provision of amino acids, 
signalling molecule phosphorylation upstream and downstream of mTOR is enhanced by the 
presence of insulin (73, 119). However, despite the incremental activation (evidenced by 
greater phosphorylation) of signalling proteins in the mTOR cascade with graded insulin 
concentration, there was no concomitant elevation of muscle protein synthesis (119). These 
data suggest that a minimum level of phosphorylation is required to activate the signalling 
proteins involved in the regulation of mRNA translation with nutrients, after which, 
additional activation of the mTOR pathway, such as with hyperinsulinemia, fails to stimulate 
protein synthesis further. While most feeding studies in humans have investigated the role of 
the insulin phosphatidylinositol 3-kinase (PI3K) pathway in the activation of mTOR (73, 83, 
93, 119), there is mounting evidence from cell culture studies indicating that amino acids can 
activate mTOR independent of insulin via a class of regulatory GTPase proteins (280) as well 
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as the type III PI3K vacuole protein sorting-34 (hVps34) (146); these pathways may 
represent a mechanism by which mTOR signalling molecule phosphorylation is enhanced by 
dietary amino acids in humans in the absence of hyperinsulinemia (59, 100, 163). 
Alternatively, the dephosphorylation of a novel and as yet unexplored in humans, site on the 
guanine nucleotide exchange factor eIF2B by amino acids has been shown to occur 
independently of mTOR activation in vitro (264). Finally, the role of 4E-BP1 in negatively 
regulating protein synthesis may be called into question based on the recent observation that 
over-expression of this protein in cultured cardiomyocytes has no effect on the rapamycin 
sensitive stimulation of global protein synthesis (123). Collectively, these data demonstrate 
the complexity regulation of mRNA translation and highlight the potential for multiple 
pathways for the activation of muscle protein synthesis with feeding in humans. 
 
1.3  Metabolic and cellular adaptations to endurance exercise and 
nutrition For competitive endurance athletes, the desired outcome of an endurance 
training regimen is to increase the ability to sustain a desired power output or speed of 
movement over a given time. Therefore, training for enhancement of endurance performance 
should aim to induce a myriad of physiological and metabolic adaptations that enable the 
athlete to: i) increase the rate of energy production from both aerobic and oxygen-
independent pathways; ii) maintain tighter metabolic control (i.e. match ATP production with 
ATP hydrolysis); iii) minimize cellular disturbances; iv) increase economy of motion; and v) 
improve the resistance of the working muscles to fatigue during exercise. Key components of 
a training regimen are the duration, intensity, total volume and the frequency with which 
training sessions are conducted. The sum of these inputs can be termed the ‘training stimulus’ 
(12). When exercise training persists over an extended period of time, ‘chronic’ adaptations 
occur. Although chronic adaptations in skeletal muscle are thought to result from the 
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cumulative effect of repeated bouts of exercise, the initial signalling responses that lead to 
these chronic adaptations are likely to occur after each training session (266). It has been 
established that the process of converting a mechanical signal generated during contraction to 
a molecular event that promotes skeletal muscle adaptation, involves the up-regulation of 
primary and secondary messengers that initiate a cascade of events that result in activation 
and/or repression of intracellular signalling pathways regulating exercise-induced gene 
expression and protein synthesis and breakdown (270).  
 
The extent to which acutely altering substrate availability might modify the training 
impulse has been a key research area among exercise physiologists and sport nutritionists for 
a number of years. Altering substrate availability affects not only resting energy metabolism 
and subsequent fuel utilization during exercise, but also the regulatory processes underlying 
gene expression (7, 109). To bring about such modifications, a number of highly coordinated 
processes occur, including gene transcription, RNA transport from the nucleus, protein 
synthesis and, in some cases, post-translational modification of the protein. 
 
1.3.1  Endurance exercise adaptations 
 Prolonged endurance training elicits a variety of metabolic and morphological 
adaptations. These include; fast-to-slow fibre-type transformation (278), glycogen sparing 
effects due to alterations in substrate metabolism (115), enhanced lactate kinetics and 
increased mitochondrial density (125). Moreover, repeated bouts of endurance exercise alter 
the expression of a host of gene products that promote adaptation toward a fatigue resistant 
phenotype (3). Mitochondria are the main sub-cellular structures that determine the oxidative 
capacity and fatigue resistance to prolonged contractile activity in skeletal muscle (118). 
Endurance training has been shown to increase mitochondrial protein content by 50–100% 
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within ≈6 weeks, but a protein turnover half-life of ≈1 week means a continuous training 
stimulus is required to maintain elevated mitochondrial content (278). While enhanced 
oxygen kinetics, substrate transport and buffering capacity all contribute to enhanced 
endurance capability in skeletal muscle, improved endurance is due primarily to increased 
mitochondrial density and enzyme activity termed ‘mitochondrial biogenesis’. 
 
1.3.2  Muscle protein metabolism after endurance exercise 
Measurement of mixed muscle protein synthesis in skeletal muscle represents a 
weighted average of the rates of synthesis of all proteins in the muscle, i.e. it does not 
distinguish the response of different proteins constituting the mixed fraction. Intuitively, 
given the divergent adaptive response to different types of training, it is safe to assume that 
resistance and endurance exercise should differentially influence distinct protein fractions. At 
present, relatively few studies have investigated the impact of endurance exercise on muscle 
protein turnover. This may be related to the general observation that endurance exercise does 
not typically result in significant gains in muscle mass. However, changes in muscle protein 
synthesis following endurance exercise are relevant for tissue repair and remodelling as well 
as changes in synthesis of non-contractile proteins (i.e. mitochondrial proteins) (35). 
Currently, differences in exercise mode and intensity utilized in previous studies, cloud our 
understanding of the protein synthetic response to endurance exercise (40, 178, 243).  
 
It has been well documented that aerobic exercise increases whole-body (39) and mixed 
muscle protein synthesis le (40, 106-108, 178, 243) (Table 1.1). Initial studies examining the 
acute response of muscle proteins to aerobic exercise established that low load treadmill 
exercise (at 40% V&O2max) stimulated an increase in muscle protein synthesis in untrained 
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subjects (40, 231). Although non-significant, Tipton et al. (243) also demonstrated that high 
intensity swimming increased muscle protein synthesis by ~40% in trained female swimmers. 
Studies investigating the protein synthetic response to endurance exercise have thus far 
yielded variable results which may be related to the muscle studied, the mode/intensity of 
exercise, or participant training status. Certainly, the latter may have considerable influence 
as it has been shown chronic endurance training increases basal rates of skeletal muscle 
protein turnover (208, 231). With regard to the synthesis of specific muscle protein fractions, 
Miller et al. (178) reported that a unique, one-legged kicking model of endurance exercise 
increased the synthesis of sarcoplasmic and myofibrillar proteins for 48 and 72 hours post-
exercise, respectively. Endurance exercise, however, is not commonly characterized by 
skeletal muscle hypertrophy as would be expected with such a robust increase in myofibrillar 
protein synthesis. Therefore, the “aerobic” nature of this exercise model may be more 
appropriately labelled a low-intensity resistive type exercise. However, a recent study by 
Wilkinson et al. (267) examined the synthetic response of myofibrillar and mitochondrial 
proteins following single-leg cycling for 45 min (75% V&O2max) in both the untrained and 
trained state. Following the cycle, a robust increase in mitochondrial protein synthesis 
occurred regardless of training status (267). Thus, mitochondrial and to a lesser extent 
sarcoplasmic proteins are the primary proteins contributing to the increase in mixed muscle 
protein synthesis after endurance exercise, potentially to counteract the suppression of muscle 
protein synthesis that occurs during endurance exercise (40). Whether this marked synthetic 
response of mitochondrial proteins can be enhanced with post-exercise nutrient provision 
remains to be elucidated. 
 
In addition to muscle protein synthesis, muscle protein breakdown is also elevated 
following acute endurance exercise (231), whilst resting rates of breakdown increase 
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following long-term endurance training (208). Direct measurement of muscle protein 
breakdown with endurance exercise is rare and the results somewhat equivocal (74, 84, 231). 
Using arteriovenous blood sampling, other investigators have demonstrated that whole-body 
protein breakdown is transiently elevated after moderate intensity walking exercise, 
compared with rest (231), but others report no change following exercise (243). These studies 
utilized moderate to low-intensity exercise, rather than high intensity exercise. However, 
studies of high-intensity endurance exercise have reported an increase in indirect markers of 
muscle protein breakdown including 3-methyl-histidine excretion (40) and net amino acid 
efflux from the leg (26, 253) during exercise.  
 
1.3.3  Intracellular signalling response to endurance exercise  
Expansion of skeletal muscle aerobic capacity is determined by changes in 
mitochondrial protein content, observed after as little as 6-7 training sessions in humans (90). 
Adaptation of mitochondrial protein content in skeletal muscle is highly complex and 
involves the coordinated expression of a number molecular targets (125), the vast majority of 
which are located in the nucleus (96). Thus, an important aspect of mitochondrial biogenesis 
is the transport of nuclear precursor proteins into the organelle (125). Critical to the 
expression of genes promoting mitochondrial biogenesis are the principles of gene regulation; 
transcription initiation and interaction at the gene promoter (125). Mitochondrial biogenesis 
with repeated endurance training stems from an increase in the activity of transcriptional 
complexes that contain PPAR γ co-activator (PGC1α). A seminal study by Pilegaard et al. 
(210) showed that acute endurance exercise increases the transcription and mRNA content of 
PGC1α, an effect that is further potentiated after repeated training bouts. 
Recently, control of mitochondrial oxidative function has been linked to transcriptional 
control of PGC1α by mTOR (56), a critical protein implicated in the regulation of muscle 
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protein synthesis through translation initiation. In support of this hypothesis, others report 
that endurance exercise mediates the phosphorylation of proteins implicated in mRNA 
translation initiation (38, 175, 267) (i.e. mTOR) elongation (175) (i.e. eEF2). Quantitatively, 
it appears that there is little difference in the extent of the acute signalling responses of leg 
muscles working in different modes of exercise (38, 267). Thus, the notion that endurance 
and resistance training adaptations occur through divergent molecular signalling pathways in 
vitro (9, 49) may not accurately reflect the adaptive process in humans. These data suggest 
that any major increase in contractile activity or possibly fuel utilization in untrained muscle 
will result in the same global anabolic response. 
 
Skeletal muscle protein breakdown is primarily mediated through the ATP dependent 
ubiquitin-proteosome pathway (UPP), which degrades myofibrillar and sarcoplasmic proteins 
in concert with the calpain system (13, 92). Atrogin-1 and muscle specific RING finger 
protein-1 (MuRF-1) are the primary atrogenes of the UPP and are induced through FOXO 
signalling (92). These factors are acutely responsive to endurance exercise, presumably as 
part of the muscle remodelling process (106, 164). Although the role of these proteolytic 
factors in regulating exercise-induced protein breakdown is not well defined, recent evidence 
indicates the mRNA expression of MuRF-1, calpain-2, atrogin-1 and MRF4 are increased 
following high-intensity resistance (164, 275) and endurance exercise (108, 164, 275). 
 
In summary, endurance exercise elevates mitochondrial protein synthesis via enhanced 
translational activity. Subsequent to this process, the activity of transcription factors and 
transcriptional co-activators is critical in the regulation of mitochondrial biogenesis. 
However, our current understanding of how translational and transcriptional processes act 
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synergistically to control mitochondrial biogenesis is limited and further studies are 
warranted.  
 
1.3.4  Muscle protein synthesis after post-endurance exercise feeding 
Currently, few studies have investigated the response of muscle protein synthesis to 
post-endurance exercise feeding. Levenhagen and colleagues (162) were the first to show that 
the ingestion of carbohydrate plus protein immediately after a 1 hour cycle (60% V&O2max), 
increased leg and whole-body protein synthesis; changes associated with a net protein gain. 
However, in the study of Levenhagen et al. (162) carbohydrate-only and carbohydrate plus 
protein beverages were not matched for energy intake, thus it was unclear whether the 
differences observed were due to the protein per se or differences in total energy intake. To 
remedy this, Howarth et al. (120) compared carbohydrate plus protein to carbohydrate-only 
beverages matched for total energy and carbohydrate content. In contrast to the single bolus 
feeding of Levenhagen et al. (162) beverages in this study were ingested at regular intervals 
during 3 hours of post-exercise (50-80% V&O2max) recovery. The authors demonstrated that 
carbohydrate plus protein increased mixed muscle protein synthesis compared with both 
carbohydrate treatments, without any significant rise in insulin concentration. Despite strong 
evidence that mixed muscle protein synthesis is stimulated by protein feeding rather than any 
change in insulin following endurance exercise, doubt has been raised by a recent study 
showing no additive effect of feeding on mixed muscle protein synthesis following a 1 hour 
cycle (~72% V&O2max) (108). However, the authors (108) measured muscle protein synthesis at 
2-6 hours post-exercise, 1 hour after feeding had occurred. Thus, the peak anabolic response 
to exercise and feeding may have occurred earlier than was measured concealing any 
potential difference (157, 268). Importantly, none of these studies (108, 120, 162) have 
attempted to resolve the specific protein fractions contributing to changes in mixed muscle 
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protein synthesis. Furthermore, it is possible that the measure of mixed muscle protein 
synthesis may not be sensitive enough to reflect changes in the synthesis of specific proteins 
(108). Recently, Moore et al. (181) demonstrated that the synergism of protein ingestion and 
resistance exercise augmented myofibrillar protein synthesis. Thus, it seems that protein 
nutrition is more than merely a substrate, but instead is an input into a system that affects 
phenotype due to the influence it exerts in regulating muscle protein synthesis. These data 
have led Howarth et al. (120) to suggest that the increase in mixed muscle protein synthesis 
with protein ingestion following endurance exercise could be due, in large part, to an increase 
in the synthesis of mitochondrial proteins. To date, this thesis has yet to be confirmed. A 
summary of studies investigating the effect of a single bout of endurance exercise on protein 
metabolism are presented in Table 1.1. 
 
1.3.5  Intracellular signalling response to post-endurance exercise feeding 
Despite the permissive role of insulin on muscle protein synthesis, it has been 
suggested that elevated plasma insulin levels are required to fully activate the translation of 
mRNA, initiated following endurance exercise (158). The suggestion is that insulin activates 
mTOR, via an upstream pathway involving PI3K and Akt (72, 147). Interestingly, relatively 
new findings from cell culture and drosophila experiments demonstrate that essential amino 
acids can directly stimulate mTOR via hVps34 (36) as well as through the Ste20 protein 
kinase, MAP4K3 (78). A family of small GTPases known as Rag proteins may also be 
important in promoting the intracellular localization of mTOR towards Rheb during amino 
acid stimulation, though this has only been observed in human embryonic kidney cell cultures 
to date (221). In summary, these data suggest that insulin and amino acids act independently 
to regulate mTOR. However, following carbohydrate plus protein feeding, amino acid-
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induced mTOR activation appears to be crucial for increasing protein synthesis as opposed to 
the rise in insulin concentration (5, 6). 
 
Relatively few studies have investigated the response of intracellular signalling to 
carbohydrate plus protein feeding following endurance exercise. Ivy et al. (126) compared the 
intracellular signalling response to carbohydrate plus protein feeding ingested over 45 
minutes after a 1 hour variable intensity cycle. The authors demonstrated that carbohydrate 
plus protein activated mTOR and rpS6 compared with a non-energetic placebo. However, the 
study design of Ivy et al. (126) did not investigate the response of protein or carbohydrate 
feeding alone. Thus the authors could not say with any certainty whether the effects of the 
drink on intracellular signalling were due to the greater amino acid availability, elevated 
plasma insulin, or a combination of the two. The same research group, (186) had earlier 
conducted a more rigorous experiment in which they showed that ingesting carbohydrate or 
protein after exhaustive exercise transiently increased the phosphorylation of mTOR, 4E-
BP1, rpS6 and p70S6K in rats. However, the phosphorylation of rpS6 and 4E-BP1 was 
sustained when carbohydrate and protein were co-ingested. Taken together, these data 
demonstrate that feeding either carbohydrate or protein alone following intense endurance 
exercise increases the phosphorylation of proteins implicated in translation initiation, but not 
to the extent of carbohydrate and protein provided together. On the other hand, recent 
evidence indicates that increasing levels of circulating insulin in the post-endurance exercise 
period through feeding interventions, may suppress the phosphorylation of proxy markers of 
muscle proteolysis (108). However, in the absence of muscle protein turnover data to support 
the intracellular signalling response, it difficult to make definitive conclusions regarding the 
precise role of post-endurance exercise nutrient ingestion on muscle protein breakdown.  
                  
 
 
 
Study 
 
Endurance 
protocol 
 
Exercise 
duration  
 
Subject training 
status 
 
 
Protein 
synthesis 
 
 
Protein 
breakdown 
 
 
Intracellular 
signalling 
 
Carraro et al. 1990 
(40) 
 
 
40% VO2max 
 
4 hours 
 
Healthy young males 
 
•  96% ↑ in mixed MPS ** 
 
• 85% ↑  in  3MH post-ex 
*  
 
 
N/A 
Tipton et al. 1996 
(243) 
 
~85-90% HRmax ~1.5 hours Trained female 
swimmers 
•  41% ↑ in mixed MPS 
 
 
• ↔  in  WBPB at 3 h 
post-ex 
N/A 
 
Sheffield-Moore et al. 
2004 (231) 
 
40% VO2max 45 min Untrained elderly and 
young males 
•  ~ 65-75% ↑ in mixed 
MPS * 
• ↑ in  WBPB at 10 min   
post-ex * 
N/A 
Miller et al. 2005 
(178)  
 
~67% Wmax 
 
1 hour Healthy young males •  52% ↑ in SARC MPS * 
•  70% ↑ in MYO MPS * 
  
N/A N/A 
Mascher et al. 2007 
(175) 
75% VO2max 1 hour 
 
Healthy young males N/A N/A • ↑ Akt, mTOR, 
p70S6K, AMPK, 
• ↓ eEF2 * 
 
Ivy et al. 2008 (126) 
 
40-90%  VO2max 1 hour Healthy young males N/A N/A • ↑ rpS6, p70S6K * 
Wilkinson et al. 2008 
(267) 
 
75% VO2max 45 min 
 
Healthy young males •  ↑ Mitochondrial MPS * N/A • ↑ mTOR, p70S6K, 
FAK, eIF4E, AMPK 
* 
Harber et al. 2010 
(108) 
~72% VO2max 1 hour Healthy young males •  57% ↑ in mixed MPS * 
 
N/A •  ↑ MuRF-1, MRF4, 
calpain-2 * 
 
Harber et al. 2010 
(107) 
75%  VO2max 45 min Trained males •  ~37% in mixed MPS * 
 
N/A N/A 
Table 1.1 Comparison of studies examining muscle protein metabolism and intracellular signalling following endurance exercise 
V&O2max; maximal oxygen uptake, HRmax; maximum heart rate, Wmax; maximal work load, MPS; muscle protein synthesis, SARC; sarcoplasmic, 
MYO; myofibrillar, WBPB; whole-body protein breakdown, 3MH; 3-methyl histidine, MuRF-1; muscle specific RING finger-1, MRF4; muscle 
regulatory factor 4, post-ex: post-exercise, ↑; increase, ↓; decrease, ↔; no change, *; P < 0.05, **; P < 0.01. 
General Introduction  24 
 
 
1.4 Influence of protein nutrition on endurance performance and recovery 
 Nutritional strategies that improve performance and assist recovery are unique to each 
sporting event and individual. Although most athletes can satisfy their nutritional 
requirements before and/or after exercise, long-duration activities require that participants 
also address their nutritional needs during exercise. Endurance exercise promotes vast 
increases in energy utilization, with significant increases in carbohydrate and fat oxidation 
rates (32, 53). Sizeable losses of fluid and electrolytes from sweat may also occur, 
particularly during prolonged exercise in the heat (192). As a result, inadequate fluid and 
nutrient intake during endurance exercise can lead to dehydration, hyponatremia, glycogen 
depletion, hypoglycemia and impaired performance. In addition, nutritional deficiencies 
during prolonged activity may limit the capacity for rapid recovery after exercise, which may 
affect subsequent performance. Numerous studies have investigated nutritional approaches to 
minimize these issues, resulting in the emergence of strategies that elicit positive effects for 
endurance athletes. For endurance athletes, carbohydrate feeding is the most commonly used 
nutritional strategy. It is generally agreed that carbohydrate beverages are effective in 
promoting fluid balance and euglycemia and augmenting performance during prolonged 
endurance activities (50, 52, 133, 248). Typical guidelines suggest ingesting sports beverages 
with 4 - 8% carbohydrate at regular intervals during exercise to provide approximately 600 - 
1400 mL of fluid and 30 - 60 g of carbohydrate per hour (4, 50, 52). The traditional role of 
carbohydrate sports beverages has been to optimize performance by delaying dehydration and 
hypoglycemia and potentially influencing glycogen depletion and central fatigue. However, 
nutrient intake during prolonged exercise may also have important implications for recovery 
from exercise. 
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 Recent interest has centred on the use of protein nutrition in sports beverages for 
endurance athletes. Specifically, it has been suggested that the co-ingestion of carbohydrate 
with protein during exercise, improves endurance performance. Moreover, recent studies 
indicate that carbohydrate-protein co-ingestion during and following exercise may reduce 
indices of muscle damage, thus enhancing the recovery of subsequent performance and 
muscle function. 
 
1.4.1  Carbohydrate-protein co-ingestion for endurance exercise performance 
 Several studies have shown that carbohydrate plus protein ingestion can extend 
endurance time-to-exhaustion in the range of 13-36% (127, 222, 223). More recently, 
Saunders et al. (224) suggested the addition of protein to carbohydrate specifically improved 
late-exercise time-trial performance. However, a number of methodological differences 
between studies make it difficult to discern whether any benefits observed for carbohydrate 
plus protein are the result of a protein-mediated effect. 
 
 First, there are discrepancies in the way exercise performance has been assessed in 
previous studies. The ecological validity of exhaustive exercise protocols (used in (127, 222, 
223)) is limited, as endurance athletes do not compete in events that require sustaining a fixed 
power output for as long as possible. Further, exhaustive exercise tests display a large 
variation between repeated bouts of ~26% (132), which may be exacerbated in lesser trained 
participants (57). Moreover, claims that the addition of protein improves late-exercise 
performance were based on a time-trial protocol that was not specifically designed to record 
power output and measure late-stage exercise performance (224). On the contrary, time-trial 
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cycle tests have been found to be highly reproducible and sensitive to small changes in 
exercise performance (132, 160, 201). Secondly, additional energy consumed when protein is 
added to a carbohydrate containing beverage may explain the performance benefits observed 
by others. Indeed, studies in which endurance capacity was extended with additional protein, 
fed a carbohydrate dose that may have been too low (<50 g·hˉ1) to attain peak exogenous 
oxidation rates (134). Thus, if carbohydrate is consumed at a rate considered optimal for 
exogenous carbohydrate oxidation, the role of protein for improving endurance performance 
may be negligible (252). Finally, the control of external variables has varied greatly between 
previous studies. Knowledge of parameters including; i) time elapsed, ii) distance travelled 
and iii) heart-rate during exercise may compromise the blinding of treatments, creating a 
placebo effect. Early studies did not report the control of these conditions (127, 219, 222-224, 
251). In contrast, investigations that implement a strictly controlled exercise environment 
reported no effect of protein co-ingestion on time-trial performance (199, 252).  
 
In addition to methodological considerations, there is currently no plausible mechanism 
to explain the reported performance benefits when protein is added to a carbohydrate 
beverage. It has been suggested that the addition of protein to carbohydrate may enhance 
endurance performance through one or a combination of several putative mechanisms. These 
include;  i) altering substrate utilization in a glycogen depleted state (i.e. during late-exercise) 
(224); ii) offsetting the decline in TCA cycle intermediates during prolonged exercise iii) 
delaying the onset of central fatigue and iv) facilitating fuel transport via an increase in fluid 
absorption. Currently, the efficacy of adding protein to carbohydrate for endurance 
performance remains unclear. 
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1.4.2  Carbohydrate-protein co-ingestion for indirect markers of muscle damage and 
recovery 
The traditional role of carbohydrate feeding in close proximity to exercise has been to 
optimize performance by delaying dehydration and hypoglycemia as well as potentially 
influencing glycogen depletion and central fatigue. However, nutrient intake during 
prolonged exercise is thought to be effective in ameliorating indices of muscle damage, 
thought to impair the rate of recovery. Thus, a number of studies have reported that 
carbohydrate plus protein co-ingestion during and following endurance exercise improves 
several indices of recovery. Specifically, these studies demonstrate that the addition of 
protein to carbohydrate prolongs subsequent time-to-exhaustion in the range of 40-55% (222, 
233, 269). Others have found additional protein results in small increases in the recovery of 
muscle function, on the order of 1-2 knee extension lifts (251) and 1-2cm in vertical jump 
height (251). In contrast to these data, several studies failed to find improvements in recovery 
of subsequent performance, assessed using various methods (19, 98, 165, 177, 219). Thus, the 
impact of adding protein to carbohydrate on recovery from intense exercise is considered to 
be somewhat equivocal. 
 
Reductions in the concentration of proxy markers of muscle damage such as plasma 
creatine kinase (91, 165, 177, 219, 222, 223, 233, 251) and lactate dehydrogenase (165, 219) 
are thought to play a key role in aiding the recovery process when protein is added to 
carbohydrate. Moreover, several studies suggest that the addition of protein to a carbohydrate 
beverage may improve recovery through attenuating subjective ratings of muscle soreness 
(165, 177, 219, 233). However, evidence to support an effect of additional protein for 
improving recovery is inconsistent with several investigations finding no difference in the 
post-exercise rise in plasma creatine kinase (20, 98), muscle soreness (20, 177) and the 
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recovery of endurance capacity (19) when additional protein is ingested. Thus, although 
many endurance athletes now considered it a ‘necessity’ to consume protein following 
exercise, the efficacy of protein supplementation as a tool to improve recovery is unclear, due 
in large part, to the applicability of different recovery assessments to the athletic environment 
and a limited understanding of the mechanisms facilitating these purported improvements. A 
comparison of studies investigating the impact of carbohydrate-protein co-ingestion on 
endurance performance and indices of recovery is highlighted in Table 1.2. 
 
 
   
                 
 
 
Study 
 
Endurance 
protocol 
 
Beverages  
 
Timing 
 
CHO 
(g·h-1) 
 
PRO 
(g·h-1) 
 
Fluid  
(mL·h-1) 
 
 
Performance 
outcome 
 
Recovery 
outcome 
 
Ivy et al. 2003 (127) 
 
• TTE at 85% 
VO2max. 
 
CHO 
C+P 
 
 
During Ex 
 
45 
45 
 
- 
4 
 
600 
 
• 36% ↑ in TTE for C+P * 
 
 
N/A 
Saunders et al. 2004 
(222) 
• TTE at 75% VO2max 
• TTE at 85% VO2max 
12-15 h later 
 
CHO 
C+P 
During and 
immediately 
post-Ex 
37* 
37* 
- 
9* 
500* • 29% ↑ in 1st TTE for C+P 
* 
• 40% ↑ in 2nd TTE for C+P 
* 
• 83% ↓ in plasma CK for 
C+P * 
Romano-Ely et al. 
2006 (219) 
• TTE at 70% VO2max 
• TTE at 80% VO2max 
24 h later 
CHO 
C+P 
 
During and 
immediately 
post-Ex 
56 * 
45 * 
- 
11* 
560* 
 
 
 
None • 65% ↓ in CK for C+P * 
• 66% ↑ in MS for CHO * 
Luden et al. 2007 
(165)  
• 5km race after 6 
days of 
supplementation 
•  
CHO 
C+P 
 
Immediately 
post-training 
102* 
102* 
- 
26* 
1400* 
 
None • ↓ MS and CK for C+P * 
van-Essen & 
Gibala.2006 (252) 
 
• 20km cycle time-
trial 
CHO 
C+P 
During Ex 60 
60 
- 
20 
1000 None N/A 
Osterberg et al. 2008 
(199) 
• Pre-loaded cycle 
time-trial 
 
CHO 
C+P 
During Ex 60 
60 
- 
20 
1000 None N/A 
Valentine et al. 2008 
(251) 
• TTE at 75% VO2max CHO 
CHO 
C+P 
PLA 
 
During Ex 78 
100 
78 
- 
- 
- 
12 
- 
1000 • C+P and CHO ↑ TTE * 
• CHO TTE similar to PLA 
• ~20% ↑in LE for C+P * 
• ~50% ↓ in CK  for C+P 
* 
Saunders et al. 2007 
(223) 
 
• TTE at 75% VO2max CHO 
C+P 
During and 
immediately 
post-Ex 
 
41* 
41* 
- 
10* 
560* 
 
• 13% ↑ TTE for C+P * 
 
• ~45% ↑ in CK for CHO 
* 
Table 1.2 Comparison of studies examining endurance performance and recovery following carbohydrate-protein co-ingestion 
TTE; time-to-exhaustion test, V&O2max; maximal oxygen uptake, Ex; exercise, CHO; carbohydrate, PRO; protein, C+P; carbohydrate plus protein, PLA; 
placebo, *; average values based on 70kg adult, CK; plasma creatine kinase, MS: muscle soreness, LE; leg extension strength, *; P < 0.05. 
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1.5 Glucose metabolism in skeletal muscle  
Insulin stimulates the uptake of glucose from the circulation into many body tissues, of 
which, skeletal muscle accounts for ~75-80% of whole body insulin-stimulated glucose 
uptake (63, 232). Thus, skeletal muscle is considered as the primary tissue for regulating 
glucose homeostasis. At the cellular level, insulin stimulates glucose uptake into skeletal 
muscle by promoting glucose transporter protein (GLUT4) translocation to the cell 
membrane through the activation of an insulin-dependent signalling pathway.  
  
1.5.1  Intracellular regulation of glycemic control in skeletal muscle 
 Appropriate signalling through the insulin pathway is critical for the regulation of 
plasma glucose levels in skeletal muscle. The binding of insulin to its receptor leads to the 
tyrosine phosphorylation of the insulin receptor (IR), the insulin receptor substrate-1 (IRS-1) 
and hence, to the activation of PI3K. The activation of PI3K leads to the production of 
phosphatidylinositol-(3, 4, 5)-P3 (PIP3), a key secondary messenger, which recruits 3-
phosphoinositide-dependent protein kinase (PDK) to the plasma membrane (257). PI3K 
activity also induces the activation of downstream signalling intermediates; Akt and atypical 
protein kinase C (PKC) (257). In skeletal muscle, Akt mediates the insulin-stimulated 
inactivation of glycogen synthase kinase-3 (GSK3) by phosphorylation, thereby allowing 
glycogen synthase (GS) to become dephosphorylated and activated (55). Activation of PI3K 
is known to result in ribosomal protein S6 kinase (p70S6K) activation, a mechanism 
involving mTOR (212), which is inhibited by the blocking agent rapamycin. p70S6K can also 
be directly phosphorylated by PDK in a rapamycin-independent manner (11) and may play an 
important role in mediating GSK3, thus promoting the activation of glycogen synthase. The 
role of Akt in the regulation of insulin stimulated glucose transport is strengthened by the 
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recent discovery of AS160, a 160-kDa protein which is phosphorylated by Akt (140). AS160 
contains a GTPase activating domain for Rabs, which are small G proteins required for 
membrane trafficking (including GLUT4 translocation). It has been shown that pAS160 in rat 
skeletal muscle is rapidly increased when exposed to a physiological increase in insulin (34). 
Furthermore, insulin-stimulated phosphorylation of AS160 occurs in a PI3K-Akt-dependent 
manner (65, 141). 
 
1.5.2  Type II diabetes and insulin resistance 
The prevalence of diabetes mellitus has reached global epidemic proportions. It is 
predicted that by 2025, 300 million people will have diabetes (279). The majority of diabetic 
patients (over 90%) suffer from Type II diabetes, a progressive metabolic disorder with a 
slow and insidious onset. The incidence of Type II diabetes and associated metabolic 
conditions stems from societies adopting ever more sedentary lifestyles in the face of an 
excessive energy intake. Consequently, diabetes imparts major health consequences at both 
individual and public health levels (136). Although several pharmacologic approaches to the 
treatment of Type II diabetes are available, there is growing interest in developing non-
pharmacological interventions to improve glycemic control. Lifestyle interventions such as 
exercise and nutrition that delay, or even prevent, Type II diabetes have the potential to 
improve the health of the population and reduce the economic burden on healthcare services. 
 
The pathophysiology of Type II diabetes develops primarily from i) defects in skeletal 
muscle sensitivity to insulin ii) defects in liver sensitivity to insulin and iii) pancreatic β cell 
dysfunction. Collectively, these defects are referred to as the Triumvirate (64). Under normal 
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circumstances, insulin binds to insulin receptors on target organ cells, resulting in a series of 
cellular events that promote intracellular glucose transport and metabolism (206). Insulin 
resistance describes the diminished sensitivity of cells to the signalling effects of insulin. It is 
generally accepted that resistance to insulin in target tissues, primarily skeletal muscle, 
precedes the development of Type II diabetes (204). In insulin resistant states, the pancreas 
compensates by secreting increased amounts of insulin to maintain normoglycemia. This 
resistance is followed by a decrease in insulin secretion as a result of progressive pancreatic 
β-cell dysfunction, leading to the onset of overt diabetes with fasting hyperglycemia. 
Comprehensive discussion of the mechanisms underpinning insulin resistance in liver tissue 
and β cell dysfunction is beyond the scope of this thesis chapter. Instead, the interested reader 
is referred to the following literature (62, 64). Thus, in the current chapter, the mechanisms 
responsible for insulin resistance will be discussed within the context of skeletal muscle 
tissue. 
 
1.5.3  Mechanisms of insulin resistance in peripheral tissues 
The intracellular signalling defects underlying insulin resistance in skeletal muscle are 
now becoming apparent. Signalling defects at the level of the insulin receptor are unlikely to 
fully account for the impairments in glucose transport in skeletal muscle from Type II 
diabetic patients (46, 154). Downstream of the insulin receptor, impaired insulin-stimulated 
PI3K activity in skeletal muscle has been confirmed in studies of obese (154, 249) and Type 
II diabetic patients (58, 144, 145). Defects in insulin signalling at the level of IRS-1 and PI3K 
probably account for the impaired insulin action on PKC reported by others (17, 145). 
Current investigations regarding cellular defects at the level of Akt in insulin resistant states 
have yielded conflicting results (17, 145, 155). These discrepant findings are likely due to 
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fundamental differences in cell culture and human study models. Thus, a combination of 
relatively minor defects downstream of IRS phosphorylation may act synergistically to cause 
insulin resistance and impair glucose tolerance, defined as the ability of skeletal muscle and 
the liver to remove glucose from the circulation (137).  
 
Along with skeletal muscle, adipose tissue is also an important site for insulin-
stimulated glucose uptake (47). In addition to Type II diabetes, insulin resistance is also 
commonly associated with obesity, hypertension and cardiovascular disease. Many studies 
have revealed an association between increased lipid availability and insulin resistance, 
suggesting that there is a causative link between the two. Studies demonstrate that high-fat 
feeding is closely associated with the accumulation of intramuscular triacylglycerol (IMTG) 
(68, 143, 198, 237). Moreover, insulin resistance can occur through short term 
(physiologically relevant) increases in lipid availability. However, it appears unlikely that the 
IMTG accumulation per se directly impairs insulin action (33). This suggestion is further 
supported by the observation that endurance trained (highly insulin sensitive) individuals 
have elevated IMTG content. Instead, it is believed that intermediates in fatty acid 
metabolism, such as fatty acyl-CoA (198), ceramides (104) or diacylglycerol (DAG) (241) 
and an elevated inflammatory state, link obesity to compromised insulin signalling in the 
muscle. DAG is identified as a potential mediator of lipid-induced insulin resistance (113, 
214). Increased DAG levels are associated with PKC activation and a reduction in both 
insulin-stimulated IRS-1 tyrosine phosphorylation and PI3K activity (276). Recently, 
Newgard et al. (187) demonstrated the accumulation of a number of acylcarnitines in skeletal 
muscle of high-fat fed rats supplemented with additional branched chain amino acids 
(BCAA’s) compared with non-supplemented rats. Thus, in the context of high-fat 
consumption, supplementation of protein and/or amino acid may contribute to obesity-
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induced insulin resistance. The efficacy of protein ingestion on FFA metabolism during a 
period of reduced energy intake provides an interesting avenue for future studies. 
 
1.6  Influence of exercise on glucose homeostasis 
 Insulin resistance and Type II diabetes are strongly associated with a decline in physical 
inactivity (70, 153). However, despite the underlying metabolic and molecular defects the 
precipitate insulin resistance, skeletal muscle contraction can effectively restore glycemic 
control in a manner independent of insulin (111). Moreover, these properties are preserved in 
individuals with Type II diabetes (97, 142). Thus, at best, exercise represents an effective 
means of preventing insulin resistance and Type II diabetes, but perhaps more realistically, 
represents a means by which to attenuate the metabolic symptoms associated with these 
conditions. Long-term intervention studies (3-5 years) show that Type II diabetes ‘risk 
reduction’ is further reduced when physical activity is implemented in combination with 
dietary modifications (75, 202). More importantly, increased physical activity and reduced 
energy intake are associated with a greater reduction in the incidence of diabetes compared 
with pharmacological interventions such as metformin (a suppressor of endogenous glucose 
production) (250). 
 
1.6.1  Resistance exercise and glycemic control 
Physical inactivity induces a wide variety of changes in both whole-body functional 
capacity and muscle metabolism (220), with most of the metabolic effects of physical 
inactivity on insulin resistance being rapid in onset and of relatively short duration (97). 
Studies investigating the role of physical activity as a means to improve the insulin sensitivity 
have generally applied endurance exercise as a model. Indeed, a single bout of moderate-to-
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high intensity endurance exercise has been shown to acutely improve insulin sensitivity 
and/or glucose tolerance (66, 67, 176, 205). This effect has been reported to persist for a 
period ranging from 2 hours (176), 4–6 hours (273), 12–16 hours (66, 67) to 48 hours post-
exercise (176, 205). In contrast to endurance exercise, limited information is available 
regarding the impact of resistance exercise on glucose metabolism. It has been demonstrated 
that 6-12 weeks of resistance training lowers the percentage of glycosylated haemoglobin and 
increases glucose disposal in Type II diabetics due, in large part, to muscle hypertrophy and 
an increase in the protein content of insulin-signalling intermediates (54, 77, 117). In 
contrast, the effectiveness of a single bout of resistance exercise on glycemic control and the 
mechanisms regulating this response are less well understood. Whereas some authors have 
reported an improved glucoregulatory response 12–24 hours after a single bout of resistance 
exercise (77, 81, 150, 258), others have failed to observe any change in insulin sensitivity 
(44, 166). These discrepant findings may be related to the method utilized to determine 
glucose and insulin kinetics (i.e. oral glucose tolerance tests vs. insulin tolerance test) or 
differences in the exercise stimulus and participant training status. Nevertheless, these data 
strongly suggest that a single bout of resistance exercise of sufficient volume and intensity 
can improve insulin sensitivity and glycemic control in humans. 
 
1.6.2  Intracellular signalling regulating glucose uptake with acute exercise 
The molecular mechanisms for enhanced glucose uptake and insulin sensitivity with 
exercise are related to the increased expression and/or activity of key enzymes and signalling 
proteins involved in skeletal muscle glucose and fat metabolism (69, 277). Prolonged 
improvements in insulin sensitivity and glucose transport may reflect changes in protein 
expression (i.e. enhanced or suppressed) that occur following each acute exercise bout. The 
immediate effects of resistance exercise on skeletal muscle glucose transport have long been 
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thought to occur via AMPK regulation of GLUT4 trafficking to the cell membrane (71, 240) 
rather than through any enhancement of proximal insulin signalling steps (122, 273). 
However, it has recently been demonstrated that contractile activity can promote GLUT4 
translocation irrespective of AMPKα2 (159). In this regard, recent work has implicated 
sucrose non-fermenting AMPK-related kinase (SNARK) protein as an novel and potentially 
important mediator of skeletal muscle glucose uptake (149). Currently, the precise signalling 
events that promote glucose uptake in skeletal muscle are unclear. 
 
 The recent discovery of the most distal signalling proteins implicated in insulin-
stimulated GLUT4 transport, AS160 and TBC1D1 (from the same family domain of 
proteins), has provided us with a clue as to how contraction-induced AMPK activity regulates 
GLUT4 translocation. Phosphorylation of AS160/TBC1D1 is thought to lead to inhibition of 
AS160’s activation of Rab-GTPase proteins associated with the GLUT4 vesicle and/or cause 
AS160 to disassociate from the GLUT4 vesicle. This mechanism of action thereby allows for 
the accumulation of Rab GTP, thus favouring GLUT4 translocation (42, 140). Several 
studies, using specific antibodies for individual phospho-sites on AS160, have reported an 
increase in AS160 phosphorylation following resistance exercise (71, 121, 246). Furthermore, 
when isolated skeletal muscle is treated with AICAR (an AMPK activator), or subjected to 
contraction in situ, both AS160 and TBC1D1 phosphorylation are increased (34, 152, 239). 
Conversely, when AMPK is inhibited (via knockout of AMPKα2), contraction-stimulated 
AS160 phosphorylation is significantly reduced (152). Recently it has been hypothesized that 
a large proportion of the contraction-stimulated increase in glucose transport may be 
attributed to TBC1D1, whereas AS160 may play a more prominent role in regulating insulin-
stimulated glucose uptake (42). To date, this thesis has yet to be confirmed in humans. At 
present, methodological limitations regarding non-specific antibody detection of 
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AS160/TBC1D1 cloud our understanding of the phospho-specific response of these two 
proteins to insulin and contraction stimuli (42). Indeed, it has recently been demonstrated in 
mice that contraction-stimulated skeletal muscle glucose uptake is regulated by site-specific 
phosphorylation of TBC1D1 (259).  
 
In summary, it has been hypothesized that AS160 and TBC1D1 act as a nexus for 
insulin-dependent and insulin-independent (i.e. contraction) signalling pathways on GLUT4 
translocation and skeletal muscle glucose uptake (43). Consequently, the intracellular signals 
emanating from contracting muscle during exercise may interact with the insulin signalling 
pathway at the level of AS160/TBC1D1, thereby acting synergistically to enhance glucose 
uptake (43). In support of this suggestion, Treebak et al. (245) recently confirmed that AS160 
phosphorylation was increased by prior exercise, both before and immediately after insulin 
stimulation.  
 
1.7  Influence of protein nutrition on glucose homeostasis 
 
Concepts regarding dietary changes that prevent or assist in the management of Type II 
diabetes are beginning to emerge. In the last decade the role of protein feeding as an 
intervention to reduce hyperglycemia has received considerable attention. Previously, when 
dietary recommendations for the general population, or for persons with diabetes were 
considered, the major focus was the relative amounts and types of carbohydrate and fat (1). 
Protein nutrition is generally considered in the context of that necessary to maintain, or gain 
lean body mass, i.e., that needed to promote a positive net muscle protein balance. However, 
in the early 1900’s, it was reported that the ingestion of egg white protein in a single-meal 
study did not elevate blood glucose concentration in healthy humans (130). In persons with 
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Type II diabetes, it has been suggested that protein ingestion lowers postprandial glucose 
concentrations (193, 196). Long-term, protein-rich diets are associated with better glycemic 
control and plasma lipid profile in obese and insulin resistant individuals and promote energy 
expenditure and greater relative fat reduction, compared with energy matched, high 
carbohydrate or high fat diets (15, 161, 265). Thus, it appears that protein nutrition could play 
an important role in glycemic control in humans. 
 
1.7.1  Insulin-stimulated hypoglycemia with protein co-ingestion 
 
Several decades ago Floyd and Fajans (76, 79, 80) showed that the infusion of high 
doses of amino acids potentiated the release of insulin. In contrast, oral ingestion of protein or 
amino acids, in an amount likely to be ingested in a high protein meal, does not alter the 
insulin response (87, 88, 138, 139, 194, 197). Alternatively, co-ingesting protein with 
carbohydrate does stimulate a greater insulin release than the ingestion of either 
macronutrient alone. The synergistic effect of protein plus carbohydrate on insulin release 
was first described in the 1960’s (200, 215) and later confirmed by Nuttall and colleagues 
(195, 196). Studies conducted in vitro (24, 25, 168, 169, 227, 228, 230) and in humans (76, 
226) demonstrate that amino acids co-ingested with carbohydrate potentiate insulin release 
from pancreas β cells. Increasing postprandial endogenous insulin release may lower blood 
glucose levels by assisting the process of skeletal muscle glucose uptake via the insulin-
dependent signalling cascade that, ultimately, enhances glucose transporter protein 
translocation to the cell membrane. Thus, protein co-ingestion may alleviate many side 
effects of diabetes (e.g. cardiovascular disease risk, glycation of tissues/neurones, 
inflammation) and postponing an individuals’ dependency on exogenous insulin therapy. 
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Several notable studies from the Dutch group of Luc Van-Loon have focussed on the 
insulinotropic effect of protein plus carbohydrate ingestion in Type II diabetics. Initially, this 
group demonstrated that the insulin response to carbohydrate intake can be nearly tripled by 
the addition of a free amino acid/protein mixture (254). Subsequently, the group showed that 
this free amino acid/protein plus glucose mix augmented insulin release and lowered plasma 
glucose excursions in Type II diabetics (173). With the use of a labelled glucose tracer 
infusion during drink ingestion, the authors attributed the reduction in plasma glucose to an 
increase in the rate of glucose disposal from the circulation, presumably taken up by skeletal 
muscle. However, recent work from this group showed that co-ingesting protein with each 
main meal (three times a day) did not reduce the prevalence of hyperglycemia over the course 
of the day in Type II diabetics (172). To explain this finding, the authors posit that the 
increase in total energy intake (~14%) when additional protein was co-ingested may have 
offset any hypoglycemic effect. Thus, protein ingestion may be best implemented in the diet 
in place of, rather than in addition to, other macronutrients. Nevertheless, these data provide 
overwhelming evidence that co-ingesting protein with carbohydrate promotes 
hyperinsulinemia. Thus, whilst the sensitivity of the pancreas to glucose is significantly 
impaired in persons with long-standing Type II diabetes (211), the capacity to secrete insulin 
when protein is co-ingested with carbohydrate remains functional (171, 173). However, the 
efficacy of protein co-ingestion as a non-pharmacological treatment for Type II diabetes in 
daily, free-living conditions is less than clear, although Manders et al. (172) hypothesized that 
the presence of free amino acids, leucine in particular, may be important in stimulating 
hyperinsulinemia (170). 
 
1.7.2  Protein absorption and hydrolysis for glucose homeostasis 
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The co-ingestion of most common food sources of protein with glucose, promotes 
hypoglycemia in Type II diabetics (86). However, the insulinotropic response is dependent on 
the protein source consumed (148, 193, 195). Differences in insulinotropic and glycemic 
properties of various protein sources are likely to be associated with; i) the post-absorptive 
pattern of amino acid appearance in the circulation and the degree of hydrolysis of the protein 
source. 
 
Casein proteins are digested slowly and induce a lower but more prolonged 
hyperaminoacidemia, whereas whey protein, which is digested quickly, induces higher 
postprandial retention of amino acids (29, 190). The greater insulinotropic response to whey 
protein feeding may be connected to more rapid digestion kinetics. The suggestion that whey-
induced hyperaminoacidemia is important in glucose homeostasis is supported by studies 
showing that glycogen content in liver (184) and skeletal muscle tissue (185) of whey protein 
fed rats, was greater than rats fed casein. In addition to the absorption kinetics, the degree of 
hydrolysis of ingested proteins may be an important determinant for maintaining 
normoglycemia. It is generally accepted that di- and tri-peptides, remaining after the initial 
peptidase digestion, are absorbed intact (101). Indeed, whey, egg and casein hydrolysates, 
containing mostly di- and tri-peptides, are more rapidly absorbed than their respective intact 
protein sources (102). However, there was no difference in the glucose and insulin response 
between animal and vegetable protein hydrolysates co-ingested with glucose (37, 48). 
Collectively, these data imply that the rate of amino acid appearance in the circulation, 
dependent on the protein source and state of hydrolysis, is an important determinant of the 
insulinotropic and hypoglycaemic response. 
 
1.7.3 Insulinotropic properties of free amino acids 
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In addition to protein co-ingestion with carbohydrate as a means to promote 
hyperinsulinemia, it is now clear that certain free amino acids act as direct insulin 
secretagogues (76, 225, 226). Nilsson et al. (190) first reported a correlation between the 
postprandial insulin and early increments in leucine, valine, lysine, and isoleucine after the 
consumption of different protein containing food sources. These data are further supported by 
studies demonstrating that the insulinemic response to BCAA’s plus glucose co-ingestion 
mimics the glycemic and insulinemic response to ingesting intact whey protein with glucose 
(183, 189). Based on these data, it is apparent that the BCAA’s are the most potent insulin 
secretagogues (45, 124, 255). Mechanistically, in vivo and in vitro work indicates that the 
BCAA leucine both stimulates and enhances pancreatic β cell insulin secretion through 
oxidative decarboxylation and allosterically activating glutamate dehydrogenase (188, 229). 
The precise mechanisms, by which amino acids promote insulin exocytosis from the 
pancreas, although not yet fully elucidated, likely involve depolarization of the plasma 
membrane via energy sensing Ca+2 and k+ channels (188, 256). At present, the impact of 
BCAA on glucoregulation in healthy and Type II diabetics is still the subject of some debate. 
Manders and co-workers (170) fed a carbohydrate plus protein beverage with or without 
additional leucine to Type II diabetics and reported no difference in the response of insulin or 
plasma glucose.  
 
1.7.4  Mechanisms of glucose uptake with amino acids   
The signalling events that facilitate the glucose uptake in skeletal muscle are highly 
sensitive to a number of stimuli, including amino acids, and can be ‘turned on’ in the 
presence and absence of insulin. Surprisingly little is known about the mechanisms regulating 
glucose homeostasis following protein and amino acid ingestion in healthy and Type II 
diabetic humans. In contrast, the last decade has seen the emergence of rat and cell culture 
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studies in which glucose uptake and the associated regulatory signalling mechanisms have 
been determined following treatment with different proteins and free amino acids, ingested 
alone or with glucose. The main findings of these studies are summarized in Table 1.3. 
Amino acids, particularly leucine, enhance the phosphorylation of mTOR and can act 
synergistically with insulin to fully activate mTOR (5, 105, 203). However, insulin and 
amino acids signal to mTOR via divergent pathways (105). Initially, Armstrong et al. (8) 
reported that amino acids promote glycogen synthesis and glucose uptake in cultured human 
muscle cells via non-insulin dependent pathways via transient inhibition of GSK3 through 
phosphorylation of p70S6K. Furthermore, amino acid-stimulated glycogen synthesis was 
blocked by the mTOR inhibitor rapamycin (8). Others (207) also demonstrate that the 
provision of leucine stimulates glycogen synthesis in L6 myotubes in an mTOR dependent 
manner. The importance of the mTOR-p70S6K pathway and the amino acid leucine for 
glucose uptake is strengthened by Nishitani et al. (191). In rats with cirrhosis, a condition 
characterized by impaired glucose metabolism, these authors demonstrated that leucine and 
isoleucine enhanced glucose uptake, thus suppressing plasma glucose excursions compared 
with saline fed controls. In soleus muscles from these rats, leucine and isoleucine were shown 
to increase GLUT4 translocation to the cell membrane in insulin-free conditions. Taken 
together, these studies demonstrate an important regulatory role of the mTOR-p70S6K 
pathway in amino acid-stimulated glucose uptake. Intracellular regulation of glycemic control 
via insulin and BCAA is summarized in Figure 1.2. 
 
Insulin is a potent activator of muscle glycogen synthesis owing to its stimulatory effect 
on glucose transport. When BCAA are provided in the presence of an elevated insulin 
response, glucose uptake is potentiated through an increase in the phosphorylation of insulin-
dependent signalling intermediates Akt, PI3K and PKC (182, 184). With regard to mTOR 
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Figure 1.2 A simplified schematic representation of insulin-, BCAA- and contraction-
stimulated signalling mechanisms regulating glucose uptake in skeletal muscle. Dashed arrows 
indicate BCAA-stimulated signalling activation. Solid arrows indicate insulin- and 
contraction-stimulated signalling activation. Proteins have been labelled to designate them as 
positive contractile (blue), positive feeding-induced (green) or negative (red) regulators of 
glucose uptake. 
signalling, evidence suggests that insulin and amino acids act synergistically to fully activate 
this protein (105, 203) and that both stimuli signal to mTOR via divergent pathways (105). 
Whereas amino acid feeding in insulin-free conditions appears to promote glycogen synthesis 
via mTOR signalling, in the presence of insulin, BCAA-stimulated mTOR phosphorylation 
has been shown to be rate-limiting for skeletal muscle glucose uptake through an enhanced 
degradation of IRS-1 (16, 128, 238, 247). Thus, it appears that mTOR signalling may be an 
important step in the regulation of glucose uptake in skeletal muscle cells. However, the 
specific role of mTOR signalling remains to be tested in healthy or Type II diabetic humans.  
 
 
  
 
Study 
 
Model 
 
Method 
 
Protein/AA source 
 
Glucose metabolism 
 
Signalling response 
 
Dependent 
on insulin 
Peyrollier et al. 
(2000) 
• L6 myotubes AA deprived muscle 
cells were incubated 
with AA.  
Leu • N/a • AA ↑ p70S6K and ↓ GSK3 * 
• Dependent on PI3K and 
mTOR but not Akt *. 
• No 
Armstrong et 
al. (2001) 
 
 
• Cultured human 
myoblasts 
Myoblasts were 
incubated in an amino 
acid medium.  
Mixed AA medium  • AA medium ↑ GS 
activation ** 
• Dependent on mTOR and 
PI3K but not Akt **. 
• AA ↑ p70S6K and ↓ GSK3 
** 
 
• No 
Nishitani et al. 
(2002) 
 
• Isolated rat 
soleus muscle  
Isolated muscles 
incubated in leucine.  
Leu • Leu ↑ glucose uptake * • Glucose uptake with AA was 
dependent on PI3K and 
αPKC but not mTOR *. 
• No 
Doi et al. 
(2003)  
 
 
• Healthy rats 
• C2C12 myotubes 
Post-OGTT BCAA 
feeding and glucose 
uptake in myotubes.  
Leu, Ile, Val or Con • Iso ↓ plasma glucose ** 
• Iso ↑ glucose consumption 
*  
 
• Dependent on PKC and 
PI3K but not mTOR * 
• No 
Nishitani et al. 
(2005) 
• Cirrhosis 
induced rats 
Post-OGTT BCAA 
feeding and isolation of 
soleus muscles.  
Leu, Ile , Val or 
control 
• Leu and Iso ↑ glucose 
tolerance and uptake * 
 
• Leu and Iso ↑GLUT4 and GS 
activity  * 
• Leu phosphorylated p70S6K 
and was dependent on mTOR 
* 
• No 
Morifuji et al. 
(2009) 
• L6 myotubes 
• isolated rat 
epitrochlearis 
muscles 
L6 myotubes and 
isolated muscle 
incubated with WPH 
dipeptides.  
 
WPH dipeptides 
Iso+Leu. 
 
• Dipeptides and Iso+Leu ↑ 
glucose uptake * 
• Iso+Leu were dependent on 
PI3K and αPKC ** 
• No 
Morifuji et al. 
(2009) 
 
• Exercise trained 
rats 
Rats ingested glucose or 
glucose plus protein 
immediately post-
exercise. 
Glu alone or with 
WPH, CH, or BCAA  
• WPH ↑ muscle glycogen 
levels at 2 hours post-ex * 
• WPH ↑ phosphorylation of 
Akt and PKC * 
• Yes 
Iwanaka et al. 
(2009) 
• Isolated rat 
epitrochlearis 
muscle 
Isolated muscle treated 
with Leu following 
insulin or contraction 
Leu • Leu ↑contraction-induced 
glucose uptake * 
• Leu ↓ insulin-stimulated 
glucose uptake * 
• Leu ↑ phosphorylation of 
p70S6K after contraction * 
• Leu ↑ phosphorylation of 
IRS-1 and ↓ Akt with insulin 
* 
• No 
 
• Yes 
OGTT; oral glucose tolerance test, BCAA; branched chain amino acids, Leu; leucine, Ile: isoleucine, Val; valine, GLUT4; glucose transporter protein, 
GS; glycogen synthase, p70S6K; ribosomal protein S6 kinase, mTOR; mammalian target of rapamycin, WPH; whey protein hydrolysate, PI3K; 
phosphatidylinositol 3-kinase, PKC; atypical protein kinase C, Akt; protein kinase B, AA; amino acids, GSK3; GS kinase-3, IRS-1; insulin receptor 
substrate-1, *; P < 0.05, **; P < 0.01. 
Table 1.3 Studies investigating glucose metabolism and intracellular signalling in response to protein/amino acids on in rat and cell culture models. 
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1.8  Specific objectives of the thesis 
 This thesis describes a series of studies investigating the effectiveness of protein 
nutrition on exercise performance, indices of recovery and the metabolic/molecular 
adaptations to endurance and resistance exercise training. Chapter 2 describes a study in 
which we determined whether the addition of protein to a carbohydrate beverage improved 
cycle time-trial performance. Furthermore, we tested the hypothesis that carbohydrate plus 
protein ingestion during exercise enhances recovery by measuring indirect markers of muscle 
damage and muscle function. Chapters 3 and 4 focus on the influence of protein nutrition on 
protein metabolism following acute endurance exercise and glucose metabolism following 
acute resistance exercise. Chapter 3 describes a study in which we determined the synthetic 
response of myofibrillar and mitochondrial proteins to carbohydrate plus protein ingestion 
following prolonged cycling exercise. We simultaneously measured the phosphorylation of 
intracellular signalling proteins implicated in translation initiation and elongation phase of 
protein synthesis, in an attempt to provide a molecular mechanism to explain the divergent 
response of specific protein fractions to post-endurance exercise protein ingestion. Chapter 4 
describes a study in which we first determined the impact of a single bout of resistance 
exercise on the glycemic response to an oral glucose load at 24 hours post-exercise. Second, 
we tested the hypothesis that co-ingesting protein with the oral glucose load would augment 
resistance exercise-induced improvements in glycemic control. During this experiment, we 
utilized dual isotopic tracer methodology to measure endogenous and exogenous glucose 
kinetics in combination with muscle biopsies to determine the underlying intracellular 
mechanisms regulating glycemic control following resistance exercise and protein ingestion. 
Chapter 5 discusses the results of the studies described in the previous chapters, providing 
an overview of the main conclusions. The practical implications of the research are discussed 
and recommendations for future research are provided. 
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2.1 Abstract 
 
 Purpose: The aim of this study was to determine whether adding protein to a 
carbohydrate beverage would improve late-exercise cycle time-trial performance over 
carbohydrate alone. Furthermore, we examined the effects of co-ingesting protein with 
carbohydrate during exercise on post-exercise markers of sarcolemmal disruption and the 
recovery of muscle function. Methods: In a double-blind, cross-over design, 12 trained male 
cyclists performed 120 min of steady-state cycling (SS) at ~55% V&O2max followed by a 
time-trial lasting ~1 h (TT). At 15 min intervals during SS exercise participants consumed 
either a carbohydrate (CHO) or carbohydrate-protein (CHO+Pro) beverage (providing 65 
g·hˉ1 carbohydrate; or 65 g·hˉ1 carbohydrate plus 19 g·hˉ1 protein). Twenty-four hours 
following the onset of the SS cycle, participants completed a maximum isometric strength 
test. At rest and 24 h post-exercise, a visual analogue scale (VAS) was used to determine 
lower-limb muscle soreness and blood samples were obtained for plasma creatine kinase 
(CK) concentration. Dietary control was implemented 24 h prior to and during the time-
course of each trial. Results: Average power output sustained during TT was similar for 
CHO and CHO+Pro with no effect of treatment on time-to-complete the time-trial (60:13 ± 
1:33 min:sec and 60:51 ± 2:40 min:sec for CHO and CHO+Pro, respectively). Post-exercise 
isometric strength significantly declined for CHO (15 ± 3%) and CHO+Pro (11 ± 3%) 
compared with baseline (486 ± 28 N). Plasma CK concentrations and VAS soreness 
significantly increased at 24 h post-exercise, with no difference between treatments. 
Conclusions: The present findings suggest CHO+Pro co-ingestion during exercise does not 
improve late-exercise time-trial performance, ameliorate markers of sarcolemmal disruption 
or enhance the recovery of muscle function at 24 h post-exercise over carbohydrate alone. 
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2.2 Introduction 
 
 The quality and quantity of nutritional intake plays a critical role in response to training 
and in athletic performance. It is well established that carbohydrate (CHO) ingestion during 
moderate to high-intensity exercise can prolong endurance capacity (7). Evidence has since 
emerged to suggest that the ingestion of multiple transportable carbohydrates can increase 
exogenous carbohydrate oxidation and improve endurance performance, over and above the 
effect of a single carbohydrate (8, 14). Recently, the addition of protein to a carbohydrate 
containing beverage (CHO+Pro) during exercise has been reported to prolong endurance 
time-to-exhaustion (TTE) in the range of 13-36% (13, 30, 31). In contrast, other well 
controlled studies did not report such an ergogenic effect of CHO+Pro on time-trial 
performance (25, 35). Recently, Saunders and co-workers (32) suggested the addition of 
protein to carbohydrate specifically improved late-exercise time-trial performance. Thus, the 
efficacy of adding protein to carbohydrates for endurance performance remains unclear. 
  
 A number of methodological differences between studies make it difficult to discern 
whether any benefits observed for CHO+Pro are the result of a protein-mediated effect. First, 
there are discrepancies in the way exercise performance is assessed for CHO and CHO+Pro 
treatments. The ecological validity of TTE protocols is limited, because endurance athletes 
do not compete in events that require sustaining a fixed power output for as long as possible. 
Moreover, claims that CHO+Pro improves late-exercise performance were based on a time-
trial protocol that was not specifically designed to record power output and measure late-
stage exercise performance (32). Secondly, additional energy consumed when protein is 
added to a carbohydrate containing beverage may explain the performance benefits observed 
by others. If carbohydrate is consumed at a rate considered optimal for exogenous 
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carbohydrate oxidation (16), the role of protein for improving endurance performance may be 
negligible (35). Finally, the control of external variables (or in some cases lack thereof) has 
varied greatly between previous studies. Investigations attempting to implement a strictly 
controlled exercise environment reported no effect of protein co-ingestion for time-trial 
performance (25, 35).  
 
 The majority of studies examining the effect of carbohydrate-protein co-ingestion have 
focused on the impact on endurance performance. Several authors suggest that consuming 
CHO+Pro during and following endurance exercise improves recovery, defined as the 
recovery of endurance capacity (30, 37) and muscle function (33, 34). Reductions in plasma 
creatine kinase (CK) concentrations (20, 21, 28, 30, 31, 33, 34) and muscle soreness (20, 21, 
28, 33), are thought to play a key role in aiding the recovery process. However, evidence to 
support an effect of additional protein for improving recovery is inconsistent. Others have 
found no difference in the post-exercise rise in plasma CK (5, 10), muscle soreness (5, 21) or 
the recovery of endurance capacity (4) for CHO+Pro. Thus, the effectiveness of additional 
protein for enhancing recovery is unclear, perhaps due to methodological and design 
differences among studies, including variable amounts of control. These issues require further 
investigation. 
 
 The primary aim of the present study was to investigate the efficacy of adding protein 
to carbohydrate for improvement of late-exercise performance. Unlike previous studies, we 
aimed to supply a recommended dose of carbohydrate during cycle exercise to determine 
whether the addition of protein improved cycle time-trial performance in a controlled 
exercise environment, when preceded by a standardized steady-state ride. Second, we aimed 
to determine the effect carbohydrate-protein beverages on indices of recovery, 24 h following 
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time-trial cycle exercise by measuring plasma CK concentration, muscle soreness and muscle 
function. Participant diet and physical activity were stringently controlled for the 48 h trial 
duration to ensure participants were in a similar state of energy balance and fuel repletion. 
 
2.3 Methods 
2.3.1 Participants 
 Twelve trained male cyclists were recruited through advertisements, from local clubs 
(subject characteristics are shown in Table 2.1). Only individuals who undertook 2 or more 
training sessions per week of 1 – 5 h duration were eligible to participate. Data was collected 
over a 4-month period, such that all participants were all in a similar phase of their training 
cycle. All trials were completed within a 3-week period with no more than 14-days between 
trials and the purpose and methodology of the study were clearly explained to participants. 
All participants signed an informed consent and a completed a general health questionnaire 
prior to taking part in the study.  The experimental protocol was approved by the School of 
Sport and Exercise Sciences Safety and Ethics Subcommittee. 
 
2.3.2 Experimental Design 
 The study design was counter-balanced, cross-over and double-blind. Maximal oxygen 
uptake and muscle function were assessed at baseline. Following baseline testing participants 
performed two trials, during which they completed a 120 min steady-state cycle, consuming 
either a carbohydrate (CHO) or carbohydrate-protein (CHO+Pro) treatment beverage. 
Following the 120 min steady-state ride at 50%Wmax, participants were then asked to 
complete a time-trial lasting ~1 h (Figure 2.1). Participants returned after a 7-14 days and 
repeated the protocol whilst consuming the alternate treatment beverage. For example if the 
participant consumed CHO+Pro during trial 1, they consumed the CHO treatment during trial 
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2. Markers of sarcolemmal disruption were obtained immediately prior to and 24 h post-
exercise and the recovery of muscle function was assessed 24 h post-exercise.  All tests were 
conducted in a fasted state at the same time-of-day to minimize any circadian variance.  
 
 
2.3.3 Baseline Testing 
 Body Mass: A digital scale was used to determine body weight to the nearest 0.1kg. 
Each participant was weighed in their cycling clothing without shoes.  This was repeated 
prior to each of the two testing visits to ensure body weight remained similar throughout. 
 Maximal Power Output: Prior to completing the treatment trials, maximal oxygen 
uptake (V&O2max) and maximal power output (Wmax) were determined using an incremental 
cycle test to exhaustion on an electrically braked cycle ergometer (LODE Excalibur Sport V 
2.0 Groningen, Netherlands). The test consisted of a 3 min warm-up at 95 W, followed by an 
increase of 35 W every 3 min until exhaustion, at a self-selected cadence. The seat position, 
handlebar height and orientation used during testing were recorded and replicated on 
subsequent visits to the laboratory. All cycle tests were conducted in thermo-neutral 
conditions (23°C, 40% relative humidity). Wmax values were used to determine the 
workload for the pre-loaded time-trial. Heart rate (HR) was measured continuously by using 
 
 
Age 
(Yrs) 
 
Weight 
(kg) 
 
Experience 
(y) 
 
BMI 
(kg·mˉ 2) 
 
VO2max 
(mL·kgˉ1·minˉ1) 
 
Wmax 
(W) 
 
Mean 
 
27 
 
70.5 
 
7.1 
 
22.4 
 
62.7 
 
350 
SD 8 5 1.5 
 
2.6 
 
6.3 
 
34 
 
  Table 2.1 Participant characteristics at baseline.  
 
  Data are presented as means ± SD 
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telemetry using HR monitor (Polar S625X; Polar Electro Oy, Kempele, Finland). V&O2 was 
considered maximal if 3 of the 4 following conditions were met: 1) a plateau in V&O2 with 
further increasing workloads (an increase of < 2 mL·kgˉ1·minˉ1); 2) a HR within 10 
beats/min of the age predicted maximum (220 bpm - age); and 3) a respiratory exchange ratio 
(RER) of >1.05; 4) a rate of perceived exertion (RPE) greater than 17. 
 Metabolic & Physiological Measures: Expired O2, CO2 and RER, were measured 
during the last 60 sec of each stage and ~60 sec prior to the cessation of exercise to determine 
V&O2 and V&CO2. Participants indicated to the investigator the point at which they felt they 
were only able to exercise for one more minute. These data were obtained using Douglas gas 
collection bags (Plysu, Milton Keynes, UK), with air expired through a 2-way breathing 
valve connected to the bag. Bags were analyzed using a gas analyzer (Servomex 1440, East 
Sussex, UK), which was calibrated before each analyses using medical-grade gasses of 
known concentrations (British Oxygen Company, UK). The RPE was obtained using the 6-20 
Borg scale.  
 Assessment of Maximal Isometric Strength: Twenty-four hours after each time–trial, a 
Tornvall chair (22) was used to determine maximal isometric strength (MIST). These values 
were compared with a single rested MIST test conducted at baseline, to determine the post-
exercise loss of isometric strength. Both voluntary and stimulated isometric contractions of 
the quadriceps femoris were determined, in the non-dominant leg. A series of known weights 
was applied to a strain gauge and the resulting voltage output was recorded daily for 
conversion into force. Participants were seated with the knee at 90o, which was fixed in place 
by a cord fastened round the ankle. The cord was attached to a strain gauge interfaced with a 
computer, on which the resultant force was displayed and recorded. Two arm straps held the 
participant in place in the chair and minimize any extraneous movement. Damp electrodes 
(13 x 8 cm) were secured proximally and distally to the anterolateral thigh. At baseline, 
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maximal electrical stimulation was determined using a twitch overlay programme; 
progressively larger voltages (mA) were applied until two produced the same force. Once this 
was determined participants received a percutaneous electrical stimulation three times before 
being encouraged to extend their knee as hard as possible. Three electrical stimulations were 
superimposed while contraction was occurring to ensure that each effort was maximal. This 
procedure occurred three times during each trial with participants resting for 90 seconds 
between efforts. The highest value was recorded as the participant’s maximal voluntary 
contraction.  
 
2.3.4 Blinded Trials 
 Two-hour Pre-load Cycle: No less than 7 days after baseline testing, participants 
underwent familiarization of the time-trial whilst consuming water only. For each trial, 
participants reported to the Human Performance Laboratory in a fasted state (06.00 – 07.00) 
having undergone 24 h of dietary control prior to this visit.  Participants completed 120 min 
of constant pre-load ergometer cycling at a work-load 50% of their previously determined 
Wmax (175 ± 5 W). Participants were instructed to maintain a comfortable cadence above 60 
revolutions per minute (rpm). 
 One-hour Time-trial: Upon completion of the 120 min pre-load cycle the ergometer 
was set in the linear mode and participants were asked to complete an energy based target 
amount of work at 70% of their pre-determined Wmax. The total amount of work for a 1 h 
time-trial (880 ± 27 kJ) was calculated according to the formula derived from Jeukendrup et 
al. (15). A linear factor, calculated as work-rate at 70% Wmax divided by (90rpm2), was 
entered into the ergometer controller. During the time-trial, participants received no verbal or 
visual feedback regarding performance time or physiological measures. Participants had 
access to a computer screen indicating the amount of the total energy target they had 
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completed. Trials were performed in a small testing laboratory with a screen placed behind 
each participant to minimize distraction.  Air conditioning and a fan were used when 
requested by participants, for which the settings were recorded and replicated during the 
second trial. 
 Metabolic & Physiological Measures: Oxygen uptake, CO2 production and RER data 
were collected for 2 min intervals every 30 min of the 120 min pre-load cycle to determine 
the intensity of the workload.  Heart-rate and RPE were obtained also to confirm a steady 
state was maintained prior to the time-trial. During the time-trial HR, RPE and average power 
output were recorded at 25, 50 and 75% of the total energy target (kJ). These same measures 
were also obtained ~10 seconds prior to completion of the trial.   
 Assessments of Muscle Function and Force Production: Twenty-four hours after the 
start of the pre-loaded cycle trial (06.00 – 07.00), participants were asked to return to the 
laboratory in a fasted state, to undergo a MIST as described previously.  
 Visual Analogue Scale of Muscle Soreness: Using a 50mm line with word descriptors at 
each end reading ‘no soreness’ and ‘extreme soreness’, participants marked on the line, the 
point that they felt represented their current degree of general muscle soreness in their non-
dominant leg. The distance to the mark was then measured in millimeters. VAS soreness was 
also rated when the knee was both flexed and extended. Average VAS soreness is reported 
here as it closely represents general, flexed and extended soreness values. A VAS was 
completed in the morning prior to each time-trial and 24 h following the onset of the pre-load 
cycle upon return to the laboratory prior to the MIST. The VAS scale has previously been 
shown to be a reliable device in measuring acute pain (6). 
 Blood Analysis: Upon arrival for each time-trial, a cannula (IV Venflon 20GX32mm) 
was inserted into the antecubital vein of the forearm. A two-way stopcock (Medex, Monsey, 
NY) was applied and opened to collect a 10mL sample at rest. A further blood sample was 
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taken upon each participants return to the laboratory for the MIST on day 2 (24 h following 
the onset of the pre-load cycle). Samples were centrifuged at 3000rpm at 4°C to allow the 
extraction of blood plasma for further analysis. All plasma samples were processed and 
stored frozen at -80°C. The exact time-points of all sample collections were recorded and 
repeated during the second blinded treatment. Enzymatic analysis of CK concentration (CK 
NAC CP, ABX diagnostics, UK) was performed in duplicate at each time-point using a semi-
automated analyzer (COBAS MIRA S-plus, ABX, UK). 
 
2.3.5 Treatment Beverages  
 The two experimental trials were a 6% maltodextrin carbohydrate beverage (65 g·hˉ1; 
CHO) and a carbohydrate + protein (CHO+Pro) beverage containing 6% maltodextrin (65 
g·hˉ1) and 1.8% protein hydrolysate (19 g·hˉ1). Treatment beverages were counter-balanced 
throughout the study to minimize any influence of order, with 6 participants receiving CHO 
first and 6 receiving CHO+Pro first. Beverages were served in non-see-through bottles, with 
a different flavor used in each trial to minimize the risk of taste comparisons between 
beverages. During pilot testing, a group of cyclists were able to successfully identify the 
beverage composition when flavors were the same. Flavors were added using 3g of non-
energetic sweetened drink mix. Participants consumed 270mL every 15 min of the 120 min 
steady state pre-load, beginning at the onset of the ride (1080mL per/hour). An investigator 
handed the participant one container at a time and verbally encouraged them to drink at an 
appropriate rate. Water was consumed ad libitum during the time-trial with the amount 
recorded  (~430 ± 26mL) and administered in the same volume during the second trial. 
Beverages were prepared by an independent investigator who had no part in the data 
collection of the study. 
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Figure 2.1 Schematic diagram of the experimental protocol.  Metabolic measures include 
V&O2, V&CO2 and RER. Physiological measures include HR, RPE and average power output. 
Time values are in hours. 
 
2.3.6 Diet & Exercise Control 
 Participant diet was standardized for the 48 h duration of each treatment. This ensured 
that nutrient intake was controlled for 24 h prior to each time-trial and over the 24 h course of 
each time-trial day, prior to the assessment of muscle function the following morning. In-
between baseline testing and each blinded trial, participants completed a 3-day food diary, 
representative of their average week. A questionnaire of food preferences was also completed 
by participants. Using an on-line diet planner, each of the 3-days was logged and the energy 
and nutrient intake estimated.  An average of the 3-days was combined with the participant’s 
weight to calculate the total energy content of the diet. The standardized diet was matched to 
each participants habitual daily energy intake and contained 8g·kgˉ1 BM carbohydrate and 
1.6g·kgˉ1 BM protein with the remainder of energy derived from fat. The macronutrient 
composition of the standardized diet was not significantly different from participants’ 
habitual diet (Table 2.2). Participants were instructed to consume only the food provided for 
 
Beverage (270mL) 
Blood sample & VAS 
Metabolic & 
Physiological Measures 
-24 0 1 2 ~3 24 25 
Dietary control 
50% Wmax 70% Wmax MIST 
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them over the two-day testing period. The same two-day food parcel was provided to each 
participant prior to the second trial.  Participants were instructed to maintain normal volume 
and intensity of training throughout the course of the study but to refrain from training for 48 
h prior to each testing phase.  
 
2.3.7 Statistical Analysis 
 Data are reported as mean ± SEM, unless otherwise stated. All data were analyzed by 
two-way analysis of variance for repeated measures (Group x Time). Significant differences 
between means were determined using SPSS (Version 15.)  Bonferroni adjustment was 
applied to post hoc means-comparison tests.  Differences were considered significant at P < 
0.05.  In keeping with recent trends in inferential statistics, we made magnitude based 
inferences about the ‘true’ values of the effect of treatment on outcomes by expressing the 
uncertainty as 90% confidence limits (CL) and by calculating and interpreting chances that 
the true effect was beneficial or detrimental. For time-trial performance data a substantial 
effect was derived from 0.5 times (11) the average of estimates for the typical error of 
measurement for time-trial performance and power output. For all other biochemical and 
psychometric variables, the smallest standardized (Cohen) difference in the mean (0.20 times 
the between-subjects standard deviation for the control group) was used to identify the 
magnitude of the smallest substantive effect. Based on an analysis of the confidence limits 
and P values using a published spreadsheet (2), the likelihood of a substantial benefit or 
detriment, increase or decrease, for an outcome was qualified as follows: <1%, almost 
certainly not; 1–5%, very unlikely; 5–25%, unlikely; 25–75%, possible; 75–95%, likely; 95–
99%, very likely; and >99%, almost certain (9); otherwise, an effect was deemed unclear or 
inconclusive if the confidence interval overlapped the thresholds for positive and negative 
substantial effects by >5%. When the mean and >50% of the confidence interval lie within 
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the threshold for a substantial effect, the effect is qualified as trivial. P values were provided 
for an inferential comparison for the main experimental outcomes only. 
 
2.4 Results 
2.4.1 Time-trial performance 
  Mean power output during the time-trial was not significantly different between 
treatments (247 ± 11 W for CHO and 247 ± 13 W for CHO+Pro, respectively). Power output 
was reduced at 75%, compared with 25 and 50% of time-trial completion (Figure 2.2); 
however, average power outputs at these time-points were not different between treatments. 
As a result there was also no significant difference in time-to-complete the time-trial for 
CHO or CHO+Pro (Figure 2.3). Inference based statistics determined the effect of CHO+Pro 
compared with CHO on time-to-complete the trial was unclear (P = 0.81). Heart rate and 
RPE were significantly elevated at completion of time-trial target compared with 25, 50 and 
75% completion (P < 0.001) with no between-group differences at any time-point between 
CHO and CHO+Pro (Table 2.3).  
 
2.4.2  Steady-state exercise 
 There was no between-group difference in heart rate and V&O2 at 0, 30, 60, 90 and 120 
min of the 120 min pre-load cycle. Average HR for CHO and CHO+Pro was 141 ± 12 and 
142 ± 12 bpm respectively (Table 2.3). Average V&O2 (34.9 ± 3.7 mL·kgˉ1·minˉ1 for CHO and 
34.3 ± 4.2 mL·kgˉ1·minˉ1 for CHO+Pro) and RER (0.88 ± 0.01 for both) were not different 
between treatments at any time-point. Metabolic data indicated participants were cycling at 
~55% V&O2max. Throughout the steady state ride RPE was not significantly different between 
treatments (Between-subject range 10 – 15). 
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Table 2.2 Comparison of habitual and standardized diet 
  Carbohydrate Protein Fat 
 
Habitual diet 
 
(g) 
 
570.3 ± 41.9 
 
104.8 ± 12 
 
74.8 ± 41.2 
(g·kg-1 BM) 8.1 ± 0.5  1.5 ± 0.1 1.1 ± 0.6 
Standardized 
diet 
(g) 565.2 ± 39.4  113.1 ± 7.8 73.4 ± 35.6 
(g·kg-1 BM) 8.0 ± 0  1.6 ± 0 1.0 ± 0.5 
 
 
 
 
 
 
 
 
2.4.3 Isometric knee extensor strength 
 A significant time effect revealed that knee extensor MIST declined 24 h after the onset 
of each trial compared with baseline MIST (15 ± 3% for CHO and 11 ± 3% for CHO+Pro; P 
  
Heart-rate (bpm) 
 
 
Rate of perceived exertion (6-20) 
 
Trial 
Completion 
 
CHO 
 
CHO+Pro 
 
CHO 
 
CHO+Pro 
 
25% 
 
165 ± 3 
 
166.8 ± 2.6 
 
16.3 ± 0.5 
 
15.8 ± 0.8 
 
50% 
 
167± 4 
 
168.1 ± 2.8 
 
17.5 ± 0.7 
 
16.6 ± 0.7 
 
75% 
 
165 ± 3 
 
169.2 ± 2.3 
 
18.0 ± 0.7 
 
17.2 ± 0.7 
 
100% 
 
 
a
 180 ± 3 
 
a
 180.6 ± 2.1 
 
a
 19.4 ± 0.6 
 
a
 19.2 ± 0.8 
  Table 2.3 Physiological data at 25, 50, 75, and 100% of time-trial completion. 
 
*: Significant increase compared with 25, 50 and 75% completion time-points (P < 0.001) 
indicated by a. Data are presented as means ± SEM.  
 
Participant daily habitual energy intake was 3373.3 ± 349.1 kcal. Habitual energy intake was 
maintained during standardized dietary control. Macronutrient intake (g·kg-1 BM) was not 
significantly different between habitual and standardized diets (P < 0.05). Values are presented as 
means ± SD. 
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< 0.002); with no significant between-group difference (Figure 2.4).  Inference based 
statistics revealed the effect of CHO+Pro over CHO on the post-exercise recovery of knee 
extensor MIST was most likely trivial (P = 0.28). 
 
2.4.4  Visual analogue scale of muscle soreness 
 A significant time effect (P < 0.05) revealed VAS soreness increased from 4.8 ± 1.2 to 
14.3 ± 4.3mm for CHO and 5.9 ± 1.9 to 14.3 ± 4.8mm for CHO+Pro, 24 h after the onset of 
each trial (Figure 2.5). No between-group difference in VAS soreness was evident at 24 h 
post-exercise. Inference based statistics indicated no clear difference in the extent of VAS 
muscle soreness between-groups (P = 0.91).  
 
2.4.5  Plasma creatine kinase concentration 
 A significant time interaction (P < 0.002) revealed plasma CK was significantly 
increased for CHO and CHO+Pro at 24 h post-exercise (Figure 2.6).  No between-group 
difference in plasma CK concentrations was evident at 24 h post-exercise (P > 0.05). 
Inference based statistics revealed the effect of CHO+Pro compared with CHO on post-
exercise CK concentrations was most likely trivial (P = 0.53).  
 
2.4.6  Treatment Blinding 
 Seven of the 12 participants completed the time-trial more quickly during their first 
treatment visit, suggesting there was no learning effect between trials. Five of the 12 
participants correctly identified the beverage order during testing. Of the 5 participants who 
identified the beverages correctly, only 2 performed faster with CHO+Pro suggesting our 
attempts to minimize treatment bias were successful. Seven of the 12 participants, performed 
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better when consuming a CHO beverage, with the remaining 5 completing the task more 
quickly with CHO+Pro.  
 
 
 
 
 
 
 
 
Time-to-Completion (min)
0 45 50 55 60 65
CHO
CHO+Pro
Figure 2.2 Average power output measured at quarterly completion of time-trial target. a, 
indicates significant reduction in power output vs. all prior time-points. b, indicates significant 
increase in power output vs. 75% completion (P < 0.05). Data are presented as means ± SEM. 
 
Figure 2.3 Time-trial time-to-completion. Data are presented as means ± SEM. 
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Figure 2.4 Maximum isometric force production of the knee extensors at baseline and 24 h post-
exercise. a, indicates significant reduction from baseline (P < 0.05). Data are presented as means 
± SEM. 
 
Figure 2.5 Average visual analogue scale of perceived muscle soreness at rest and 24 h post 
exercise. Muscle soreness scored on a scale of 0 (no soreness) to 50 (extreme soreness). a, 
indicates significant increase from rest (P < 0.05). Data are presented as means ± SEM. 
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2.5  Discussion 
 The present study is the first to our knowledge, to determine the effect of a CHO+Pro 
beverage on late-stage cycle time-trial performance and post-exercise indices of recovery. 
Here we show that the addition of protein to a moderate carbohydrate dose did not improve 
late-exercise time-trial performance when beverages were consumed during a steady-state 
pre-load cycle. Furthermore, there were no differences in power output between treatments at 
any stage of the time-trial. Finally, the addition of protein to a carbohydrate containing 
beverage did not improve any of the measured indices of post-exercise recovery. Thus, our 
results do not support the notion that carbohydrate-protein co-ingestion during exercise 
enhances late-exercise performance or post-exercise recovery over to carbohydrate alone. 
 In contrast to the present findings, several investigations suggest that the addition of 
protein to carbohydrate improves endurance performance (13, 30-32). In many cases the 
Figure 2.6 Plasma creatine kinase (CK) concentration at rest and 24 h post-exercise. a, indicates 
significant increase from rest (P < 0.05). Data are presented as means ± SE. 
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discrepancies between studies may be due to differences in the exercise test used to assess 
performance. Studies suggesting improved performance actually measured time-to-
exhaustion (13, 30, 31), not performance per se. Currell and Jeukendrup (9) highlighted the 
fact that the ecological validity of exhaustive exercise protocols is limited, because endurance 
athletes do not compete in events that require sustaining a fixed power output for as long as 
possible. Furthermore, the precision of time-to-exhaustion is reportedly in the range of 26% 
(15). On the contrary, time-trial cycle tests have been found to be highly reproducible and 
sensitive to small changes in exercise performance (15, 18, 26). Our observation of no 
improvement in time-trial performance for CHO+Pro is consistent with other studies 
measuring overall time-trial performance (25, 35). It should be noted that the final 
measurement of performance is influenced not only by the exercise test, but by control 
measures employed and subject feedback during exercise. Knowledge of parameters such as 
time elapsed; distanced travelled and heart rate during exercise, may compromise the 
blinding of treatments, creating a placebo effect (23), particularly when additional protein is 
consumed which is often difficult to mask. Early studies did not report the control of these 
conditions (13, 28, 30-32, 34). Further to the well controlled study protocol we used, 
participant diet was assessed and standardized, whilst physical activity was minimized to 
ensure participants were in a similar state of energy balance and fuel repletion prior to and 
during each treatment trial. Thus, when performance, rather than endurance capacity is 
measured in a controlled environment, additional protein does not seem to be advantageous 
for performance. 
 Recently, the importance of additional protein on more specific aspects of endurance 
performance has been touted. In particular, the notion that additional protein is important for 
enhancement of performance late in exercise has been put forward (32). Despite no difference 
in 60km time-trial performance between CHO and CHO+Pro treatments, ingestion of 
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additional protein resulted in improved performance during the final stages of the time-trial 
(32). Whereas this result can be interpreted as important for endurance athletes, it should be 
emphasized that overall performance was not improved, thus minimizing the importance of 
any late exercise improvement. Given that overall performance was not different, the shorter 
time taken to complete late-exercise stages with CHO+Pro may have been due to a slower 
completion of earlier exercise stages, or greater variability in the earlier section of the time-
trial relative to more reliable late-exercise performance. Whereas, these results contrast with 
our findings, the differences may be due to the fact that Saunders and colleagues (32) did not 
design their study to specifically examine the impact of additional protein on late-stage 
performance. The pre-loaded cycle time-trial used in the present study was designed to record 
power output and determine late-exercise time-trial performance and has been validated in 
previous studies from our laboratory (9, 15). In support of our findings, a recent study by 
Osterberg and colleagues (25) found no enhancement of late-exercise time-trial performance 
preceded by a 120 min steady-state ride, when protein was added to carbohydrate. Accurate 
determination of late-exercise performance requires that the exercise intensity of the prior 
bout should be standardized and power output reported. Thus, it seems that when properly 
controlled, late-stage exercise performance is not improved by the addition or protein to 
carbohydrate during exercise.  
 Furthermore, lack of a definitive physiological mechanism also contributes to doubt of 
the importance of adding protein to carbohydrate during exercise. Several mechanisms have 
been theorized (29), but only one has any support in studies. Koopman and colleagues (17) 
showed that ingesting CHO+Pro during ultra-endurance exercise resulted in two-fold greater 
protein oxidation compared with CHO. Thus, studies in which extended time-to-exhaustion 
was found, suggest that the addition of protein may alter substrate utilization, potentially 
sparing muscle glycogen (13, 30, 31). However, carbohydrate intake in these studies was too 
Chapter 2. 89
low (<50 g·hˉ1) to attain peak exogenous oxidation rates (16) and the protein plus 
carbohydrate provided more energy than the carbohydrate alone. Investigations in which the 
total energy content of CHO and CHO+Pro beverages was matched, have found no difference 
in time-to-exhaustion (28, 34). Thus, the benefit of adding protein to carbohydrate likely is 
due to the additional energy delivered by protein as opposed to a protein per se. We show the 
addition of protein (19 g·hˉ1) to a carbohydrate dose (65 g·hˉ1) that meets the recommended 
upper-limit to attain peak exogenous carbohydrate oxidation rates, did not improve late-
exercise time-trial performance despite increasing the total beverage energy load by 29%. To 
our knowledge, no other purported mechanism for the enhancement of performance by 
additional protein has been demonstrated at this time. 
 In addition to the enhancement of endurance performance, adding protein to 
carbohydrate has been promoted to enhance recovery. Previous studies have shown 
CHO+Pro beverages prolong subsequent time-to-exhaustion in the range of 40 and 55% (30, 
33, 37). Others have found the addition of protein to carbohydrate results in small increases 
in the recovery of muscle function, on the order of 1-2 knee extension lifts (34) and 1-2cm in 
vertical jump height (34). Whereas these data suggest the addition of protein to carbohydrate 
improves the recovery of performance and function, there are many factors that differ 
between studies, thus the picture is less than clear. It is difficult to determine whether these 
benefits were influenced by the timing of beverage ingestion (prior to, during, or post-
exercise), the way in which recovery was measured, or the time given between exercise and 
the assessment of recovery. We chose to measure maximal isometric strength at 24 h post-
exercise because of its practical relevance (1). Athletes often repeat their training or compete 
24 hours after an exercise bout and therefore recovery of muscle function and exercise 
performance would be important in this time frame. In concert with two recent studies (5, 
10), we showed that the co-ingestion of carbohydrate and protein, does not improve the 
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recovery of isometric strength. Others have failed to show improvements in recovery as based 
on improved subsequent performance assessed in various methods (4, 10, 20, 21, 28) . Thus, 
the impact of adding protein to carbohydrate on recovery from intense exercise must still be 
considered to be somewhat equivocal. 
 Studies that report improvements in the recovery of endurance capacity typically 
measured these changes several hours following protein ingestion (30, 37). The ingestion of 
protein is known to stimulate muscle protein synthesis (12) resulting in positive net whole-
body protein balance following endurance exercise (19), which has been suggested to 
enhance recovery through the repair and remodeling of damaged proteins (20, 30, 31). 
However, the turnover of myofibrillar proteins is relatively slow, on order of days to weeks 
(27). Thus, it is difficult to comprehend how this process may influence changes noted in just 
a few hours (30, 37). So, if recovery is enhanced by adding protein to carbohydrate, it is 
unlikely to be due to the improved net muscle protein balance from the protein. 
 Whereas recovery may be defined by the ability to reproduce an optimal level of 
performance, several investigations have sought to measure the effect of CHO+Pro on the 
other markers thought to be important to the recovery process. Studies have shown that 
CHO+Pro beverages reduce plasma CK, a putative marker of sarcolemmal disruption and 
muscle soreness, (20, 21, 28, 31, 32). Others have found that lower CK concentrations and 
lower ratings of muscle soreness accompany improvements in the recovery of time-to 
exhaustion (30, 33) and vertical jump height (33). Consequently, previous studies suggest 
that protein co-ingestion may play an important role in reducing plasma CK and muscle 
soreness, thus improving recovery.  However, the changes in plasma CK when protein is 
added to carbohydrate are often minimal (20, 28, 31, 32, 34) and the inter-individual variation 
is very large, making it difficult to determine the physiological significance. Moreover, the 
plasma CK and muscle soreness values found in our study are in a similar range to those 
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reported previously, yet we show that CHO+Pro did not ameliorate post-exercise markers of 
sarcolemmal disruption. A recent study from Betts et al. (5) used a strenuous bout of 
intermittent shuttle running to induce a greater degree of sarcolemmal disruption than the 
cycle time-trial used in our study.  In support of our findings, the authors showed that the 
addition of protein to a carbohydrate beverage did not ameliorate post-exercise plasma CK 
and muscle soreness. Thus, it is not clear what impact, if any, ingestion of protein has on 
recovery by ameliorating CK and soreness. 
 It is likely that the importance of plasma CK and muscle soreness for enhancement of 
recovery has been over emphasized by studies that suggest the addition of protein to 
carbohydrate attenuates these responses (20, 21, 28, 31, 32). At best, plasma CK and muscle 
soreness should be considered putative markers of muscle damage. Studies have shown that 
these indirect markers have a poor relationship with the loss of muscle function (24) and 
direct markers of sarcolemmal disruption (3, 36). Moreover, ‘true’ treatment effects may be 
masked by the inherent variability of the CK response (5, 24, 36). Further to this suggestion, 
three participants in our study exhibited three-fold greater resting plasma CK response 
compared with the group average when protein was co-ingested. Resting CK concentrations 
for these same individuals were vastly reduced during the carbohydrate-only trial.  Thus, our 
results suggest a clear need to further investigate the impact of protein ingestion on recovery 
from endurance exercise. It would seem that studying direct markers of sarcolemmal 
disruption (biopsy or MRI techniques) in concert with post-exercise tests of muscle function 
may provide clearer answers regarding the efficacy of CHO+Pro for improving recovery. 
 In conclusion, when energy intake is controlled and carbohydrate is ingested at rates 
considered optimal for peak exogenous carbohydrate oxidation, the addition of protein does 
not improve late-exercise cycle time-trial performance or recovery of muscle function at 24 h 
post-exercise. The metabolic and physiological response to CHO+Pro may be dependent on 
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the mode, duration and intensity of the exercise bout and warrants further study. Based on our 
findings and other carefully controlled studies (25, 35) there is currently no basis to 
recommend CHO+Pro beverages to endurance athletes for performance enhancement or 
improved recovery.  
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3.1 Abstract 
Purpose: The aim of the present study was to determine mitochondrial and 
myofibrillar muscle protein synthesis (MPS) when carbohydrate (CHO) or carbohydrate plus 
protein (C+P) beverages were ingested following prolonged cycling exercise. The 
intracellular mechanisms thought to regulate MPS were also determined. Method: In a 
single-blind, cross-over study, 10 trained cyclists (age 29 ± 6 yr, V&O2max 66.5 ± 5 
mL·kgˉ1·minˉ1) completed two trials in a randomized order. Subjects cycled for 90 min at 
~77 ± 1% V&O2max before ingesting a CHO (25g of carbohydrate) or C+P (25g carbohydrate 
+ 10g whey protein) beverage immediately and 30 min post-exercise. A primed constant 
infusion of L-[ring-13C6] phenylalanine began 1.5 h prior to exercise and continued until 4 h 
post-exercise. Muscle biopsy samples were obtained to determine myofibrillar and 
mitochondrial MPS and the phosphorylation of intracellular signalling proteins. Arterialized 
blood samples were obtained throughout the protocol. Results: Plasma amino acid, plasma 
urea and serum insulin concentrations increased following ingestion of C+P only. 
Myofibrillar protein synthesis was greater for C+P compared with CHO (0.087 ± 0.007 and 
0.057 ± 0.006 %·h-1, respectively; P = 0.025). Mitochondrial protein synthesis rates were 
similar for C+P and CHO. mTORSer2448 phosphorylation was greater for C+P compared with 
CHO at 4 h post-exercise (P < 0.05). p70S6KThr389 phosphorylation increased at 4 h post-
exercise for C+P (P < 0.05), whilst eEF2Thr56 phosphorylation increased by ~40% at 4 h post-
exercise for CHO only (P < 0.01). Conclusions: The present study demonstrates that the 
ingestion of C+P following prolonged cycling stimulates an increase in myofibrillar MPS. 
These data indicate that the increase in myofibrillar MPS for C+P may be mediated through 
the phosphorylation of p70S6K, downstream of mTOR, which in turn may release the 
inhibition of eEF2 on translation elongation. 
Key words: cycling, skeletal muscle, protein turnover, training adaptation.  
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Abbreviations: EE, endurance exercise; RE, resistance exercise; MPS, muscle protein 
synthesis; C+P, carbohydrate plus protein; CHO, carbohydrate-only; V&O2, oxygen uptake; 
mTOR, mammalian target of rapamycin; p70S6K, 70kDa S6 protein kinase; Akt, protein 
kinase B; 4E-BP1, eukaryotic initiation factor 4E binding protein 1; eEF2, eukaryotic 
elongation factor 2; PRAS40,  proline-rich Akt substrate 40 kDa; p38 MAPK,  p38 mitogen-
activated protein kinase; AMPK, AMP-activated protein kinase. 
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3.2 Introduction 
Endurance (EE) and resistance exercise (RE) training regimens result in divergent 
phenotypic adaptations. Whereas RE promotes muscle hypertrophy and an increase in 
contractile force output (20, 29), EE training is characterized by an expansion of oxidative 
capacity, brought about through an increase in the size and density of mitochondria (25, 47). 
At the metabolic level, the adaptation to exercise is determined by summing the acute (22, 35, 
48) transcriptional (24, 42) and translational responses (54) to each exercise stimulus and the 
subsequent increase in synthesis of muscle proteins. Recently, Wilkinson and colleagues (54) 
showed the response of myofibrillar and mitochondrial muscle protein synthesis (MPS) were 
dependant on the type of exercise performed. Furthermore, the interaction of exercise and 
protein nutrition varies between different protein fractions (38). Thus, it is important to 
examine the response of different protein pools to exercise in order to determine whether a 
particular nutritional intervention is having the desired effect. 
 
Whereas the response of mixed MPS to different types of exercise has been 
investigated (19, 41, 50), there is less information on the response of various proteins to 
exercise and nutrition. It is widely recognized that ingesting protein potentiates the anabolic 
effect of RE (45), seemingly due to the essential amino acid content (49). Recently, Moore et 
al. (38) showed a differential response of myofibrillar and sarcoplasmic proteins to RE and 
protein nutrition. However, very few studies have sought to determine the effect of protein 
ingestion on MPS following EE. Levenhagen et al. (34) showed that adding protein to a 
carbohydrate treatment (C+P) increased post-EE leg and whole-body protein synthesis and 
this increase in synthesis was associated with net protein gain. However, it was unclear 
whether the benefits observed were due to the protein per se, or an increase in total energy 
intake. To remedy this, Howarth and colleagues (27) showed that C+P ingestion increased 
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mixed MPS compared with CHO treatments matched for total energy and carbohydrate 
content. On the other hand, another recent study showed no increase in mixed MPS when 
C+P was ingested following EE (19). Importantly, none of these studies (19, 27, 34) have 
attempted to resolve the specific protein fractions contributing to changes in mixed MPS, or 
the mechanism accounting for the adaptations. Therefore, specifically investigating the acute 
response of mitochondrial or myofibrillar protein synthesis to C+P ingestion following EE 
may resolve this issue. 
 
Acute changes in transcription and translation that occur following exercise regulate 
skeletal muscle protein turnover through a number of intracellular signalling proteins. The 
mammalian target of rapamycin (mTOR) is a key regulator of translational control, 
integrating environmental signals from nutrients and exercise to control cell growth (13). The 
activation of mTOR signalling leads to the phosphorylation of downstream targets involved 
in the mRNA translation initiation and elongation (6), e.g. p70 ribosomal protein S6 kinase-1 
(p70S6K). In concert with an increase in mitochondrial MPS following EE, Wilkinson et al. 
(54) showed an increase in the phosphorylation of signalling proteins in the mTOR–p70S6K 
pathway. Furthermore, human (28) and rat studies (39) indicate that post-EE C+P ingestion 
increases the phosphorylation of intermediates in the mTOR-p70S6K pathway. To date, no 
study has characterized the response of signalling proteins to changes in myofibrillar and 
mitochondrial MPS following post-EE protein ingestion.  
 
Thus, the primary aim of the present study was to determine whether ingesting 
additional protein with carbohydrate following prolonged cycling exercise modified the 
synthetic response of mitochondrial and myofibrillar muscle proteins. The second aim of the 
study was to elucidate the potential intracellular signalling mechanisms (in the mTOR-
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p70S6K pathway) regulating the differential response of myofibrillar and mitochondrial MPS 
following post-EE protein ingestion. 
 
3.3 Methods 
3.3.1 Participants 
 Ten well-trained, male cyclists were recruited from local clubs through advertisements. 
The mean (±SD) age of the cohort was 29 ± 6 yr, body mass was 77 ± 6.5 kg, maximal 
oxygen consumption was 66.5 ± 5 mL·kgˉ1·minˉ1 and maximal power output was 383 ± 25 
W. Only cyclists who undertook 2 or more training sessions per week of 1–5 h duration were 
eligible to participate. Participants had 6.5 ± 3 yr of competitive cycling experience. All tests 
were completed within a 4-week period with both treatment trials separated by 14 to 21-days, 
with the exception of one participant who completed the second trial 32-days after the first. 
The purpose and methodology of the study were clearly explained to the participants. All 
participants gave their informed consent prior to taking part in the study and were deemed 
healthy based on their response to a general health questionnaire. The experimental protocol 
was approved by the Black Country Research Ethics Committee (Rec No: 08/H1202/130).  
 
3.3.2 Study Design 
 Participants reported to the laboratory on 3 separate occasions. During the first visit 
maximal aerobic fitness was determined. Approximately 2-weeks later participants 
performed the first blinded trial in which they consumed a carbohydrate (CHO) or 
carbohydrate-protein beverage (C+P; Lucozade Sport Recovery Powder, GlaxoSmithKline, 
Brentford, UK). Briefly, during each trial participants performed a 90 min high intensity, 
steady-state cycle before consuming CHO or C+P, immediately and 30 min following the 
exercise bout. Mitochondrial and myofibrillar MPS were measured by incorporating isotopic 
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tracer infusion and muscle biopsy techniques. Participants returned to the laboratory for the 
second blinded trial 14 to 21-days after the first trial, thereby serving as their own control. 
Trial order was randomized and counter-balanced. 
 
3.3.3 Preliminary Testing 
 Body Mass: A digital scale was used to determine body mass to the nearest 0.1kg. Each 
participant was weighed in their cycling clothing without shoes on. Measurement of body 
mass was repeated prior to each of the two testing visits to ensure body mass remained 
constant throughout the study. 
 
 Maximal Power Output: Maximum oxygen uptake (V&O2max) and maximal power output 
(Wmax) were determined using an incremental cycle test-to-exhaustion on an electrically 
braked cycle ergometer (LODE Excalibur Sport V 2.0 Groningen, Netherlands). The test 
consisted of a 3 min warm-up at 95 W, followed by an increase of 35 W every 3 min until 
exhaustion, at a self-selected cadence. Breath-by-breath measurements were taken throughout 
exercise, using an OxyCon Pro automated gas analysis system (Jaeger, Wuerzeburg, 
Germany). The gas analyzers were calibrated using a 4.95% CO2 - 95.05% N2 gas mixture 
(BOC Gases, Surrey, UK) and the volume transducer was calibrated with a 3L calibration 
syringe. Heart rate (HR) was measured continuously via telemetry using a HR monitor (Polar 
S625X; Polar Electro Oy, Kempele, Finland). V&O2 was considered maximal if 3 of the 4 
following conditions were met: 1) a plateau in V&O2 with further increasing workloads (an 
increase of < 2 mL·kgˉ1·minˉ1); 2) a HR within 10 beats/min of the age predicted maximum 
(220 bpm - age); 3) a respiratory exchange ratio (RER) of >1.05; and 4) a rate of perceived 
exertion (RPE) greater than 17. The seat position, handlebar height and orientation used 
during baseline testing were recorded and replicated on subsequent visits to the laboratory. 
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All exercise bouts were conducted in thermo-neutral conditions (21°C, 40% relative 
humidity). 
 
 Dietary Analysis & Control: Participant diet was standardized for 48 h prior to each 
treatment. During the preliminary testing phase, participants completed a 3-day food diary, 
representative of their average week (2 weekdays and 1 weekend day). A questionnaire of 
food preferences was also completed by participants. Using an on-line diet planner (Weight 
Loss Resources), each of the 3-days was logged and energy and macronutrient intake was 
estimated. In our study cohort the average total daily energy intake was ~2787 ± 164 kcal 
(5.3 ± 0.4 g·kg-1 BM carbohydrate; 1.2 ± 0.1 g·kg-1 BM fat; 1.5 ± 0.2 g·kg-1 BM protein). The 
food parcels given to each participant matched their habitual energy and macronutrient 
intake. Participants were instructed to refrain from caffeine and alcohol and to consume only 
the food provided for them over the two-days prior to arriving for each trial. Participants 
were also asked to consume their final meal no later than 2200 h to ensure a 10 h fast prior to 
measuring myofibrillar and mitochondrial protein synthesis. An identical two-day food parcel 
was provided to each participant prior to the second trial.  
 
 Physical activity control: Participants were instructed to maintain their normal training 
volume and intensity throughout the course of the study but to refrain from training for 48 h 
prior to each treatment trial. To monitor physical activity between trials, participants were 
asked to record all training 7-days prior to each trial. No differences were noted in training 
volume in the 7-days prior to each trial. 
 
3.3.4 Experimental trial protocol 
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 Each participant was instructed to arrive at the Human Performance Laboratory at 
0630 h after an overnight fast, where standard measures of height and weight were taken. A 
cannula was placed into the forearm vein of one arm and a hand vein of the other. The 
forearm cannula was used to infuse a stable isotopic tracer whilst the hand vein was heated 
for frequent arterialized blood sampling. After a resting blood sample had been obtained, 
participants then received a primed constant infusion of L-[ring-13C6] phenylalanine (prime: 2 
µmol·kg-1; infusion: 0.05 µmol·kg-1·min-1; Cambridge Isotope Laboratories, MA, USA) to 
determine skeletal muscle protein kinetics (described below). Approximately 90 min after the 
start of the infusion, having rested in a supine position, participants were asked to complete a 
90 min cycling exercise bout on a Lode Cycle Ergometer at a self selected cadence ≥ 60 
revolutions per minute (rpm). The exercise bout consisted of a warm-up cycle at 50% Wmax 
(189 ± 4 W) for 10 min followed by 80 min, initially at 75% Wmax (283 ± 6 W). V&O2, RER, 
HR and RPE were recorded over 25-30 min, 55-60 min and 85-90 min of the exercise bout 
(as described above). If participants indicated during exercise that the workload was too 
difficult and they were unlikely to complete the full 80 min, workload was lowered in 5% 
decrements to no less than 65% Wmax. Air conditioning and a fan were used when requested 
by participants. The exact settings of the air conditioning/fan and the time of any change in 
workload were recorded and replicated during the second trial. Throughout each trial 
participants were allowed to drink water ad libitum. The amount of water consumed 
throughout the course of the each trial was found to be similar (1556 ± 249mL for CHO and 
1674 ± 233mL for C+P).  
 
 Muscle biopsy and blood sampling Using a 5-mm Bergstrom biopsy needle, two 
muscle biopsies (~100-150 mg of muscle tissue per biopsy) were obtained from the same leg 
during each trial. The order of biopsied leg was randomized and counterbalanced for each 
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trial. Prior to the exercise bout (~15min) under local anaesthetic (1% Lidocaine), the lateral 
portion of one thigh was prepared for the extraction of a needle biopsy sample from the 
vastus lateralis muscle. Biopsy incisions were made prior to exercise to allow the sample to 
be obtained as quickly as possible after exercise (5 ± 1 min post-exercise). Immediately after 
the post-exercise muscle biopsy was obtained, participants were asked to consume one of two 
treatment beverages described below. Four hours after consuming the treatment beverage, the 
second muscle biopsy was obtained (Figure 3.1). The second biopsy was taken ~1 cm 
proximal to the first biopsy. Biopsy samples were quickly rinsed, blotted and divided into two 
to three pieces, before being frozen in liquid nitrogen and stored at -80°C until later analysis. 
Arterialized blood samples from a heated hand vein were collected at rest, immediately post-
exercise and every 15 min following beverage consumption for 2 h. Thereafter, blood 
samples were obtained at regular intervals for the remainder of the infusion. Blood was 
collected in EDTA-containing, lithium heparin-containing and serum separator tubes and 
spun at 3500rpm for 15 min at 4°C. Aliquots of plasma and serum were the frozen at -80°C 
until later analysis. 
 
-180 2400 60 120 180-120 -60
* * * * ** * * ** * * *
Exercise
Time (min)
Biopsy
Blood
Primed-continuous L-[ring-¹³C6] phenylalanine infusion
Beverage
Figure 3.1 Schematic diagram of the experimental protocol. 
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 Treatment beverages Immediately after the first muscle biopsy sample was obtained, 
subjects ingested either 25.2g of carbohydrate (CHO) or 25.4g of carbohydrate plus 10.2g of 
whey protein (C+P) dissolved in 250 mL of cold water (~11 ± 0 min post-exercise). A second 
identical beverage was consumed 30 min after the first beverage was finished. This dose 
regime provided a total carbohydrate and protein intake of 50.8g and 20.4g, respectively in 
C+P and a total carbohydrate intake of 50.3g in CHO. Participants were encouraged to 
consume the beverages within 2 min. Both CHO and C+P treatment beverages were matched 
for flavour (orange and passion fruit) and appearance. Beverages were administered to 
participants in a single-blinded manner, the order of which was randomized. Eight out of the 
ten participants correctly identified the order of the treatments. The amino acid content of the 
whey protein was (in percent content, wt:wt): Ala, 5.2; Arg, 2.2; Asp, 11.4; Cys, 2.3; Gln, 
18.8; Gly, 1.5; His, 1.8; Ile, 6.7; Leu, 11; Lys, 10; Met, 2.3; Phe, 3.1; Pro, 5.7; Ser, 4.8; Thr, 
7; Trp, 1.5; Tyr, 2.7; and Val, 6.1. A small amount of L-[ring-13C6] phenylalanine tracer was 
added to the C+P drink (6% of phenylalanine content) in order to minimize changes in blood 
phenylalanine enrichment after drink ingestion.  
 
3.3.5 Analyses 
 Blood analyses: Plasma glucose, plasma lactate and plasma urea concentrations were 
analyzed using an ILAB automated analyzer (Instrumentation Laboratory, Cheshire, UK). 
Serum insulin was analyzed using a commercially available ELISA kit (IBL International, 
Hamburg, Germany), following the manufacturer’s instructions. Concentrations of 
phenylalanine, leucine, threonine and 13C6 phenylalanine tracer-to-tracee (t/T) enrichment 
were determined by Gas Chromatography Mass Spectrometry (GCMS) (model 5973; Hewlett 
Packard, Palo Alto, CA). On thawing, plasma samples were diluted 1:1 in acetic acid and 
purified on cation-exchange columns (Dowex 50W-X8-200, Sigma-Aldrich Poole, UK). The 
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amino acids were then converted to their N-tert-butyldimethyl-silyl-N-
methyltrifluoracetamide (MTBSTFA) derivative. Plasma 13C6 phenylalanine enrichment was 
determined by monitoring at ions 234/240. Appropriate corrections were made for any 
spectra that overlapped, contributing to the t/T ratio. Amino acid concentrations were 
determined using an internal standard method (49, 51), based on the known volume of blood 
and internal standard added. The internal standards used were U-[13C9-15N] phenylalanine 
(50µmol/l), L-[2H3] leucine (120µmol/l) and L-[2H4] threonine (182µmol/l) added in a ratio 
of 100 µl/ml of blood. Leucine, threonine and phenylalanine concentrations were determined 
by monitoring at ions 302/308, 404/409 and 336/346, respectively.  
 
Muscle tissue analyses: Muscle samples were analyzed for enrichment of L-[ring-13C6] 
phenylalanine in the intracellular pool and bound myofibrillar and mitochondrial protein 
fractions. Intracellular amino acids were liberated from ~10-20 mg of muscle. The tissue was 
powdered under liquid nitrogen using a mortar and pestle and 500 µl of 0.2M perchloric acid 
was added. The mixture was centrifuged at 10,000g for 10 min. The pH of the supernatant 
was then adjusted to 5–7 with 2M KOH and treated with 20µL of urease for removal of urea. 
The free amino acids from the intracellular pool were purified on cation-exchange columns 
(described above). Intracellular amino acids were converted to their MTBSTFA derivative 
and 13C6 phenylalanine enrichment determined by monitoring at ions 234/240 (as described 
above). 
 Mitochondrial and myofibrillar protein isolation was achieved using a protocol adapted 
from Wilkinson et al. (54). Approximately 70-100mg of muscle tissue was homogenized in a 
2mL Eppendorf with a Teflon pestle in 10µL·mg-1 of ice-cold homogenizing buffer (0.1 mM 
KCl, 50 mM Tris, 5 mM MgCl, 1 mM EDTA, 10 mM β-glycerophosphate, 50 mM NaF, 
1.5% BSA, pH 7.5). The homogenate was spun at 1,000g for 10 min at 4ºC. The supernatant 
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was transferred to another Eppendorf tube and spun at 10,000g for 10 min at 4ºC to pellet the 
sarcoplasmic mitochondria (SM). The supernatant was then removed and discarded. The 
pellet that remained from the original 1,000g spin was washed twice with homogenization 
buffer. A glass Dounce homogenizer and tight fitting glass pestle were used to forcefully 
homogenize the pellet in homogenization buffer to liberate intermyofibrillar mitochondria 
(IM). The resulting mixture of myofibrillar proteins (MYO) and IM was spun at 1,000g for 
10 min at 4ºC to pellet out the MYO. The supernatant was removed and spun at 10,000g for 
10 min at 4º C to pellet the IM. The MYO, SM and IM pellets were washed twice with 
homogenizing buffer containing no BSA. The MYO fraction was separated from any 
collagen by dissolving in 0.3 M NaCl, removing the supernatant and precipitating the 
proteins with 1.0 M PCA. All samples were washed once with 95% ethanol. In order to 
determine 13C6 phenylalanine enrichment in the mitochondrial protein fraction, IM and SM 
fractions were combined as per Wilkinson et al. (54). Mitochondrial and myofibrillar 
fractions were then hydrolysed overnight at 110 ºC  in 0.05 M HCl/Dowex 50WX8-200 
(Sigma Ltd, Poole, UK) and the constituent amino acids purified on cation-exchange columns 
(Dowex 50W-X8-200, Sigma-Aldrich Poole, UK). The amino acids were then converted to 
their N-acetyl-n-propyl ester derivative. Phenylalanine labelling was determined by gas-
chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS, Delta-plus XL, 
Thermofinnigan, Hemel Hempstead, UK) by monitoring at ions 336/342 for labelled and 
unlabelled CO2. Unfortunately during processing 2 samples were lost for the mitochondrial 
fractions, therefore the data represent n = 8. No myofibrillar fractions were lost during 
processing (n = 10). 
We assessed the purity of our protein fractions on muscle tissue collected during a pilot 
study. Western blots revealed a greater abundance of myosin heavy chain protein content in 
the myofibrillar fraction and a greater abundance of cytochrome c oxidase protein content in 
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the mitochondrial fraction. In addition, we measured citrate synthase (CS) activity in a mixed 
muscle homogenate and each of the IM and SM mitochondrial fractions during method 
development. We found that the CS activity was ~4-fold higher in the mitochondrial fractions 
than the mixed homogenate. Data for these experiments is presented in Chapter 6 (sub-
section 6.1) of this thesis. 
 
Western Blots: The remaining muscle tissue (25-40mg) was powdered on dry ice under 
liquid nitrogen using a mortar and pestle. Approximately 20mg of powdered muscle was 
homegenized in lysis buffer (50mM Tris pH 7.5; 250mM Sucrose; 1mM EDTA; 1mM 
EGTA; 1% Triton X-100; 1mM NaVO4; 50mM NaF; 0.50% PIC), using a hand-held 
homogenizer (PRO200, UK). Samples were shaken at 4ºC for 30 min (12,000rpm), 
centrifuged for 5 min at 6,000g and the supernatant removed for protein determination. 
Protein concentration was determined using the DC protein assay (Bio Rad, Hertfordshire, 
UK). Equal aliquots of protein were boiled in Laemmli sample buffer (250mM Tris-HCl, pH 
6.8; 2% SDS; 10% glycerol; 0.01% bromophenol blue; 5% β-mercaptoethanol) and separated 
on SDS polyacrylamide gels (10 – 12.5%) for 1 h at 58mA. Following electrophoresis; 
proteins were transferred to a Protran nitrocellulose membrane (Whatman, Dassel, Germany) 
at 100 V for 1 h. The membranes were incubated overnight at 4°C with the appropriate 
primary antibody. The primary antibodies used were AMPKThr172 (Millipore 15-115), 
mTORSer2448 (Cell signalling 2976), S6KThr389 (Cell signalling 9234), AktThr308 (Cell 
signalling 4056), 4E-BP1Thr37 (Santa Cruz SC6025), eEF2Thr56 (Cell signalling 2332), 
PRAS40Thr246 (Cell Signalling 2610) and p38 MAPKThr180 (Cell Signalling 9212). The 
following morning the membrane was rinsed in wash buffer (TBS with 0.1% Tween-20) 
three times for 5 min. The membrane was then incubated for 1 h at room temperature within 
wash buffer containing the appropriate secondary antibody, either horseradish (HRP)-linked 
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anti-mouse IgG (New England Biolabs, 7072; 1:1,000) or anti-rabbit IgG (New England 
Biolabs, 7074; 1:1,000). The membrane was then cleared in wash buffer three times for 5 
min. Antibody binding was detected using enhanced chemiluminescence (Millipore, 
Billerica, MA). Imaging and band quantification were carried out using a Chemi Genius 
Bioimaging Gel Doc System (Syngene, Cambridge, UK). Intracellular signalling targets were 
determined with n = 8 for CHO and C+P trials. 
 
3.3.6 Calculations 
The fractional synthetic rate (FSR) of mitochondrial and myofibrillar proteins were 
calculated using the standard precursor-product method:  
  
FSR (%·h-1) = ∆Eb/Ep × 1/t × 100        (1) 
 
Where ∆Eb is the change in bound 13C6 phenylalanine enrichment between two biopsy 
samples, Ep is the precursor enrichment and t is the time between muscle biopsies. 
 
The true precursor enrichment would be the labelled phenylalanine-tRNA (1). 
However, measurement of this enrichment requires large amounts of tissue, which cannot 
typically be obtained from human volunteers. Thus, the intracellular (IC) free phenylalanine 
enrichment is commonly used in studies (27, 38, 49), primarily because it is considered a 
superior precursor surrogate. Unfortunately, due to technical difficulties, the IC enrichment 
was available for only 5 participants. Thus, we chose to use the plasma precursor to estimate 
the IC enrichment. A comparison of plasma and IC enrichments from the samples available 
(n =5) revealed the IC enrichment to be 70 ± 2% of the plasma (range 67-77%). Furthermore, 
a comprehensive examination of studies (for example; (2, 30, 46)) in which phenylalanine 
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tracers were used to determine FSR revealed the IC phenylalanine enrichment to be ~70% of 
the plasma enrichment. We chose not to use the plasma enrichment, per se, as the precursor 
for ease of comparison of the results to other previously published studies. 
 
3.3.7 Statistical analysis 
A within-subject repeated measures design was utilized for the current study. Exercise 
variables, blood analytes and Western blot data were analyzed using a two-way ANOVA 
with repeated measures (treatment x time) to determine differences between each treatment 
beverage across time. Myofibrillar and mitochondrial FSR data were analyzed using one-
factor (treatment) repeated measures ANOVA. When a significant main effect or interaction 
was identified, data were subsequently analyzed using a Bonferroni post hoc test. All 
statistical tests were analyzed using statistical package for social sciences (SPSS) version 
18.0 (Illinois, Chicago, U.S). Significance for all analyses was set at P < 0.05. All values are 
presented as means ± standard error of the mean (SEM). 
 
3.4 Results 
3.4.1 Exercise variables 
There was no between-trial difference in heart rate, cadence, V&O2 and RER measured at 
25-30, 55-60 and 85-90 min of the steady state cycle (Table 3.1). Average HR over the 90 
min cycle was 172 ± 3 and 172 ± 4 bpm for CHO and C+P, respectively. Average V&O2 over 
90 min (51.3 ± 1.6 mL·kg-1·min-1 for CHO and 51.6 ± 1.2 mL·kg-1·min-1 for C+P) and RER 
over 90 min (0.88 ± 0.01 for CHO and C+P) were not different between treatments. 
Metabolic data indicated participants were cycling at 77 ± 1% of V&O2max during CHO and 
C+P trials. Average RPE over 90 min was similar for CHO and C+P (16 ± 4 for CHO and 
C+P).  
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3.4.2 Blood analytes 
Fasted blood glucose was 5.1 ± 0.3 mmol·L and 5.3 ± 0.3 mmol·L for CHO and C+P, 
respectively and remained similar immediately post-exercise. Approximately 30 min after 
consuming the first treatment beverage, plasma glucose concentration increased by ~32% and 
~20% for CHO and C+P, respectively, with no significant difference between treatments. 
Plasma glucose concentration returned to basal values by 1.5 h post-exercise for CHO and 
C+P and was constant for the remainder of the infusion. Fasted serum insulin concentration 
was 6.0 ± 0.8 and 5.5 ± 0.5 µU·ml-1 for CHO and C+P, respectively (Figure 3.2A). Following 
drink ingestion, serum insulin concentration increased for both CHO and C+P, peaking at 30 
min post-exercise (P < 0.001). Serum insulin increased to a greater extent for C+P (~285%) 
compared with CHO (~60%; P < 0.001). Serum insulin returned to basal values by 1.5 h 
post-exercise for CHO and C+P and remained constant until the end of the infusion. 
Following exercise, plasma lactate concentration increased 150% and 175% compared with 
resting values for CHO and C+P, respectively (P < 0.001), with no difference between 
treatments. Lactate concentration returned to basal values by 3 h post-exercise for CHO and 
C+P. Resting plasma urea concentration was similar for CHO and C+P and was stable 
immediately post-exercise (Figure 3.2B). Following the ingestion of C+P, plasma urea 
concentration increased by ~20% compared with resting values and remained elevated at 4 h 
post-exercise (P < 0.05). Plasma urea concentration remained unchanged for CHO compared 
with resting values. From 15 min to 4 h post-exercise, plasma urea concentration for C+P was 
significantly greater than CHO (P < 0.05). 
 
3.4.3 Plasma amino acid concentrations 
Prior to and immediately post-exercise, plasma amino acid concentrations of 
phenylalanine, leucine and threonine were similar for CHO and C+P (Figure 3.3). Following 
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the ingestion of C+P, plasma concentrations of phenylalanine, leucine and threonine 
increased by 37, 130 and 58%, respectively (P < 0.001) and peaked at 1 h post-exercise (30 
min after the second drink was ingested), after which, amino acid concentrations returned to 
basal levels such that there were no differences between CHO and C+P at 4 h post-exercise. 
Following the ingestion of CHO, plasma phenylalanine and threonine concentrations did not 
change. Plasma leucine concentration was reduced following CHO ingestion (P = 0.04) 
returning to pre-exercise levels by 2 h post-exercise. 
 
3.4.4 Plasma and intracellular 13C6 phenylalanine enrichment 
Plasma 13C6 phenylalanine enrichment increased from immediately pre- to post-
exercise but was stable across the time of tracer incorporation, immediately post-exercise to 4 
h post-exercise for CHO and C+P (7.2 ± 0.03% t/T for both; Figure 4). These data 
demonstrate that the additional tracer added to the C+P treatment beverage did not appear in 
the circulation more rapidly than the amino acids from the protein and that all measurements 
were made at isotopic equilibrium. Intracellular 13C6 phenylalanine enrichment for an 
available sub-set of participants (n = 5) was stable across the time of tracer incorporation for 
CHO and C+P (4.8 ± 0.5 and 4.5 ± 0.7% t/T, respectively). Based on the relationship between 
plasma and intracellular enrichments, the mean predicted intracellular enrichment for the 
complete study cohort (n = 10) was 5.0 ± 0.1 and 5.1 ± 0.2% t/T for C+P and CHO, 
respectively. Trial order did not influence the tracer enrichment in plasma (7.0 ± 0.3 and 7.4 
± 0.2% t/T for trials 1 and 2, respectively; P = 0.2) or in the available intracellular samples 
(4.5 ± 0.4 and 4.8 ± 0.3% t/T for trials 1 and 2, respectively; P = 0.2). 
 
3.4.5 Post-exercise protein phosphorylation 
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Immediately post-exercise, mTORSer2448 phosphorylation was similar for CHO and 
C+P. At 4 h post-exercise mTOR phosphorylation showed a tendency to increase for C+P (P 
= 0.08), whereas mTOR phosphorylation tended to decrease for CHO (P = 0.07). At 4 h post-
exercise mTOR phosphorylation was greater for C+P compared with CHO (P = 0.02; Figure 
3.5A). Immediately post-exercise, eEF2Thr56 phosphorylation was similar for CHO and C+P. 
At 4 h post-exercise phosphorylation increased 1.4-fold for CHO compared with immediately 
post-exercise (P = 0.02). Furthermore, eEF2 phosphorylation for CHO was greater than C+P 
at 4 h post-exercise (P = 0.04; Figure 3.5B). Immediately post-exercise, p38 MAPKThr180 
phosphorylation was similar for CHO and C+P. At 4 h post-exercise p38 MAPK 
phosphorylation was unchanged for CHO and tended to increase for C+P (P = 0.08) with no 
significant difference between treatments (Table 3.2). Immediately post-exercise, 
p70S6KThr389 phosphorylation was similar for CHO and C+P. The phosphorylation of 
p70S6K increased at 4 h for C+P compared with immediately post-exercise (P = 0.05) but 
was not significantly different from CHO (Figure 3.5C). Immediately post-exercise, 4E-
BP1Thr37 phosphorylation was similar for CHO and C+P. At 4 h post-exercise 4E-BP1 
phosphorylation showed a tendency to increase for CHO and C+P (P = 0.09) with no 
difference between treatments (Table 3.2). There was no difference in the phosphorylation of 
AMPKThr172, AktThr308 and PRAS40Ser246 immediately post-exercise between CHO and C+P. 
Furthermore, the phosphorylation of AMPK, Akt and PRAS40 remained unchanged at 4 h 
post-exercise for CHO and C+P (Table 3.2). 
 
3.4.6 Mitochondrial and myofibrillar FSR 
Mitochondrial protein synthesis rates were similar for CHO and C+P (confidence 
interval [CI]: 0.06 - 0.12 and 0.06 - 0.10 %·h-1, respectively; Figure 3.6). Myofibrillar protein 
synthesis rates were ~35% higher for C+P compared with CHO (CI: 0.07 - 0.11 and 0.05 - 
Chapter 3. 115 
0.07 %·h-1, respectively; P = 0.025). Rates of mitochondrial and myofibrillar protein 
synthesis were 30 ± 0.9% lower when the unadjusted plasma precursor was used in the 
calculation of FSR. However, the statistical outcome was not different (data not presented).  
  
 
 
 
CHO C+P 
Ex time (min) 
 
25-30 55-60 85-90 25-30 55-60 85-90 
HR (bpm) 
 
172 ± 5 172 ± 3 172 ± 1 174 ± 4 172 ± 1 171 ± 2 
Cadence (rpm) 
 
*84 ± 5 79 ± 5 80 ± 3 *84 ± 4 80 ± 3 79 ± 5 
V&O2 (mL·kgˉ1·minˉ1) 
 
53.2 ± 2.0 50.7 ± 2.0 50.9 ± 2.0 52.6 ± 1.9 50.5 ± 1.9 50.9 ± 2.6 
%V&O2max 
 
80 ± 3 77 ± 2 76 ± 5 79 ± 2 76 ± 2 77 ± 3 
RER 
 
0.89 ± 0.01 0.87 ± 0.02 0.87 ± 0.02 0.91 ± 0.01 0.87 ± 0.02 0.87 ± 0.01 
RPE 16 ± 1 17 ± 1 17 ± 1 16 ± 1 17 ± 1 18 ± 1 
 
 
Table 3.1 Exercise variables 
Values are the average recording over each 5 min phase and are presented as mean ± SEM.  * indicates significant 
difference at 25-30 min compared with other time phases (P < 0.05). 
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Figure 3.2 (A) Plasma urea and (B) serum insulin concentration in CHO and C+P trials. Means 
with different subscripts are significantly different from each other (P < 0.05). *: significant 
difference between CHO and C+P. Values are means ±SEM; n = 10. 
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Figure 3.3 Plasma concentrations of (A) phenylalanine, (B) leucine and (C) threonine. Means 
with different subscripts are significantly different from each other. *: significant difference 
between CHO and C+P (P < 0.05). Values are means ±SEM; n = 10. 
 
Figure 3.4 Enrichment of 13C6 phenylalanine in plasma. % t/T: percentage of tracer-to-tracee 
ratio. Values are means ± SEM; n = 10. 
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Treatment CHO C+P 
 
Time post-exercise (h) 0 - 4 0 – 4 
 
 
AMPKThr172 
 
0.95 ± 0.03 
 
0.89 ± 0.08 
 
AktThr308 
 
 
0.92 ± 0.04 
 
1.04 ± 0.04 
4E-BP1Thr37 
 
1.03 ± 0.02 1.04 ± 0.02 
eEF2Thr56 1.4 ± 0.11*† 1.05 ± 0.12 
 
  
mTORSer2448 
 
0.91 ± 0.09 1.05 ± 0.05† 
P38 MAPKThr180 
 
1.15 ± 0.21 1.28 ± 0.08 
p70S6KThr389 
 
1.06 ± 0.04 1.13 ± 0.05* 
PRAS40Ser246 
 
0.97 ± 0.08 1.03 ± 0.08 
Values are mean fold-change ± SEM over 4 hours post-exercise. * indicates significant increase 
in phosphorylation at 4 h compared with 0 h post-exercise (P < 0.05). † indicates significant 
difference between CHO and C+P at 4 h post-exercise (P < 0.05); n = 8 
Table 3.2 Post-exercise protein phosphorylation 
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Figure 3.5 Post-exercise protein phosphorylation of (A) mTORSer2448, (B) eEF2Thr56 and (C) 
p70S6KThr389 *: significant increase in phosphorylation at 4 h compared with 0 h post-exercise 
(P < 0.05) †: significant difference between CHO and C+P at 4 h post-exercise (P < 0.05). 
Values are means ± SEM; n = 8. 
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3.5 Discussion 
The present study findings expand on those of previous investigations (27, 34) to show 
that the ingestion of protein with carbohydrate (C+P) following 90 min of cycling by well-
trained individuals, stimulates an increase in myofibrillar muscle protein synthesis (MPS) 
compared with carbohydrate alone (CHO). Interestingly, C+P did not increase mitochondrial 
MPS compared with CHO. The mechanism facilitating the adaptive response of myofibrillar 
MPS seems to involve the phosphorylation of mTOR and p70S6K, which in turn, may 
increase translation initiation and release the inhibition of eEF2 on elongation. 
 
It has been well documented that EE increases whole-body (9) and mixed muscle 
protein synthesis (10, 18, 19, 50). Further, the synthesis of different protein sub-fractions 
Myofibrillar Mitochondrial
FS
R 
(%
·
h-
1 )
0.00
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*
Figure 3.6 Myofibrillar (n = 10) and mitochondrial (n = 8) fractional synthetic rate. *: 
significant difference between CHO and C+P (P < 0.05). Values are means ±SEM. 
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increases in response to EE (37, 54). Changes in MPS following EE are thought to be 
relevant for tissue repair and remodelling and not skeletal muscle hypertrophy. Indeed, it was 
recently shown that EE stimulates an increase in the synthesis of mitochondrial proteins, with 
no significant rise in myofibrillar MPS (54). The same authors demonstrate that the response 
of mitochondrial and myofibrillar MPS is reversed following an acute bout of resistance 
exercise (RE) (54). Post-RE protein ingestion also augments myofibrillar MPS (26). Given 
evidence that the pattern of response of mitochondrial and myofibrillar proteins to the 
provision of amino acids is similar under resting conditions (4, 5), it has been postulated that 
the increase in mixed MPS observed when protein is ingested post-EE (27, 34), could be due, 
in part, to an increase in the synthesis of mitochondrial proteins. However, our findings 
seemingly contradict this hypothesis and indicate that myofibrillar proteins are preferentially 
synthesized when protein is ingested following EE. Recently Harber et al. (19) showed no 
response of mixed MPS to post-EE protein ingestion following a 60 min cycle. These authors 
(19) measured mixed MPS at 2-6 hours post-EE, starting at 1 hour after feeding. Thus, the 
peak anabolic response to exercise and feeding (32, 55) may have occurred earlier than was 
measured, concealing any potential difference. Based on the data of Harber et al. (19), we 
suggest that the measure of mixed MPS may not be sensitive enough to reflect changes in 
myofibrillar and mitochondrial MPS. 
 
The rise in myofibrillar MPS following a single bout of RE with protein ingestion (55), 
is predictive of gains in lean muscle mass when the training and feeding stimulus is repeated 
over an extended time-period (20). Thus, one interpretation of our data is that repeated post-
EE protein ingestion may enhance muscle hypertrophy in endurance athletes, which, 
depending on the competitive goals of the athlete, may, or may not be a desirable adaptation. 
Gains in lean mass may result in a decreased power-to-mass ratio that accompanies an 
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increase in overall body weight. Indeed, evidence indicates that the primary goal of strength 
training for endurance populations is neuromuscular adaptations, rather than hypertrophy, to 
enhance performance (40). However, we hypothesize that the increase in power output that 
accompanies gains in lean mass may offset the gains in overall body weight, resulting in no 
decrement in performance. In support of this thesis, Hickson et al. (23) demonstrated that 
gains in thigh mass and thus, total body weight following strength training, extend short-term 
endurance capacity. Thus, manipulation of the power-to-mass ratio in competitive cyclists 
would likely have a profound impact on overall performance depending on the requirements 
of the particular event (11, 31). At this time, the implications of muscle hypertrophy for 
endurance performance are less than clear, as is the notion that post-EE protein ingestion 
promotes muscle hypertrophy. Clearly, these topics warrant further investigation. 
 
Alternatively, the increase in myofibrillar MPS we observed following exercise may 
not lead to an increase in lean mass. Where the magnitude of myofibrillar muscle protein 
breakdown (MPB) equals or exceeds that of myofibrillar MPS, structural proteins would not 
accumulate to increase lean mass. Direct measurement of muscle protein breakdown with 
endurance exercise is rare and the results somewhat equivocal (12, 15, 44). Using venous 
blood sampling, other investigators have demonstrated that whole-body protein breakdown is 
transiently elevated after moderate intensity walking exercise, compared with rest (44), but 
others report no change following exercise (50). These studies investigated the response to 
moderate to low intensity exercise, rather than the high intensity exercise performed by our 
subjects. However, studies of endurance exercise have reported an increase in indirect 
markers of MPB including 3-methyl-histidine excretion (10) and net amino acid efflux from 
the leg (3, 52) during exercise. Thus, elevated myofibrillar MPS may also represent an 
increase in protein turnover in response to an increase in the degradation of myofibrillar 
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proteins during and following intense exercise. Combining these data, it is possible that 
increased myofibrillar MPS we observed when protein is ingested following intense EE, 
serves to counteract the fasted state losses that occurred during exercise and thus, represents 
an increase in myofibrillar protein turnover. Increased protein turnover may be important for 
the remodelling of contractile proteins. However, this hypothesis is not supported by a recent 
study by Harber et al. (19) that demonstrated that protein ingestion following an intense cycle 
attenuates the expression of  proteolytic factors such as MuRF-1 and calpain-2. However, the 
relationship between the expression of these genes and protein degradation is uncertain (17). 
Further studies are required to determine the influence of post-EE protein ingestion on 
myofibrillar protein degradation and longitudinal intervention studies are needed to determine 
the relevance of increased protein turnover to the adaptive response to EE and performance. 
 
The addition of protein to ingested carbohydrate did not increase the synthesis of 
mitochondrial proteins in the first 4 hours following exercise. Thus, the acute translational 
response to EE (Wilkinson et al., 2008) may not be sensitive to protein ingestion. However, 
the long-term response of mitochondria to EE is transcriptionally mediated and occurs later 
than four hours post-EE (16, 21, 43), reaching a zenith between 10-24 hours post-EE (33, 37). 
Combining these data with recent evidence that mixed MPS remains elevated above rest at 24 
h post-EE (18), it is conceivable that the major response of mitochondrial MPS to post-EE 
protein ingestion may have occurred later than the time frame in which we measured.  
 
Another possibility is that the training status of the subjects and the exercise protocol 
utilized in the present study may explain the lack of change in mitochondrial MPS. Indeed, 
compared with pre-training values, Wilkinson et al. (54) found that the response of 
mitochondrial MPS to acute EE was blunted in legs that had undergone 10 weeks of either 
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EE or RE training. Thus, it is possible that the synthetic response of mitochondrial proteins in 
well-trained individuals reaches a ‘ceiling’; the point beyond which, further contractile and/or 
nutrient stimuli fail to augment the synthetic response. Whether the pattern of myofibrillar 
and mitochondrial MPS we found is the same in untrained individuals remains to be 
elucidated.  
 
EE can activate proteins that regulate translation initiation (7, 36, 54) (i.e. mTOR) and 
elongation (36) (i.e. eEF2). The transient increase in mTOR signalling following EE (7, 36), 
returns to basal levels by 3-4 hours post-EE (54, 56). Fujita et al. (14) and others have shown 
that ingesting protein and/or amino acids at rest increases MPS via mTOR-p70S6K 
signalling. To our knowledge, the only study in humans to investigate the combined effect of 
EE and protein ingestion on signalling protein phosphorylation was conducted by Ivy et al. 
(28). In this study, trained cyclists ingested C+P over 45 minutes after a 1 hour variable 
intensity cycle. The authors demonstrated that the C+P group showed higher mTOR and rpS6 
phosphorylation than a non-energetic placebo. However, due to the study design, it was 
unclear whether these effects were due to greater amino acid availability, elevated plasma 
insulin concentration, or a combination of the two following C+P ingestion. The same group 
had earlier conducted a similar, more rigorous experiment, in which rats were fed 
immediately after an exhaustive swim (39). The authors demonstrated that ingesting CHO, 
C+P or protein-only, transiently increased the phosphorylation of mTOR, 4E-BP1, rpS6 and 
p70S6K, with the phosphorylation of rpS6 and 4E-BP1 sustained by C+P ingestion (39). Our 
data show that protein ingestion following EE sustained the phosphorylation of mTOR, such 
that by 4 hours post-exercise the difference between C+P and CHO was significant. Further, 
p70S6K phosphorylation increased by 4 hours post-exercise for C+P, compared with 
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immediately post-exercise. Thus, since mTOR activation is associated with increased 
initiation, this suggests that C+P prolongs the effect of EE on protein synthesis. 
 
In addition to initiation, it is now recognized that translation elongation is regulated by 
exercise and nutrient provision. Reduced phosphorylation of eEF2 due to eEF2 kinase 
inhibition results in better translocation of the ribosome along the mRNA, thereby 
contributing to faster elongation and greater MPS (8). Mascher et al. (36) showed that eEF2 
phosphorylation was blunted following EE, reaching a nadir at 60 min and remaining 
suppressed at 180 min post-EE. Concomitant with an increase in MPS, Fujita et al. (14) noted 
that essential amino acid-carbohydrate co-ingestion suppressed the phosphorylation of eEF2. 
Thus, eEF2 phosphorylation is sensitive to EE and protein ingestion. In this regard, we show 
that eEF2 phosphorylation increased by ~40% at 4 h post-EE in the CHO group, whereas 
there was no change with protein ingestion. Our findings are further supported by human (14) 
and cell culture (53) studies showing that mTOR regulation of p70S6K is inversely related to 
eEF2 phosphorylation. Taken together, these data suggest that the sustained phosphorylation 
of p70S6K, suppressed the phosphorylation of eEF2 following C+P ingestion, thereby 
increasing the rate of elongation. Together with the increase in initiation due to prolonged 
mTOR activation, this would lead to a rise in myofibrillar MPS. 
 
In conclusion, we have shown that when protein is added to carbohydrate intervention 
following cycling exercise, myofibrillar proteins are preferentially synthesized. However, 
from our acute study it is not possible to determine whether frequent post-EE protein 
ingestion promotes muscle hypertrophy over time. Alternatively, the rise in myofibrillar MPS 
with protein ingestion, may serve to counteract a fasted-state rise in myofibrillar protein 
breakdown during EE. Consequently, protein ingestion may increase the rate of myofibrillar 
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protein turnover. The importance of an increase in myofibrillar protein turnover for 
endurance-trained individuals remains to be elucidated, but may be relevant for the 
maintenance and structural integrity of contractile proteins. Thus, we posit that post-EE 
protein nutrition could have important implications on the adaptive response to endurance 
exercise and, potentially, the recovery of muscle function. Finally, the synthetic response of 
different protein fractions to endurance exercise and protein ingestion may be dependent on 
the individual training status, intensity and duration of the exercise bout, as well as the timing 
and quantity of post-EE nutrient strategies. Future studies should seek to address these issues 
in greater depth. 
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4.1 Abstract 
Purpose: To investigate the mechanisms underpinning modifications in glucose 
homeostasis and insulin sensitivity at 24 h after a bout of resistance exercise (RE) with or 
without protein ingestion. Methods: Twenty-four healthy males were assigned to a control 
(CON; n = 8), exercise (EX; n = 8) or exercise plus protein condition (EX+PRO; n = 8). EX 
and EX+PRO completed 8 x 10 repetitions of leg press and leg extension exercise at 75% 
1RM. Muscle biopsy and blood samples were obtained for all groups at rest and immediately 
post-RE for EX and EX+PRO. At 24 h post-RE (or post-resting biopsy for CON), a third 
muscle biopsy was obtained. Participants then underwent an oral glucose tolerance test 
(OGTT) containing 2g of [U-13C] glucose. Thereafter, blood samples were obtained every 10 
min for 2 h. Glucose kinetics were assessed with an infusion of 6, 6-[2H2] glucose during the 
OGTT. EX+PRO ingested an additional 25g of intact whey protein with the OGTT. A final 
biopsy sample was obtained at the end of the OGTT. Biopsies were analyzed for insulin-
stimulated signalling phosphorylation and muscle glycogen content. Results: Basal, fasting 
plasma glucose and insulin were similar for all groups and were not different immediately 
post- and 24 h post-RE. Immediately post-RE, muscle glycogen was 26 ± 8 and 19 ± 6% 
lower in EX and EX+PRO, respectively. During OGTT, plasma glucose AUC was lower for 
EX and EX+PRO (75.1 ± 2.7 and 75.3 ± 2.8 mU·mL-1: 120 min, respectively) compared with 
CON (90.6 ± 4.1 mU·mL-1: 120 min; P < 0.05). Plasma insulin response was 13 ± 2 and 21 ± 
4% lower for EX and CON, respectively, compared with EX+PRO (P < 0.05). Post-prandial 
insulin sensitivity was greater for EX and EX+PRO compared with CON (P < 0.05). Glucose 
disappearance from the circulation was ~12% greater in EX and EX+PRO compared with 
CON (P < 0.05). Basal and insulin-stimulated PAS-AS160 phosphorylation was greater for 
EX and EX+PRO (P < 0.05). Conclusions: Prior RE improves glycemic control and insulin 
sensitivity through an increase in the rate at which glucose is disposed from the circulation. 
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However, co-ingesting protein during a high-glucose load does not augment this response at 
24 h post-exercise. 
 
Keywords:  Type II diabetes, insulin resistance, physical activity, nutrition, skeletal muscle. 
 
Abbreviations: GLUT4; glucose transporter protein, RE; resistance exercise, AMPK; AMP-
activated protein kinase, Akt; protein kinase B, AS160; Akt-substrate of 160-kDa, TBC1D1; 
TBC1 domain family member 1, p70S6K; ribosomal protein S6 kinase, mTOR; mammalian 
target of rapamycin. 
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4.2 Introduction 
Metabolic complications, such as insulin resistance and Type II diabetes, represent a 
major individual and public health burden (25) and are associated with the presence of 
obesity and physical inactivity (13, 22, 41). Suppressed pancreatic β cell insulin production 
(7) and impaired glucose uptake in skeletal muscle (8, 70), are major contributors to 
hyperglycemia, which eventually leads to Type II diabetes. Insulin stimulates the uptake of 
glucose from the circulation into many body tissues, of which, skeletal muscle accounts for 
~75-80% (9, 56). Insulin-stimulated glucose uptake in skeletal muscle occurs via insulin-
dependent signalling that promotes glucose transporter (GLUT4) translocation to the cell 
membrane. Even though pharmacologic approaches are available to manage Type II diabetes, 
there is growing interest in lifestyle interventions, such as physical activity and dietary 
modification, which together can reduce the incidence of diabetes to a greater extent than 
pharmacological agents (61).  
 
Skeletal muscle contraction can effectively enhance glucose uptake independent of 
insulin. Importantly, these properties are preserved in individuals with Type II diabetes (19, 
28). A number of studies have demonstrated that aerobic exercise improves glycemic control 
and insulin sensitivity (10, 11, 40, 50). More recently, evidence has emerged to suggest that a 
single bout of resistance exercise (RE) improves whole-body insulin sensitivity (15, 30) and 
glycemic control (14) between 12 and 24 h post-RE. However, not all studies demonstrate a 
beneficial effect of RE on glucose metabolism (5, 33). The discrepant findings between 
studies may be due to methodological differences, including, the total exercise volume, the 
muscle groups exercised, the amount of time between the exercise and testing, and individual 
training status.  
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The glucose transporter GLUT4 plays an important role in skeletal muscle glucose 
homeostasis by regulating glucose uptake (23). Insulin regulates GLUT4 translocation from 
an intracellular location to the cell surface via a well-described pathway involving protein 
kinase B (Akt) and the recently discovered GTPase, Akt substrate of 160kDa (AS160) (21). 
Although enhanced glucose uptake with acute RE is thought to occur via mechanisms that 
bypass proximal insulin-signalling intermediates, such as Akt (3, 6, 29), AS160 appears to act 
as a point of convergence for insulin- and contraction-stimulated glucose transport in skeletal 
muscle (21, 32, 58). Recently, basal and insulin-stimulated AS160 phosphorylation was 
shown to increase several hours after endurance and resistance exercise in humans (12, 21) 
and up to 27 h post-exercise in animals (16, 60). However, the sustained response of AS160 
has not been investigated in humans. Thus, the molecular and physiological mechanisms by 
which RE improves glucose metabolism in the 24 h after exercise have yet to be elucidated. 
 
In addition to RE, dietary modifications that acutely raise endogenous insulin secretion, 
represent a clinically relevant strategy to improve blood glucose homeostasis in Type II 
diabetes. A number of recent studies suggest that co-ingesting protein and/or amino acids 
with carbohydrate induces a greater insulin release than the ingestion of either macronutrient 
alone (46, 49, 62). Indeed, the rise in plasma insulin with carbohydrate plus protein ingestion 
blunts the prevailing glucose response in Type II diabetics (34, 36), primarily due to an 
increase in the rate of glucose disposal from the circulation (36). Thus, in persons with Type 
II diabetes, co-ingesting protein with each main meal may be an effective strategy to acutely 
lower postprandial glucose excursions (44, 46). The combined effect of protein ingestion and 
RE has largely been considered in the context of muscle hypertrophy (42, 59). However, the 
hypothesis that post-RE protein ingestion acutely enhances glucose uptake has not been 
investigated in humans. 
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In the present study we used dual isotopic tracers during an oral glucose load to first 
determine the impact of an acute bout of RE on post-prandial glucose kinetics 24 h post-
exercise. Second, we aimed to determine whether co-ingesting protein with the glucose load 
would further augment the glucose-lowering effect of the RE bout. Finally, we obtained 
muscle biopsy samples to examine the mechanistic basis of the effect of RE on glycemic 
control. 
 
4.3 Methods 
 
4.3.1 Participants 
 Twenty-four untrained, recreationally active, healthy males were recruited through 
advertisements to participate in the study. Individuals who were engaged in regular structured 
resistance or endurance training, defined as ≥ 2 training sessions per week of 60 mins or 
more, were ineligible to participate. All testing visits were completed within a 3-week period. 
The purpose and methodology of the study were clearly explained to the participants. All 
participants gave their informed consent prior to taking part in the study and were deemed 
healthy based on their response to a general health questionnaire. The experimental protocol 
was approved by the NHS Birmingham East, North & Solihull Research Ethics Committee 
(Rec No: 09/H1206/102). 
 
4.3.2 Study design 
 In a randomized, parallel designed study, participants were assigned to either a non-
exercise control (CON; n = 8), exercise only (EX; n = 8) or exercise plus protein (EX+PRO; n 
= 8) condition. Participant characteristics are presented in Table 4.1. Following a preliminary 
assessment of maximal lower-limb strength, participants reported to the laboratory in a fasted 
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state, on two consecutive mornings. On the first morning, a resting muscle biopsy sample was 
obtained, thereafter EX and EX+PRO performed an intense lower-limb workout. A second 
biopsy was obtained immediately post-exercise for EX and EX+PRO only. Twenty-four hours 
later another muscle biopsy was obtained, after which, participants completed an oral glucose 
tolerance test (OGTT). Participants assigned to EX+PRO co-ingested protein with the OGTT 
to determine whether the addition of protein augmented the impact of resistance exercise on 
glucose metabolism. During OGTT, dual isotopic glucose tracers were utilized and frequent 
blood samples obtained over 2 h to determine glucose kinetics and insulin sensitivity. A final 
muscle biopsy was obtained at the end of the 2 h OGTT to examine the phosphorylation of 
contraction- and insulin-mediated intracellular protein phosphorylation. 
 
 
 
Parameter 
 
 
CON (n = 8) 
 
EX (n = 8) 
 
EX+PRO (n = 8) 
 
Age (y) 
 
 
22 ± 3 
 
20 ± 3 
 
22 ± 6 
Weight (kg) 
 
77.0 ± 6.3 79.7 ± 14.5 75.6 ± 13.1 
BMI (kg·m-2) 
 
24 ± 2.3 25.1 ± 3.9 23.5 ± 4.8 
LP 1RM (kg) 200 ± 44 212 ± 50 206 ± 60 
LP 1RM (kg·BM-1) 
 
5.7 ± 0.8 5.9 ± 1.8 6.0 ± 1.3 
LE 1RM (kg) 
 
111 ± 22 121 ± 21 115 ± 29 
LE 1RM (kg·BM-1) 
 
3.5 ± 1.2 3.7 ± 0.7 3.4 ± 0.6 
Exercise volume (kg) ¯  18,314 ± 2154 18,277 ± 2406 
 
CON: resting control group, EX: exercise only group, EX+PRO: exercise plus protein group 
BMI; body mass index, 1RM; one-repetition maximum, LP: leg press, LE; leg extension. 
Exercise volume is defined as number of repetitions x number of sets x weight lifted. Values 
are presented as means ± SD.   
Table 4.1 Characteristics of participants in each group 
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4.3.3 Preliminary testing 
 Body Mass: A digital scale was used to determine body mass to the nearest 0.1kg. 
Participant weight and height were recorded in exercise clothing without shoes on. This was 
repeated prior to each of the two testing visits to ensure body mass remained stable 
throughout testing. 
 
Maximal Strength: Bilateral 1 Repetition Maximum (1RM) was determined for leg 
press and leg extension exercises (Cybex VR/3). After warming up at a self selected 
resistance, the load was set at a level designed to allow the subject to perform at least two, but 
less than ten repetitions before failure. This estimation protocol of 1RM was designed to 
minimise the number of attempts necessary to determine 1RM (39). After each successful lift 
the load was increased by 2.5-5 kg until failure to complete two repetitions. Between each 
successive attempt a 2 min rest period was allowed. A repetition was considered valid if the 
subject used proper form and was able to complete the entire lift in a controlled manner 
without assistance. 
 
Diet and Physical Activity Control:  Participant diet was standardized for the entire 48 h 
testing period. During preliminary testing participants completed a 3-day food diary, 
representative of their average week (two week days and one weekend day). A questionnaire 
of food preferences was also completed by participants. Using an on-line diet planner (Weight 
Loss Resources) the total energy and macronutrient content of each of the 3-days was 
estimated. Food parcels were provided to each participant with a total energy and 
macronutrient intake equivalent to their average habitual intake. Thus, participant diet was not 
manipulated during the study. Participants were instructed to consume only the food provided 
for them over the two-day testing period (i.e. 24 h prior to Day 1 and during Day 1). There 
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was no difference in total energy intake or macronutrient composition of the food parcels for 
CON, EX and EX+PRO (Table 4.2). 
 
Physical activity control: Participants were instructed to maintain normal habitual 
activities of daily living but to refrain from any strenuous activity for 48 h prior to reporting to 
the laboratory on Day 1. After completion of testing on Day 1, participants were also 
instructed to refrain from strenuous activity prior to returning the following morning on Day 
2. 
 
4.3.4 Treatment trials 
Day 1 - Exercise/Control Trial: Participants reported to the Human Performance 
Laboratory between 0600 and 0700 h in a fasted state, 7-14 days after preliminary strength 
tests. After resting in a supine position for 30 min a cannula was inserted into an antecubital 
forearm vein and a resting blood sample obtained for analysis of background isotopic 
enrichment. Thereafter, the lateral portion of one thigh was prepared under local anaesthetic 
(1% Lidocaine) and a 5-mm Bergstrom biopsy needle was used to extract a resting muscle 
biopsy sample from the vastus lateralis muscle. After the resting biopsy was obtained the 
biopsied leg was bandaged and EX and EX+PRO were instructed to complete a bout of 
intense lower-limb resistance exercise, whereas CON were permitted to consume the 
standardized breakfast and leave the laboratory. For EX and EX+PRO a second biopsy 
sample was obtained post-exercise (6 ± 1 min) 1 cm distal from the resting biopsy. For EX 
and EX+PRO both biopsy incisions were made at rest to allow the post-exercise biopsy 
sample to be obtained as quickly as possible. The order of biopsied leg was counterbalanced 
between groups. Biopsy samples were blotted and freed of any visible fat and connective 
Chapter 4 
 
 
144
tissue, frozen in liquid nitrogen (within ~60 s of being taken from the muscle) and stored at -
80°C until further analysis. 
 
The resistance exercise bout consisted of a standardized warm-up on a leg-press 
machine (12 x 50% 1RM + 10 x 60% 1RM + 8 x 70% 1RM + 2 x 75% 1RM) followed by 8 
sets of 10 bilateral repetitions at 75% 1RM. Participants then completed 8 sets of 10 bilateral 
repetitions on a leg-extension machine at 75% 1RM. In the event that a participant failed to 
complete 10 repetitions in a set the weight was decreased by 2.5-5kg for the following set. 
Failure was defined as the point at which the exercise could not be completed or technique 
failed. Participants were instructed on proper lifting cadence using a metronome set to 50 
beats min−1, which corresponded to 1 s concentric muscle action, 0 s pause and a 1 s eccentric 
muscle action. Strong verbal encouragement was given throughout exercise. Between-set rest 
intervals of 2 min were given and participants completed the exercise bout in 45 ± 3 min. 
Participants were permitted to consume water ad libitum throughout Day 1.  
 
Day 2 - Infusion Trial: Participants returned to the laboratory the following morning 
between 0600 and 0700 h in a fasted state. A schematic diagram of the study protocol is 
presented in Figure 4.1. A cannula was inserted into the antecubital vein of one arm for the 
infusion of a stable isotopic tracer. A second cannula was inserted into a hand vein of the 
opposite arm and a resting venous blood sample obtained. At a time-point corresponding to 
~23 h post-exercise for EX and EX+PRO a primed infusion of 6, 6-[2H2] glucose (Cambridge 
Isotope Laboratories, MA, USA) was initiated (prime: 13.5 µmol.kg-1; infusion: 0.35 µmol.kg-
1
.min-1) and continued for ~180 min. For CON, the infusion was initiated at a time-point 
corresponding to ~23 h after the resting biopsy on Day 1. Approximately 60 min into the 
infusion (~24 h post-exercise or resting biopsy) a muscle biopsy sample was obtained from 
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the vastus lateralis of the opposite leg to that sampled the previous day. Immediately after the 
muscle biopsy was obtained CON and EX consumed an oral glucose load (oral glucose 
tolerance test; OGTT) described below. EX+PRO consumed the same glucose load plus 
additional protein. The time at which the beverage was completely consumed was considered 
t = 0, thereafter participants rested in the supine position and venous blood samples were 
obtained every 10 min until t = 120. A final muscle biopsy sample was obtained at t = 120 
from a separate incision (~26 h post-exercise or resting biopsy). Water intake was restricted 
during Day 2 to ensure participants consumed only the treatment beverage.  
 
4.3.5 Treatment beverages 
Sixty minutes into the infusion on Day 2, participants ingested 73g of glucose (80.3g 
dextrose monohydrate when corrected for water content) plus an additional 2g of [U-13C] 
glucose (99%, Cambridge Isotope Laboratories, MA, USA) to determine the contribution of 
exogenous glucose production to the total rate of appearance of glucose. Thus, participants 
ingested a total of 75g of glucose. Participants assigned to EX+PRO ingested an additional 
25g of whey protein with the 75g glucose load. Glucose was provided in the form of dextrose 
monohydrate obtained from Roquette™ (Lestrem, France) and intact whey protein (Volactive 
ultrawhey 90) was a generous gift from Volac™ (Royston, UK). The amino acid content of 
the protein was (in percent content, wt:wt): Ala, 5; Arg, 2.1; Asp, 11; Cys, 2.2; Gln, 18.1; 
Gly, 1.4; His, 1.7; Ile, 6.4; Leu, 10.6; Lys, 9.6; Met, 2.2; Phe, 3; Pro, 5.5; Ser, 4.6; Thr, 6.7; 
Trp, 1.4; Tyr, 2.6; and Val, 5.9. Both treatments were consumed in water in a total volume of 
300mL. Treatments were not matched for flavour or appearance due to the parallel study 
design. Participants were instructed to consume the treatment beverage within 2 min. 
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4.3.6 Analyses 
Blood analytes: Blood was collected in EDTA-containing tubes and spun at 3,500rpm 
for 15 min at 4°C. Aliquots of plasma were the frozen at -80°C until later analysis. Plasma 
glucose concentration was analyzed using an ILAB automated analyzer (Instrumentation 
Laboratory, Cheshire, UK). Plasma insulin concentration was analyzed using a commercially 
available ELISA kit (IBL International, Hamburg, Germany) following the manufacturer’s 
instructions. The enrichment of [13C] and [2H2] glucose in plasma was determined by gas 
chromatography-mass spectrometry (model 5973; Hewlett Packard, Palo Alto, CA). 
Derivatization was carried out with butane boronic acid in pyridine and acetic anhydride. The 
glucose derivative was quantified by selected ion monitoring at mass-to-charge ratios (m/z) 
-1 0 21
Primed-continuous [6,6-2H2] glucose infusion
Time (h) -24-25
* ** *** **
Exercise
Biopsy
Blood
Beverage
* * * *** * * *
-1 0 21
Primed-continuous [6,6-2H2] glucose infusion
Time (h) -24-25
Rest
Biopsy
Blood
Beverage
** *** ** * * * *** * * *
Figure 4.1 Schematic diagram of the study protocol. (A) Indicates protocol for exercise only 
and exercise plus protein participants. (B) Indicates protocol for non-exercised control 
participants.  
(A) 
(B) 
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297, 299 and 303 for [12C]-, [2H2]- and [U-13C] glucose, respectively. Two sets of enriched 
standards were measured containing known amounts of [2H2]- and [U-13C] glucose. By 
establishing the relationship between the enrichment of the glucose standards, the enrichment 
in plasma samples was determined.  
 
 Western blots:  Muscle biopsy samples (~40mg) were powdered on dry ice under liquid 
nitrogen using a mortar and pestle. Approximately 25mg of powdered muscle was 
homegenized in lysis buffer (50mM Tris pH 7.5; 250mM Sucrose; 1mM EDTA; 1mM 
EGTA; 1% Triton X-100; 1mM NaVO4; 50mM NaF; 0.50% PIC) using a hand-held 
homogenizer (PRO200, UK). Samples were shaken at 4ºC for 30 min (12,000rpm), 
centrifuged for 5 min at 6,000g and the supernatant removed for protein determination. 
Protein concentration was determined using the DC protein assay (Bio Rad, Hertfordshire, 
UK). Equal aliquots of protein were boiled in Laemmli sample buffer (250mM Tris-HCl, pH 
6.8; 2% SDS; 10% glycerol; 0.01% bromophenol blue; 5% β-mercaptoethanol) and separated 
on SDS polyacrylamide gels (10-12.5%) for 1 h at 58mA. Following electrophoresis; proteins 
were transferred to a Protran nitrocellulose membrane (Whatman, Dassel, Germany) at 100 V 
for 1 h. The membranes were incubated overnight at 4°C with the appropriate primary 
antibody. The primary antibodies used were total Akt, Aktser473 (Cell signalling 3787), total 
AS160 and phospho AS160 were a generous gift from Prof. Grahame Hardie, University of 
Dundee, the PAS-AS160 antibody was generated by the division of signal transduction 
therapy (DSTT), University of Dundee. Total p70S6K and phospho p70S6KThr389 was from 
Santa Cruz (11759/7984R). The following morning the membrane was rinsed in wash buffer 
(TBS with 0.1% Tween-20) three times for 5 min. The membrane was then incubated for 1 h 
at room temperature within wash buffer containing the appropriate secondary antibody, either 
horseradish (HRP)-linked anti-mouse IgG (New England Biolabs, 7072; 1:1,000) or anti-
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rabbit IgG (New England Biolabs, 7074; 1:1,000). The membrane was then cleared in wash 
buffer three times for 5 min. Antibody binding was detected using enhanced 
chemiluminescence (Millipore, Billerica, MA). Imaging and band quantification were carried 
out using a Chemi Genius Bioimaging Gel Doc System (Syngene, Cambridge, UK). Western 
blots analyses were determined for 18 participants (n = 6 per group). 
 
Immunoprecipitations: Endogenous AS160 and p70S6K proteins were immuno-
precipitated (IP) overnight at 4°C with 0.8µg of AS160 or p70S6K antibodies in a mix of 
protein G-agarose beads (Millipore, Glostrup, DK) and lysate (600µg). The following day 
immunocomplexes were washed two times in sucrose lysis buffer and two times in TNE (10 
mM Tris, pH 7.5, 150 mM NaCl, 10 mM EDTA and 0.1 mM Na2VO4). The 
immunocomplexes were re-suspended in 50 µL of 1 x Laemmli
 
sample buffer and boiled for 
5 min (96°C) upon which they were subjected to western blotting as previously described. 
 
Muscle glycogen measurement: Powdered muscle (~20 mg) was hydrolyzed in 250 µl 
of 2 N HCl by heating at 95°C for 3 h. The solution was neutralized with 250 µl 2 N NaOH 
and the resulting free glycosyl units were assayed spectrophotometrically using a hexokinase-
dependant assay kit (Glucose HK, ABX diagnostics, UK) against glucose standards of known 
concentrations (4). 
 
4.3.7 Calculations 
  Insulin sensitivity: Plasma glucose and insulin concentrations during the 120 min 
OGTT were used to determine the whole-body insulin sensitivity index (ISI) according to the 
following equation of Matsuda (37): 
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Matsuda (ISI) = 1000/ √ (FPI·FPG) · (mean OGTT insulin) ·  (mean OGTT glucose) (1) 
 
Where FPG is the fasting plasma glucose concentration, FPI is the fasting insulin 
concentration and 1000 represents a constant that allows numbers between 1 and 10 to be 
obtained. 
 
Post-absorptive insulin sensitivity was also estimated by the homeostasis model assessment 
(HOMA-IR) index which is calculated by dividing the product of FPG and FPI by 22.5 (38). 
  
Glucose kinetics: From the [2H2] glucose tracer, the total Ra (Eq. 2) and Rd (Eq. 3) of 
glucose were calculated with the single-pool non-steady-state equations of Steele (57) as 
modified for use with stable isotopes (68). Total Ra represents the splanchnic Ra of glucose 
from ingested glucose, the liver and potentially some glycogenolysis and gluconeogenesis 
from the kidneys.  
 
Ra total = F - (V· (C2 + C1)/2· (Ep2 – Ep1)/t2 – t1)) / (Ep2 + Epl)/2)    (2) 
 
Rd = Ra total – V· (C2 + C1/ t2 – t1)         (3) 
 
Where Epl and Ep2 are the [2H2] glucose enrichments in plasma at time-points t1 and t2, 
respectively; and C1 and C2 are glucose concentrations at t1 and t2, respectively; and V is 
volume of distribution in 160 mL·kg-1.  
 
The [U-13C] glucose tracer added to each beverage was used to calculate the Ra of glucose 
from the gut. The Ra of [13C] glucose (Ra gut) into plasma was determined by transposition of 
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the Steele equation and the known 13C enrichment of the ingested glucose (52) adapted for use 
with stable isotopes (24). 
 
 F2 = Ra ·  [(Ep2 + Ep1)/2 + (C2 + C1)/2· (Ep2 - Ep1)/ (t2 - t1) ·V]     (4) 
 
Where F2 is the Ra of [13C] glucose in the blood; Ra is the previously determined total Ra of 
glucose (Eq. 2). Knowing the Ra of [13C] glucose in the blood, one can determine the 
absorption rate of glucose from the gut from the known enrichment of the ingested glucose. 
 
Ra gut = F2/Eing           (5)  
 
Where Ra gut is the Ra of gut-derived glucose and Eing is the 13C enrichment of the ingested 
glucose. The rate of endogenous glucose (EGP) was calculated as the difference between Ra 
total and Ra gut. 
 
EGP = Ra total - Ra gut         (6) 
 
Ra, Rd, Ra gut and EGP were converted to g.min-1 for graphical representation (= µmol·kg-
1
·min-1 x kg x 180.2 / 10-6). 
 
4.3.9 Statistical Analysis 
A between-subject repeated measures design was utilized for the current study. 
Exercise variables, blood analytes, plasma enrichment and Western blot data were analyzed 
using a two-way ANOVA with repeated measures (treatment x time) to determine differences 
between each condition across time. When a significant main effect or interaction was 
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identified, data were subsequently analyzed using a Bonferroni post hoc test. Plasma glucose 
and insulin concentrations over the 120 min OGTT were calculated as area under the curve 
(AUC). Within-group changes over time; glucose kinetics and blood analyte AUC data were 
checked for statistical significance using one-way repeated-measures ANOVA. All statistical 
tests were analyzed using statistical package for social sciences (SPSS) version 18.0 (Illinois, 
Chicago, U.S). Significance for all analyses was set at P < 0.05. All values are presented as 
means ± standard error of the mean (SEM). 
 
4.4 Results 
4.4.1 Dietary intake 
 Dietary analysis indicated that daily energy intake and macronutrient composition of the 
diet was similar for CON, EX and EX+PRO (Table 4.2). Thus, the contents of the 
standardized diet provided prior to and during Day 1 of the study were similar for all groups. 
 
 
 
 
 
 
 
 
 
 
CON (n = 8) 
 
EX (n = 8) 
 
EX+PRO (n = 8) 
Daily energy intake (kJ) 9,353 ± 469 9,487 ± 691 10,345 ± 452 
Carbohydrate (%) 71.1 ± 6.6 66.2 ± 3.9 69 ± 7.1 
Protein (%) 15.8 ± 3.0 18.2 ± 3.3 17.9 ± 6.5 
Fat (%) 13.1 ± 3.1 15.6 ± 0.4 13.1 ± 4.8 
Table 4.2 Participant habitual dietary intake and macronutrient composition. 
Groups as per Table 1. Values are presented as means ± SEM.   
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4.4.2 Exercise variables 
 Leg-press and leg-extension 1RM values determined during pre-testing, were not 
different between groups (Table 4.1). Based on the measured 1RM, the resistance lifted on the 
leg-press machine during Day 1 was 150 ± 17 and 156 ± 17 kg and for EX and EX+PRO, 
respectively (P > 0.05). Leg-extension resistance was set at 85 ± 11 and 84 ± 9 kg for EX and 
EX+PRO, respectively (P > 0.05). All participants were able to complete the leg-press 
exercise without reducing the weight. Six participants (four from EX and two from EX+PRO) 
were unable to complete the leg-extension exercise at the desired resistance, which was then 
lowered by 2.5-5 kg to enable participants to complete ten repetitions. However, the total 
exercise volume performed for EX and EX+PRO was not different (Table 4.1).  
 
4.4.3  Plasma glucose 
 Fasting plasma glucose (5.1 ± 0.4, 5.3 ± 0.7 and 5.7 ± 0.2 mmol·L-1 for CON, EX and 
EX+PRO, respectively) were in the normal range. Basal plasma glucose concentrations were 
similar on Day 2 (24 h post-exercise) for all groups (5.6 ± 0.3, 4.9 ± 0.3 and 5.1± 0.6 
mmol·L-1 for CON, EX and EX+PRO, respectively). During the OGTT, plasma glucose 
concentration increased in all groups, peaking between 30-50 min after feeding (P < 0.05; 
Figure 4.2A). Plasma glucose peaked at 92 ± 7, 88 ± 9 and 80 ± 8% above basal fasted values 
for CON, EX and EX+PRO, respectively. Following the peak, plasma glucose concentration 
decreased, such that by 120 min post-OGTT plasma glucose concentration had returned to 
basal fasted values. Plasma glucose AUC during OGTT was 17 ± 3% lower for EX and 
EX+PRO (P = 0.02 for both) compared with CON (Figure 4.2B).  
 
4.4.4  Plasma insulin 
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 Fasting plasma insulin concentrations (7.2 ± 0.6, 5.9 ± 0.7 and 7.1 ± 0.6 µU·ml-1 for 
CON, EX and EX+PRO, respectively) were in the normal range. Basal plasma insulin 
concentrations were similar on Day 2 for all groups (6.2 ± 0.7, 6.5 ± 0.4 and 6.9 ± 0.5 µU·ml-
1
 for CON, EX and EX+PRO, respectively). Plasma insulin concentrations during OGTT 
increased by 8.6-, 9.1- and 11.1-fold above basal fasted values for CON, EX and EX+PRO, 
respectively peaking between 30-40 min after feeding (Figure 4.3A). Plasma insulin AUC 
during OGTT was significantly greater for EX+PRO compared with EX (P = 0.04) and CON 
(P = 0.01). There was no difference in insulin AUC between EX and CON (Figure 4.3B). 
 
 Insulin sensitivity: HOMA-(IR) index on Day 1 was 1.55 ± 0.13, 1.69 ± 0.32 and 1.51 ± 
0.12 for CON, EX and EX+PRO, respectively. HOMA-(IR) index was not different on Day 2 
(1.46 ± 0.17, 1.5 ± 0.12 and 1.64 ± 0.17 for CON, EX and EX+PRO, respectively). Post-
prandial insulin sensitivity, calculated using the Matsuda ISI, was greater for EX and 
EX+PRO (6.95 ± 0.5 and 6.82 ± 0.41, respectively) compared with CON (6.21 ± 0.72; P < 
0.05). There was no difference in Matsuda ISI between EX and EX+PRO.  
 
4.4.5  Glucose tracer kinetics 
 Plasma enrichment of infused 6, 6-[2H2] and ingested [U-13C] glucose are presented in 
Figure 4.4A. Ra total, Ra gut, EGP and Rd over time are presented in Figure 4.4 (B, C, D, 
respectively). Average plasma glucose tracer kinetics are presented in Table 4.3. In all groups, 
plasma glucose Ra total increased over time (P < 0.05), peaking between 70-90 min after 
feeding (Figure 4.4B). There was no difference in the plasma glucose Ra total between 
groups. Glucose Ra gut demonstrated an increasing contribution to Ra total with time (P < 
0.05), whereas EGP demonstrated a reduced contribution to Ra total with time (P < 0.05; 
Figure 4.4C). The increase in Ra gut peaked between 70-90 min after feeding, whereas the 
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decline in EGP reached a nadir between 90-100 min after feeding. Glucose Rd increased over 
time in all groups (P < 0.05; Figure 4.4D). Glucose Rd increased by 127 ± 13, 131 ± 15 and 
150 ± 18% above basal values for CON, EX and EX+PRO, respectively. Glucose Rd was 
significantly lower for CON between 40-70 min after feeding compared with EX and 
EX+PRO (P < 0.05). Average glucose Rd and whole-body glucose disposal, (Rd expressed as 
% of Ra total) was significantly lower for CON compared with EX and EX+PRO (P < 0.01; 
Table 4.3). The time taken for Rd to match the Ra total was greater for CON than EX and 
EX+PRO (P < 0.05). There was no difference in average glucose tracer kinetics between EX 
and EX+PRO. 
 
4.4.6  Muscle glycogen 
 Basal muscle glycogen concentration was similar for all groups (Figure 4.5). 
Immediately post-exercise, muscle glycogen concentration was 26 ± 8 and 19 ± 6% lower for 
EX and EX+PRO, with no difference between groups (P < 0.05). Muscle glycogen 
concentration at 24 h post-exercise was similar to basal values for all groups. There was no 
significant change in muscle glycogen concentration following OGTT (~26 h post-exercise), 
compared with 24 h post-exercise. 
 
4.4.7  Protein phosphorylation 
 Western blot phospho-images are presented in Figure 4.6. Basal PAS-AS160 
phosphorylation (Day 1) was similar for all groups (Figure 4.7A). Compared with basal, 
AS160 phosphorylation did not change immediately post-exercise but was increased at 24 h 
post-exercise for EX and EX+PRO only (P < 0.05). AS160 phosphorylation at 24 h post-
exercise was significantly greater for EX and EX+PRO compared with CON (P < 0.01). At 
26 h post-exercise, following OGTT, AS160 phosphorylation increased by 1.4-fold for CON 
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and 1.3-fold for EX and EX+PRO compared with 24 h post-exercise (P < 0.05). AS160 
phosphorylation at 26 h post-exercise was greater for EX and EX+PRO compared with CON 
(P < 0.05). Basal Aktser473 phosphorylation (Day 1) was similar for all groups (Figure 4.7B). 
Compared with basal, Akt phosphorylation did not change immediately post- and 24 h post-
exercise in all groups. At 26 h post-exercise, following OGTT, Akt phosphorylation increased 
by 2.2-, 2.3 and 1.9-fold for EX and EX+PRO, respectively, compared with 24 h post-
exercise (P < 0.05). Akt phosphorylation at 26 h post-exercise was greater for EX and 
EX+PRO compared with CON (P < 0.05). Basal p70S6KThr389 phosphorylation (Day 1) was 
similar for all groups (Figure 4.7C). Compared with basal, p70S6K phosphorylation was not 
different immediately-, 24 h- or 26 h-post exercise. There was no between-group difference in 
p70S6K phosphorylation immediately-, 24 h- or 26 h-post exercise. 
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CON (n = 8) 
 
EX (n = 8) 
 
EX+PRO (n = 8) 
Ra total (g·min-1) 0.34 ± 0.02 0.36 ± 0.02 0.36 ± 0.03 
Ra gut (g·min-1) 0.24 ± 0.03 0.26 ± 0.03 0.26 ± 0.04 
Exogenous contribution 
(Ra gut as % of Ra) 65.7 ± 6 68.5 ± 6 65.9 ± 7 
EGP  (g·min-1) 0.1 ± 0.01 0.1 ± 0.01 0.1 ± 0.01 
Endogenous contribution 
(EGP as % of Ra) 34.2 ± 7 31.4 ± 7 33.9 ± 7 
Rd (g·min-1) 0.31 ± 0.02* 0.35 ± 0.02 0.35 ± 0.02 
Glucose disposal (Rd as % of Ra) 89.4 ± 1.7* 94.1 ± 0.5 95.9 ± 0.6 
Time for Rd to match Ra (min) 59 ± 8* 42 ± 5 45 ± 6 
Ingested glucose appearance (%) 
 
38.4 ± 7.1 41.6 ± 7.6 42.2 ± 7.8 
Table 4.3 Plasma glucose kinetics for the 3 groups during OGTT 
Data presented for [6, 6- 2H2] glucose rate of appearance (Ra total) and disappearance (Rd) and Rd 
expressed as % of Ra. Contribution of exogenous [U-13C] glucose from the gut (Ra Gut) and 
endogenous glucose production (EGP) to Ra total are presented. Groups as per Table 4.1. * 
indicates significantly lower than EX and EX+PRO (P < 0.05). Values are presented as means ± 
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Figure 4.2 Plasma glucose concentration (A) and AUC (B) during OGTT 24 h following 
resistance exercise in untrained volunteers. Groups as per Table 4.1. Values are means ±SEM; 
n = 8 per group. *: significantly greater glucose concentration/AUC for CON compared with 
EX and EX+PRO (P < 0.05).  
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Figure 4.3 Plasma insulin concentration (A) and AUC (B) during OGTT 24 h following 
resistance exercise in untrained volunteers. Groups as per Table 4.1. Values are means ±SEM; 
n = 8 per group. *: significantly greater insulin concentration/AUC than CON (P < 0.05). †: 
significantly greater insulin concentration than EX. (P < 0.05).  
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Figure 4.4 Tracer enrichments and glucose kinetics over 120 min OGTT. (A) Enrichment of 6, 
6-[2H2] and [U-13C] glucose in plasma. Average for all 3 groups presented, n = 24. MPE (%): 
mole percent excess. (B) Total rate of glucose appearance in plasma (Ra). (C) Contribution of 
exogenous glucose appearing from the gut (Ra gut) and endogenous glucose production (EGP) to 
the Ra Total; solid lines indicate Ra gut, dashed arrows indicate EGP. (D) Rate of glucose 
disappearance from plasma (Rd). Means with different subscripts are significantly different from 
each other. *: significantly lower Rd for CON compared with EX and EX+PRO. Values are 
means ±SEM; n = 8 per group. 
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 Figure 4.5 Muscle glycogen content. Values obtained at basal, immediately post-exercise 
(Post 0), 24 h post-exercise (Post 24) and immediately following OGTT (Post 26). Groups as 
per Table 4.1. Values are means ± SEM; n = 6 per group. *: significantly lower compared with 
basal (P < 0.05). 
Figure 4.6 Representative protein phosphorylation blots. Proteins phosphorylation was studied 
in the basal, fasted state (Basal), immediately post-exercise (Post 0), 24 h post-exercise (Post 
24) and 26 h post-exercise following the OGTT (Post 26) and normalized to total protein 
content. 
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Figure 4.7 Signalling protein phosphorylation of (A) 
Aktser473, (B) PAS-AS160 and (C) p70S6KThr389 from 
muscle samples taken at 4 different time points. Groups as 
per Table 4.1. Values are means ± SEM; n = 6 per group. 
Means with different letters are significantly different from 
each other (P < 0.05). *: significantly lower 
phosphorylation for CON compared with EX and EX+PRO 
(P < 0.05).  
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4.5 Discussion 
 
 The present study expands on the findings of previous investigations (14, 30, 66) by 
providing a physiological mechanism to support evidence that a single bout of intense lower-
body resistance exercise (RE) improves insulin sensitivity in healthy, normoglycemic adults. 
Using isotopic tracer techniques, we report that prior RE conducted 24 h earlier suppresses 
plasma glucose excursions during an oral glucose tolerance test (OGTT) by increasing the rate 
of glucose disappearance from the circulation (presumably taken up by skeletal muscle). 
Furthermore, we attribute the improvement in insulin-stimulated glucose disposal with prior 
RE, in part, to a greater basal and insulin-stimulated phosphorylation of AS160. However, co-
ingesting protein during OGTT did not augment the response of plasma glucose, insulin 
sensitivity or glucose kinetics to resistance exercise despite a greater insulin response. 
 
 To date, studies investigating the acute effect of RE on insulin sensitivity and glucose 
homeostasis have provided conflicting results (5, 14, 15, 30, 33, 66). Whilst questions have 
been raised concerning the method used to assess insulin sensitivity (30), the discrepancies 
between prior studies may be due, in large part, to; i) the total RE volume, ii) the exercised 
muscle group and iii) the physical characteristics of the study cohort. Prior studies utilizing 
whole-body RE with a total volume of ~6500 kg (5, 15) showed no effect on plasma glucose 
between 12-18 h post-RE, in healthy young (15, 33) and insulin resistant populations (5, 15). 
On the other hand, Koopman et al. (30) demonstrated that a lower-limb RE protocol with total 
volume ~ 3-fold greater than the aforementioned studies (5, 15), was sufficient to improve 
insulin sensitivity in healthy adults. In the present study, we employed an identical RE 
protocol Koopman et al. (30) eliciting a similar total RE volume. Accordingly, we too 
demonstrated that RE improves insulin sensitivity and lowers post-prandial glucose 
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excursions at 24 h post-RE. However, we acknowledge that such intense RE may not be 
feasible for all insulin resistant/type II diabetic patients. To date, the minimum RE dose 
required to counteract symptoms of metabolic disease has not been determined. 
 
 In addition to the intensity of exercise, we posit that high-intensity RE confined to the 
leg muscles, may promote a greater increase in skeletal muscle glucose uptake than upper-
body RE. Support for this notion comes from a study by Olsen et al. (48), in which, glucose 
uptake was found to be relatively well preserved in the arms of Type II diabetics compared 
with the legs, indicating that Type II diabetes may be, primarily, a disease of the lower-limbs. 
Taken together with the data mentioned above, these findings suggest that a substantial 
loading, particularly of the leg muscles, may be an important prerequisite for improved 
glucoregulation with RE. Thus, either intensity and/or muscles that are exercised may be 
important for improvement of glucose control. 
 
 Finally, in combination with RE intensity and muscle groups utilized, the physical 
characteristics of the study cohort should be considered when assessing the impact of RE on 
glycemic control. For example, Luebbers and colleagues (33) recruited young, resistance-
trained males who habitually completed ≥ 3 RE sessions per week. Participants in this study 
completed a whole-body RE protocol at high (85% of 10RM) and low (45% of 10RM) 
intensities, matched for total volume (~12,600 kg). Compared with a non-exercise control 
trial, the authors reported no effect of low-, and more surprisingly, high-intensity RE on 
glucose uptake and insulin sensitivity during a hyperinsulinemic-euglycemic clamp. In 
contrast, others (14) have shown that normoglycemia is better maintained in Type II diabetics 
who completed a whole-body RE protocol (80% of 3RM) similar to that employed by 
Luebbers (33). Taken together, these data suggest that the physical characteristics of the study 
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cohort must be taken into account when prescribing an exercise volume intended to induce 
sufficient ‘stress’ across the exercised muscle to lower blood glucose. 
 
 The 17% reduction in plasma glucose response we observed with prior RE is in line 
with previous studies (14). However, modifications in blood analytes do not necessarily 
reflect adaptations in skeletal muscle glucose uptake. Therefore, we applied dual isotopic 
tracer methodology to determine the rate of glucose disappearance from the circulation 
(indicative of skeletal muscle glucose uptake (9)) and the contribution of exogenous glucose 
appearance and endogenous glucose production to total glucose appearance. Total glucose 
appearance and the contribution from endogenous and exogenous sources was not different 
between groups, indicating that gastric emptying, intestinal uptake and hepatic glucose output 
were not altered by prior RE or protein co-ingestion during OGTT. However, plasma glucose 
disappearance/disposal from the circulation did increase with prior RE. Further, we calculated 
that the time taken for glucose disappearance to match glucose appearance was reduced by 
~37%. Thus, RE may be potent intervention to reverse the compromised insulin-stimulated 
glucose disposal that is prevalent in Type II diabetes (67). Despite the greater increase in 
glucose disposal in all groups during OGTT we report no increase, or between-group 
difference, in post-OGTT muscle glycogen content. This may not be surprising given that the 
amount of ingested glucose disposed from the circulation over 120 min of OGTT was not 
vastly different between exercised (~55%) and non-exercised groups (~50%).  
 
 Enhancement of glucose disposal with prior exercise appears to be mediated through the 
insulin signalling pathway. A number of studies have found that prior exercise has no effect 
on proximal insulin signalling steps, such as Akt phosphorylation (1, 20). Similarly, we report 
no effect of RE on basal Akt phosphorylation at 24 h post-exercise. In contrast, the Rab-
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GTPase-activating protein AS160 is the most distal signalling protein implicated in insulin-
stimulated glucose uptake in skeletal muscle. Studies in humans (12, 21) demonstrate that 
basal and insulin-stimulated PAS-AS160 phosphorylation is increased several hours post-RE. 
Until now, the sustained effect of prior exercise on PAS-AS160 phosphorylation has been 
demonstrated in animals only (1, 16). Here we demonstrate for the first time, in humans, that 
immunoprecipitated PAS-AS160 phosphorylation is greater at 24 h post-RE compared with 
basal and non-exercise values. Moreover, although the insulin-stimulated rise PAS-AS160 
phosphorylation was similar for all groups, the final level of PAS-AS160 phosphorylation 
was greater for EX and EX+PRO compared with CON following the OGTT. 
 
 Important to note is that not all studies report similar adaptations in PAS-AS160 
phosphorylation with prior exercise. Treebak and colleagues (60) have shown that basal and 
insulin-stimulated site-specific, but not PAS, phosphorylation of AS160 increased 4 h after a 
60 min unilateral leg kicking protocol. Given that we and others observed a marked increase 
in basal PAS-AS160 phosphorylation following high-intensity RE loading, we speculate that 
the PAS-AS160 antibody may only be effective in detecting robust modifications in AS160 
phosphorylation, whereas site-specific AS160 phosphorylation may be required to detect 
more subtle phospho-changes that occur with moderate-intensity exercise. Thus, regardless of 
the antibody used to detect AS160 phosphorylation our data expand human work (12, 21) and 
support animal studies (1, 16) showing the persistent increase in insulin-stimulated skeletal 
muscle glucose transport following acute RE is attributable, in part, to the sustained increase 
in basal AS160 phosphorylation. These data do not exclude the possibility that prior exercise 
also amplifies insulin-signalling steps other than AS160. 
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 To our knowledge, this study is the first to attempt to determine if protein co-ingestion 
augments the response of RE on glycemic control at 24 h post-exercise. Under resting 
conditions, it has been demonstrated that the marked increase plasma insulin concentration 
that prevails when protein and/or amino acids are ingested with carbohydrate can effectively 
increase glucose disposal (36) and reduce plasma glucose excursions (62, 65). In our hands, 
the elevated insulin response with protein co-ingestion did not augment the RE-induced rise in 
glucose disposal or lower plasma glucose excursions. These data are supported by the 
response of the intracellular signalling indicating that although the final level of PAS-AS160 
phosphorylation was greater with prior exercise, there was no difference with protein 
ingestion. We posit that the lack of a glycemic-lowering effect of additional protein could be 
attributed to the insulin response to our feeding protocol. Our data reveal that the transient rise 
in plasma insulin with additional protein peaked at 30 min post-feeding (21 and 13% greater 
than CON and EX, respectively) but was no longer evident by 60 min. In contrast, studies that 
report a glucose lowering effect with protein co-ingestion have favoured frequent feeding of 
small boluses to promote a sustained rise in plasma insulin, much greater than the present 
study (36, 62, 63, 65). For example, participants in the study of Manders et al. (36) ingested 
beverages every 15 min over 165 min supplying ~60g·h-1 carbohydrate alone or with ~30g·h-1 
of additional protein. The greater plasma insulin response that prevailed with additional 
protein was sustained for the best part of 3 h. In contrast, the greater insulin response we 
observed with additional protein was relatively transient (between 30-50 min post-feeding). 
Thus, this relatively brief period of hyperinsulinemia may have been insufficient to further 
lower plasma glucose excursions. However, this approach has not been tried following 
resistance exercise. 
 
Chapter 4  167 
 
 
 
 
 A limitation of our protocol and that of other studies (36, 62, 63, 65) is that feeding 
high-glucose loads and/or repeated boluses does not represent a physiological feeding pattern 
of Type II diabetic populations. Conversely, the group of Nuttall and Gannon (17, 18, 26, 27, 
45, 47) systematically investigated the insulinotropic properties of ≈ 5g of essential (arginine, 
phenylalanine, lysine and leucine) and non-essential amino acids (glycine, proline) co-
ingested with 25g of glucose, closely mimicking the composition of a high-protein meal. By 
and large, these studies demonstrate that free amino acid co-ingestion initiates only a modest 
rise in insulin, but markedly attenuates the plasma glucose response. Combining these data 
with our observation that protein co-ingestion with a high glucose load did not lower blood 
glucose, one could suggest that co-ingesting specific free amino acids with glucose in an 
amount likely to be ingested during a typical meal, may lower plasma glucose excursions via 
subtle changes in plasma insulin or direct mechanisms acting independently of the insulin. 
 
 The lack of a glucose-lowering effect with protein co-ingestion could also be explained 
by the relatively modest leucine content (~2.65g) in the 25g of intact whey protein we 
provided. A number of studies have demonstrated that certain free amino acids can act as 
potent insulin secretagogues (53, 54). Indeed, a series of studies (31, 63-65) revealed that 
adding ~7.5g of free leucine to a protein hydrolysate plus carbohydrate beverage augmented 
the insulinotropic response. Subsequently, this mixture was shown to suppress post-prandial 
glucose excursions in Type II diabetics (35, 62). In vitro studies indicate this response may be 
due to the potency of leucine in secreting insulin release from pancreas β cells (55, 69). 
Furthermore, there is mounting evidence in animal and cell culture models, that leucine 
directly promotes glucose transport into skeletal muscle by increasing GLUT4 translocation 
via the mammalian target of rapamycin (mTOR) signalling pathway (2, 43, 51). Thus, given 
that we saw no change in p70S6K phosphorylation (downstream of mTOR) for EX+PRO, it is 
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possible that ingesting additional free amino acids, leucine in particular, are essential to 
facilitate glucose uptake in skeletal muscle and disposal from the circulation. Further work is 
required to determine the effectiveness of ingesting specific free amino acids, particularly 
leucine, in combination with RE for improving glycemic control. 
 
 Finally, it is worth mentioning that the studies discussed above, reporting a glucose-
lowering effect of protein co-ingestion, were conducted under resting conditions. In contrast, 
we report no additive effect of protein co-ingestion, perhaps due to the fact that the 
glucoregulatory effects of feeding were assessed following high-intensity RE. Thus, we 
speculate that the robust increase in basal PAS-AS160 phosphorylation with prior exercise 
may have masked any additive effect of additional protein/insulin. Indeed our signalling data 
indicate that the insulin-stimulated rise in PAS-AS160 phosphorylation during OGTT was 
similar for all groups. Based on these data, it is unclear whether a synergy exists between RE 
and protein ingestion for promoting hypoglycemia.  
 
  In conclusion, we have shown that high-intensity resistance exercise improves insulin 
sensitivity and increases the rate of postprandial glucose disposal, which subsequently lowers 
post-prandial glucose excursions in healthy, normoglycemic adults. However, despite strong 
evidence that co-ingesting protein and/or amino acids with carbohydrate lowers glucose 
excursions at rest, we show no effect of protein co-ingestion on glycemic control, despite a 
marked rise in insulin secretion. Thus, we hypothesize that the co-ingestion of additional free 
amino acids and/or sustained hyperinsulinemia may be essential in order to increase skeletal 
muscle glucose uptake.   
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CHAPTER 5 
GENERAL DISCUSSION 
 
Several studies have demonstrated that ingesting protein with carbohydrate during 
exercise can extend endurance capacity (20, 37, 38) and improve late-exercise performance 
(39). In the post-exercise period, protein ingestion may also impact the metabolic adaptation 
in skeletal muscle and potentially improve the recovery of muscle function. However, 
concerns regarding the way in which exercise performance and recovery are assessed, 
coupled with the lack of a clear physiological mechanism to explain the reported 
improvements, hampers our understanding of the role of protein nutrition for endurance 
athletes. Beyond athletic performance, there is great interest in modulating skeletal muscle 
metabolism to counter insulin resistance and Type II diabetes. Indeed resistance exercise has 
been demonstrated to improve whole-body insulin sensitivity (8, 23) and glycemic control 
(7), yet the mechanisms underpinning this adaptive response remain elusive. Furthermore, the 
notion that protein nutrition can help to maintain normoglycemia is yet to be investigated in 
combination with resistance exercise. Thus, the purpose of this thesis was three-fold: 
 
i) To determine the effectiveness of co-ingesting protein with carbohydrate during 
exercise on endurance performance and the recovery of muscle function. 
ii)  To determine the impact of post-endurance exercise protein ingestion on the 
synthesis of specific skeletal muscle proteins. 
iii)  To understand the mechanisms underpinning improved glycemic control following 
resistance exercise and investigate whether ingesting additional protein augments 
this response. 
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The present chapter summarizes the key findings from the studies described in 
Chapters 2-4 of this thesis. First, based on the findings described in Chapters 2 and 3, this 
section will provide recommendations for future research investigating the effectiveness of 
protein ingestion for endurance performance and changes in protein metabolism that, over 
time, may quicken the recovery of muscle function and alter the phenotypic adaptation to 
training. Second, based on the findings described in Chapter 4, this section will provide 
recommendations for future research studies expanding on our investigation of the 
effectiveness of resistance exercise, with or without protein ingestion, on glycemic control. 
 
5.1 Protein nutrition for endurance performance 
 Over the last decade a number of studies have emerged to suggest that the co-ingestion 
of protein with carbohydrate during prolonged endurance exercise can extend endurance 
capacity (20, 37, 38). Furthermore, others have reported that protein co-ingestion specifically 
improves late-exercise time-trial performance (39). However, methodological differences in 
the performance test employed in previous studies makes it difficult to determine whether 
adding protein to carbohydrate improves endurance performance per se or merely time-to-
exhaustion. In support of this notion, several studies report no ergogenic benefit of 
carbohydrate plus protein co-ingestion on time-trial performance in a well-controlled testing 
environment (33, 44). Furthermore, when sufficient carbohydrate is ingested the role of 
protein for improving endurance performance may be negligible (44). In an attempt to 
improve our understanding of the role of protein for endurance athletes, the logical extension 
of these findings was to examine the effectiveness of protein co-ingestion using a 
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performance model that replicates endurance competition and a carbohydrate dose that meets 
the recommended upper-limit to attain peak exogenous carbohydrate oxidation rates.  
 
 Thus, in our study (Chapter 2) we provided a recommended dose of carbohydrate (65 
g·hˉ1) during cycle exercise to determine whether the addition of protein (19 g·hˉ1) improved 
cycle time-trial performance in a controlled exercise environment, when preceded by a 
standardized steady-state ride. Our data demonstrate no difference in average power output 
during the time-trial or overall time-to-completion between carbohydrate plus protein and 
carbohydrate alone. Thus, these data oppose the notion that carbohydrate-protein co-ingestion 
during exercise enhances late-exercise performance when sufficient carbohydrate is ingested.  
  
5.1.1  Future studies 
 In the study described in Chapter 2, we examined the effectiveness of adding protein 
to a carbohydrate-containing beverage on late-exercise time-trial performance and the 
recovery of muscle function. Our decision not to match treatment beverages for total energy 
was based on the observation that others report an extended endurance capacity when protein 
was co-ingested with a carbohydrate dose deemed sub-optimal to attain peak rates of 
exogenous carbohydrate oxidation (20, 37, 38). Thus, our findings support those of van-Essen 
et al. (44), indicating that there is no benefit of co-ingesting additional protein in a sports 
beverage on time-trial performance provided sufficient carbohydrate is consumed. However, 
the metabolic and physiological response to carbohydrate-protein co-ingestion may be 
dependent on the mode, duration and intensity of the exercise bout. In this regard there is 
evidence that protein oxidation is increased when protein is ingested with a carbohydrate 
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intervention during ultra-endurance exercise (24). However, the effectiveness of protein co-
ingestion for performance, in situations where carbohydrate availability is limited and muscle 
glycogen stores are depleted has yet to be investigated, but would prove interesting given 
evidence from almost 20 years ago that runners ingesting branched-chain amino acid alone 
took less time to complete a marathon (2).  
 
5.2 Muscle adaptation to acute endurance exercise and protein nutrition 
 Endurance exercise stimulates an increase in mixed muscle protein synthesis. This 
response has been shown to result primarily from a rise in the synthesis of mitochondrial 
proteins, with little or no change reported in the synthesis of myofibrillar proteins (51). Given 
evidence that ingesting protein and/or amino acids potentiates resistance exercise-stimulated 
muscle protein synthesis, investigators have suggested that protein nutrition may enhance the 
synthesis of mitochondrial proteins following endurance exercise (19). Our study (Chapter 
3) examined the response of mitochondrial and myofibrillar protein fractions to protein 
ingestion following endurance exercise. We report that myofibrillar protein synthesis was 
greater when protein was ingested with a carbohydrate beverage (~0.087%·h-1) than 
carbohydrate ingested alone (~0.057%·h-1). Conversely, protein ingestion did not stimulate 
an increase in mitochondrial protein synthesis. Thus, we are able to attribute the increase in 
mixed muscle protein synthesis demonstrated by Howarth et al. (19) to a rise in the synthesis 
of myofibrillar, but not mitochondrial proteins. 
 
 Although the primary aim of our study was to determine the synthesis of specific 
protein fractions, in collaboration with Drs Keith Baar and Andy Philp of the University of 
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California, Davis, we were able to measure the phosphorylation of signalling proteins 
implicated in the translation initiation and elongation phase of muscle protein synthesis 
immediately and 4 hours post-exercise for 8 participants. In spite of the fact that some of the 
anabolic signalling response may have occurred between 0 and 4 hours post-exercise, we 
demonstrate that the phosphorylation of intracellular proteins was increased (mTOR, 
p70S6K) or was suppressed (eEF2) following protein ingestion, thereby providing a 
mechanism to support our muscle protein synthesis data. Collectively, these data suggest that 
when protein is ingested following intense cycling exercise contractile proteins are 
preferentially synthesized in the initial 4 hour post-exercise period.  
 
5.2.1  Future studies 
 An acute increase in myofibrillar protein synthesis, with protein ingestion and exercise, 
is predictive of long-term muscle hypertrophy (17, 52). Thus, one interpretation of the data 
presented in Chapter 3 is that protein ingestion following prolonged high-intensity cycling 
over an extended period may increase lean mass. However, the rise in myofibrillar protein 
synthesis we observed post-exercise, may serve to counteract a fasted-state rise in protein 
breakdown thought to occur during and following intense endurance exercise (3, 12, 45). 
Thus, the rise in myofibrillar protein synthesis may represent an increase in protein turnover; 
important in the maintenance of a higher quality of contractile protein. However, we did not 
measure protein breakdown and thus, this notion is speculative at this point. Thus, it would be 
prudent for future studies to ascertain changes in muscle protein breakdown (and proteins 
implicated in proteolysis) during and following endurance exercise with protein feeding. 
Finally, given that resistance-exercise performed in the fed-state elevates muscle protein 
synthesis (54) over that performed when fasted, it is likely that the adaptive response to 
Chapter 5  180 
 
 
protein ingestion after endurance exercise would be dramatically altered by prior feeding. 
This approach may also represent, more closely, common practice amongst athletes and 
warrants further investigation. Based on data from previous studies (3, 12, 16, 45) and our 
observation that myofibrillar proteins are preferentially synthesized when protein is ingested 
after endurance exercise, we present herein the proposed temporal response of myofibrillar 
net protein balance over the course of the carbohydrate plus protein trial (Figure 5.1).  
 
 In our study, muscle protein synthesis was assessed over 4 hours post-exercise. The 
response of mitochondria to endurance exercise is a transcriptionally mediated process and 
occurs later than the time-course of our investigation (11, 18, 40). Thus, a logical extension to 
our findings would be to investigate the response of myofibrillar and mitochondrial protein 
synthesis to endurance exercise and protein ingestion beyond 4 hours post-exercise. Such an 
approach would improve our understanding of the muscle adaptations that occur when 
protein is ingested after endurance exercise. Furthermore, to resolve the precise role of 
protein nutrition for endurance athletes we suggest that longitudinal studies must be 
conducted, in which, protein is ingested post-exercise over the course of a training regimen to 
determine the chronic phenotypic and physiological adaptations. 
 
 Other possibilities to explain the lack of change in mitochondrial muscle protein 
synthesis is that the training status of the subjects and the exercise protocol utilized in the 
present study. It has previously been demonstrated that the response of mitochondrial protein 
synthesis to an acute bout of cycling tends to be lower in individuals after 10-weeks of 
endurance training (51). Thus, our data may suggest that the synthetic response of 
mitochondrial proteins in well-trained individuals reaches a ‘ceiling’; the point beyond 
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which, further contractile and/or nutrient stimuli fail to augment the synthetic response. Thus, 
future studies should seek to characterize the response of different protein fractions to 
endurance exercise in cohorts with divergent phenotypes (i.e. untrained healthy, untrained 
obese, resistance trained).  
 
 
 
 
 
 
 
 
5.3 Protein nutrition for recovery from endurance exercise 
 Although we have demonstrated that there is no effect of carbohydrate-protein co-
ingestion on endurance exercise performance, the findings of Chapter 3 indicate that protein 
ingestion after endurance exercise has a marked influence on the synthesis of contractile 
Figure 5.1 Proposed time-course of net myofibrillar protein balance following endurance 
exercise and protein feeding. Temporal swing of negative (-NBAL) and positive (+NBAL) 
net myofibrillar protein balance throughout the protocol described in Chapter 3. 
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proteins and this may play an important role in the recovery process. The increase in muscle 
protein synthesis we and others (19, 25) demonstrate when protein is ingested after endurance 
exercise has been suggested as a potential mechanism to explain how protein ingestion 
attenuates indirect markers of ultra-structural damage such as, for example, plasma creatine 
kinase concentration (26, 29, 36-38, 41, 43). Ultimately, these acute adaptations are thought 
to improve the subsequent rate of recovery; defined as the recovery of endurance capacity 
(37, 53) or muscle function (41, 43).  
 
 During the study outlined in Chapter 2, participants returned to the laboratory 24 hours 
post-exercise to determine whether the additional protein ingested during the initial exercise 
bout ameliorated muscle soreness, plasma creatine kinase concentration and improved the 
recovery of maximal isometric strength. As expected, we observed a rise in plasma creatine 
kinase and perceived muscle soreness and a resultant decline in isometric strength at 24 hours 
post-exercise. However, the additional protein did not attenuate indices of muscle damage or 
improve the recovery of isometric strength. Thus, despite evidence in Chapter 3 indicating 
that ingesting additional protein in the post-exercise period increases the synthesis of 
structural proteins, we demonstrate no effect of protein ingestion during exercise on any of 
the indices of recovery we measured.  
 
5.3.1  Future studies 
 The effectiveness of protein nutrition as a means to improve the rate of recovery is 
likely hampered by time lapse between exercise completion and the assessment of recovery. 
Reported changes in muscle damage with protein ingestion are typically demonstrated several 
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hours after exercise (37, 53). Despite the robust acute increase in myofibrillar protein 
synthesis we observed, the complete turnover of myofibrillar proteins (i.e. incorporated into 
the myofiber) is relatively slow; on the order of days-to-weeks (34, 35). Thus, it is difficult to 
comprehend how this process may influence changes noted in just a few hours. These data 
may explain why we and others (13) were unable to detect any influence of protein ingestion 
on recovery between 24 hours post-exercise. Therefore, based on our combined findings in 
Chapters 2 and 3, it would prove useful for future studies to examine recovery in the 
immediate hours through to several-days post-exercise. 
 
 The lack of conformity between the data presented may also be explained by the 
different feeding protocols employed. The absence of any improvement in recovery (Chapter 
2) was demonstrated when protein was ingested during prior exercise. Conversely, the 
increase in myofibrillar protein synthesis we report (Chapter 3) occurred when protein was 
ingested following exercise. Given that no study has investigated the influence of 
manipulating the timing and/or frequency of carbohydrate-protein co-ingestion on subsequent 
rates of recovery, this avenue of investigation is important in order to shed further light on the 
effectiveness of protein nutrition for endurance athletes.  
 
5.4 Metabolic adaptation to acute resistance exercise and protein nutrition  
 Acute resistance exercise can improve glycemic control in healthy (23) and Type II 
diabetic individuals (7) via insulin-independent mechanisms (6, 42). Further, co-ingesting 
protein and/or amino acids with carbohydrate loads potentiates the release of insulin, 
reducing the prevailing plasma glucose response (28, 48). Thus, resistance exercise and 
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protein nutrition represent safe alternatives to pharmacological interventions to alleviate or 
reverse the manifestations of Type II and its co-morbidities. 
  
 Our study (Chapter 4) examined the effectiveness of an intense lower-limb resistance 
exercise bout on glycemic control during a glucose challenge at 24 hours post-exercise. One 
group of participants co-ingested additional protein during the glucose challenge to determine 
whether protein feeding would augment the exercise-induced changes in glucoregulation. 
Using a dual stable isotopic tracer technique during the glucose challenge, we demonstrated 
that prior exercise increased the rate of glucose disposal from the circulation by ~12%, which 
ultimately, lowered post-prandial plasma glucose excursions by ~17% compared with non-
exercised controls. At the skeletal muscle level, we demonstrate that prior exercise increased 
basal PAS-AS160 phosphorylation. These data suggest that greater basal AS160 
phosphorylation with prior exercise enhances insulin-stimulated glucose uptake, as evidenced 
by the greater rate of glucose disposal and the final level of PAS-AS160 phosphorylation 
following OGTT. Interestingly, protein co-ingestion during the glucose challenge did not 
augment the exercise-induced improvement in glycemic control or modify signalling protein 
phosphorylation, despite an elevated insulin response in this sub-group.  
 
5.4.1  Future studies 
The high-intensity exercise model utilized in Chapter 4 was adopted based on data 
suggesting that a substantial total exercise volume is required in order to promote a beneficial 
effect on glucose homeostasis (4, 8, 23, 27), particularly in non-diabetic individuals. Whilst 
the total exercise volume in our study and that of Koopman et al. (23) was ~3-fold greater 
than studies demonstrating no glucose-lowering effect of resistance exercise (4, 8, 27), the 
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fact that exercise was restricted to the lower-limbs may also have contributed to the reduction 
in blood glucose. Indeed, Olsen et al. (32) have shown that Type II diabetes may, primarily, 
be a disease of the lower limbs (32). Thus, investigating the chronic effects of lower-limb 
versus whole-body resistance training regimens on glucose homeostasis and insulin 
sensitivity in Type II diabetics would be an interesting route for future studies. Furthermore, 
although a growing body of experimental evidence suggests that long-term resistance training 
improves metabolic homeostasis in a manner distinct from endurance training; our 
understanding of how this precisely occurs is rudimentary. Thus, additional research is 
clearly needed to better understand how different modes of physical training (i.e., resistance, 
endurance or an interval exercise) change the metabolic and qualitative characteristics of 
skeletal muscle and improve glycemic control. Finally, given that the typical physiological 
characteristics of Type II diabetics are dramatically different from young, healthy, 
normoglycemic males we recruited, the high-intensity resistance exercise protocol in our 
study may not be feasible for Type II diabetic individuals to complete. Thus, future studies 
should seek to determine the minimum ‘dose’ of resistance exercise required to counteract 
symptoms of metabolic disease. 
 
In Chapter 4 we demonstrated that basal and PAS-AS160 phosphorylation was 
increased with prior exercise. Thus, the elevated glucose disposal with prior exercise can be 
attributed, in large part, to an increase skeletal muscle glucose uptake mediated by AS160. 
However, this does not exclude the possibility that prior exercise also amplifies insulin-
signalling steps other than AS160. In addition, we and others (1, 15) report no effect of prior 
exercise on the basal phosphorylation of AktSer473. Interestingly, we did observe an increase 
in insulin-stimulated Akt phosphorylation with prior exercise. Thus, future studies should 
seek to characterize, in greater detail, basal and insulin-stimulated modifications in insulin-
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signalling intermediates following acute resistance exercise. Finally, it should be noted that 
this study presents a limitation due to the number of the participants analyzed for protein 
phosphorylation (6 per group). Thus, due to the small sample size and insufficient statistical 
power, it is possible the analyses may have contained a type 2 error. As a consequence, the 
lack of statistical significance in proximal insulin signalling intermediates should be taken 
with caution. 
 
Under resting conditions, the insulinotropic response of co-ingesting protein with 
carbohydrate is thought to facilitate the reduction in plasma glucose excursions (46, 49). In 
Chapter 4, we show that, despite an elevated insulin response, protein co-ingestion during a 
glucose challenge did not augment the beneficial effect of resistance exercise on plasma 
glucose disposal or glucose excursions. We posit that this null finding may be due to; i) the 
relatively brief period of hyperinsulinemia with protein co-ingestion, ii) the absence of 
specific amino acids or iii) the fact that the robust effect of prior exercise on insulin signalling 
and glucose disposal may have masked an additive effect of protein/insulin. Indeed, the 
hypoglycaemic effect of protein co-ingestion has been demonstrated with different feeding 
protocols to that used in our study. In summary, these data suggest that a period of sustained 
hyperinsulinemia (28, 46, 47, 49) or specific free amino acids (9, 10, 21, 22, 30, 31) may be 
important in order for protein ingestion to lower blood glucose concentration. Given the 
potency of protein ingestion for maintaining glucose homeostasis, further studies should 
investigate the effect of different protein feeding strategies (for example, frequent feeding 
and branched-chain amino acid ingestion) following resistance exercise to ascertain whether 
protein and/or amino acids can augment the metabolic benefits we have found. 
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 Finally, it would be remiss not to mention that ingesting protein and/or amino acids 
confers other benefits to metabolic health benefits besides glucoregulation. In addition to 
hyperinsulinemia, co-ingesting protein with carbohydrate promotes hyperaminoacidemia and 
has been found to stimulate protein synthesis and inhibit protein breakdown (14, 50). Thus, 
ingesting amino acids following resistance exercise may blunt the markedly elevated muscle 
protein breakdown rates commonly found in uncontrolled Type II diabetes (5). Future studies 
should seek to clarify this hypothesis. 
 
5.5 Conclusions 
 In this thesis we have demonstrated that protein nutrition during exercise does not 
improve cycle time-trial performance, attenuate purported markers of muscle damage or 
enhance the recovery of muscle strength. Alternatively, protein ingestion following 
endurance exercise can affect the acute response of intracellular signalling proteins 
implicated in mRNA translation, thereby increasing the synthesis of contractile muscle 
proteins. Thus, over time this acute adaptive response may; i) promote muscle hypertrophy or 
ii) confer benefits for muscle recovery and regeneration. However, it is possible that an 
increase in mitochondrial protein synthesis may occur at a later time-point in the recovery 
process. 
 
 Beyond athletic performance and adaptation, data presented in this thesis demonstrate 
that a single bout of high-intensity resistance exercise increases insulin-stimulated glucose 
uptake, lowering plasma glucose concentration during feeding 24 hours post-exercise. The 
mechanism accounting for this action appears to involve a greater phosphorylation of distal 
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insulin-signalling intermediates that subsequently promote an increase in insulin-stimulated 
glucose transport in skeletal muscle. However, in this study the ingestion of additional 
protein did not impact the signalling response in skeletal muscle or improve glycemic control.  
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CHAPTER 6  
APPENDICES - METHOD DEVELOPMENT 
 
6.1 Method of mitochondrial and myofibrillar protein isolation 
  
 Studies measuring abundant skeletal muscle protein fractions, for example, myofibrillar 
and sarcoplasmic proteins have been relatively forthcoming since methods to separate out 
these fractions were developed in the late 1990s. Yet, studies reporting the effects of 
interventions on mitochondrial protein synthesis have been elusive. This apparent 
underreporting of mitochondrial protein synthesis is likely due to technical difficulties rather 
than a lack of aspiration by researchers in this area. Indeed, the amount of mitochondrial 
protein from rat skeletal muscle yields ~1 and 2-4 mg/g muscle wet weight of sub-
sarcolemmal (SS) and intermyofibrillar (IMF) mitochondria, respectively (5). Most human 
muscle biopsies taken from the vastus lateralis muscle weigh ~100-200 mg wet. Therefore, 
the expected yield of mitochondrial protein from muscle biopsy tissues would be < 1 mg. 
This amount of protein is challenging to measure using current GCMS and GC-C-IRMS 
methods. Therefore, it is not surprising that limited research is available on the regulation of 
mitochondrial protein synthesis with exercise or nutrient provision. 
 
 There are two sub-populations of mitochondria in the muscle; IMF mitochondria are 
located between myofibrils and SS mitochondria are located beneath the sarcolemma. SS 
mitochondria represent 20% of mitochondria within skeletal muscle and IMF mitochondria 
account for the remaining 80% (2). In humans, both populations of mitochondria have been 
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shown to adapt to endurance exercise training by increasing in number (3, 4). Until recently, 
studies in humans had only characterized the rates of protein synthesis of SS mitochondria at 
rest (1, 6). In one of these studies, Rooyackers et al. (6) stated that they were unable to obtain 
the IMF mitochondria because the proteolytic enzymes required to do so interfered with the 
measurements of the rate of synthesis of myofibrillar proteins. More recently, Wilkinson et 
al. (7) characterized the synthetic response of mitochondrial proteins to different modes of 
exercise by combining both IMF and SS mitochondrial fractions obtained during sample 
processing. 
 
In Chapter 3 of this thesis, we adapted the method of protein isolation from Wilkinson 
et al. (7). This method utilizes techniques of muscle tissue homogenization and centrifugation 
to separate cellular components of different densities. The principle underlying this technique 
is that the heaviest (or most dense) cell components pellet in less time and with less force 
than is required to pellet lighter organelles such as mitochondria. Therefore, once the tissue 
homogenate is obtained, a first slow speed spin (~1000g for 10 min) is used to pellet the 
myofibrillar protein. The supernatant is then removed and transferred to another tube and 
centrifuged at a higher speed (~10,000g for 10 min) to pellet the lighter mitochondria. Prior 
to study analyses, we confirmed (in human tissue from pilot studies) that this method was 
appropriate to obtain both mitochondria and myofibrillar proteins from a mixed muscle 
homogenate. 
 
6.1.1 Method preparation and supplies 
 
• Tissue needed: Possible with 40-50mg but better with 70-80mg. 
•  4mL black screw top glass vials. 
• Coated razorblade to divide muscle in N2. 
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• Teflon (polypropylene) pestles (Schutt Labortechnik GmbH: Product # 3.200.512). 
• Steel dish to store samples in N2. 
• 1.5mL Eppendorf. 
• Pipette tips (blue, yellow, pastette pipettes). 
• Glass culture tubes (Fisher scientific 10x75mm: Product # 14-961-25). 
• Glass Dounce homogenizer with glass pestle x 2. 
 
6.1.2 Sample preparation prior to isolation 
 
• When weighing the sample always keep on N2 or dry ice. 
• Use fresh 1.5mL eppendorf to zero the balance. Once sample (in cryotube) is out of 
duer and into dish of N2 (or dry ice) open cap and tip muscle out into the N2. 
• Using razorblade/scalpel, chip the frozen muscle to weigh out very specific amounts 
then add to 1.5mL eppendorf. 
• Discard old cryotube. 
 
6.1.3 Reagent preparation 
 
• 0.3 M Sodium hydroxide (NaOH) 
• 95% Ethanol (EtOH) 
• 6 M Hydrochloric acid (HCl) 
• 1 M Perchloric acid (PCA) 
• β-2-glycerophosphate (Sigma: Product # G9891-25G) 
• MgCL (Sigma 99.0 – 102%: Product #M9272-100G) 
• NaFl (Sigma: Product # 51504-100G) 
• Tris base / Tris HCl (Sigma: Product #T6066-1KG / Sigma: Product # T5941-500G) 
• EDTA (Siga: Product # E9884-100G) 
• KCl (Sigma 99%: Product # P4505-1KG) 
 
Buffer is made up into 20mL of 50mM Tris buffer. Tris buffer contains 6.75g/L of Tris HCl 
and 1.18g/L of Tris base for 0.05 M solution. The following reagents are weighed and placed 
into 50mL falcon tube with 20mL of Tris buffer added on top. 
.  
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• 10mM β-2-glycerophosphate = 43.2mg 
• 5mM MgCl2 (203.3 g/mol) = 20.33mg  
• 50mM NaFl (42 g/mol) = 42mg 
• 1mM EDTA (372.2g/mol) = 7.4mg 
• 0.1mM KCl (10mM stock) = 20uL 
 
Split buffer into 2 x 10mL aliquots, 1 x 10mL with 1.5% BSA and 1 x 10mL BSA free. 
Therefore 10mL buffer with 1.5% BSA = 150mg BSA added. 
 
 
Note: A minimum of 70mg of muscle tissue is required to reliably and repeatedly extract 
myofibrillar and mitochondrial (combining IMF and SS mitochondria) protein fractions using 
a [13C6] phenylalanine tracer. 
 
 
 
 
 
 
 
  
Figure 6.1 Protein isolation protocol. Procedure for separating myofibrillar, IMF and SS mitochondrial, collagen and sarcoplasmic protein fractions 
 
Dounce homogenization of muscle on ice 
 
1. Add 10 µl /mg cold homogenization buffer (+BSA) to sample in the 1.5mL eppendorf. Use Teflon pestle whilst sample is still frozen to homogenize until 
majority of tissue suspended. 
2. Spin tube at 1000 g for 10 min @ 4ºC 
3. Transfer supernatant with pipette (being careful not to pipette any of the pellet) to another eppendorf labelled SS MITO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.5ml eppendorf tube 
 
1. Add ~400 µl of homogenization buffer (+BSA) to the pellet  
2. Homogenize with Teflon pestle. Transfer all to glass 
Dounce homogenizer. 
3. Homogenize in Dounce tube with glass pestle leaving no 
large amts of tissue (TIGHT pestle is best). 
4. Transfer to new eppendorf labelled MYO 
5. Add 100µl more buffer (+BSA) to Dounce to wash extra 
muscle in and also transfer to MYOFIB tube. 
6. Spin at 1000 g for 10 min @ 4ºC 
7. Pipette off supernatant to new 1.5mL eppendorf labelled 
IMF MITO 
 
SS and IMF MITO tubes 
 
1. Spin tubes at 10,000 g for 10 min @ 4ºC 
2. Remove supernatants and put in one 1.5mL eppendorf labelled SARC being careful not to 
disturb mitochondrial pellet 
MYO and COLLAGEN pellet 
 
1. Add 500 µl homogenizing buffer (-BSA) and vortex to 
fully suspend. Spin at 1000g for 5 min @ 4ºC. 
2. Remove and discard supernatant. Repeat (to remove 
BSA protein from myofibrillar and collagen pellet) 
3. To the remaining pellet add 1 mL 0.3 M NaOH. Vortex 
thoroughly and heat @ 37 ºC for 30 mins. 
4. Transfer supernatant in glass vials for IRMS. 
5. Add 500 µl 0.3 M NaOH and vortex  to fully suspend 
then heat @ 37 ºC for 10 mins 
6. Remove supernatant and add to glass vial. Pellet contains 
COLLAGEN. 
SS and IMF MITO pellets 
 
1. Add 500 µl buffer (-BSA). Vortex to fully suspend. 
Spin at 10,000g for 5 min @ 4 ºC. 
2. Remove and discard supernatant 
3. Repeat steps 1 and 2. 
4. Add 500 µl EtOH (95%). Vortex and spin @ 10,000g 
for 10 min @ 4 ºC. 
5. Remove and discard EtOH 
6. Add 500µL 0.05 M HCL to pellet and break up using 
pipette. 
7. Add re-suspended pellet to new glass tube 
8. Repeat steps 6 and 6 
9. Add 1mL Dowex resin and hydrolyze  overnight @ 110 
ºC 
MYO tube (Myofibrillar protein recovery) 
 
1. To the supernatant add 1000 µl of 1 M PCA. 
2. Spin tube at 1000 g for ~10 min @ 4ºC. Place vials (without caps) in centrifuge cups using 
tweezers. 
3. Remove and discard supernatant 
4. Add 500 µl EtOH. Spin at 1000g for 10 mins @ 4ºC. Remove and discard EtOH. 
5. Add 500µL 0.05 M HCL to pellet and break up using pipette 
6. Repeat steps 6-9 of SS and IMF MITO pellets (see above) 
SARC tube 
 
1. Add 500 µl of 1 M PCA. 
Vortex to suspend. Spin at 
10,000g for 5 min @ 4ºC 
(precipitate the AA’s). 
2. Remove and discard 
supernatant 
3. Add 500 µl EtOH (95%). 
Vortex quickly do not re-
suspend pellet. Spin at 10,000g 
for 5 min @ 4 ºC. 
4. Repeat steps  6-9 of SS and 
IMF MITO pellets (see right) 
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6.1.4 Analysis of [13C6] phenylalanine enrichment by gas chromatography-combustion-isotope 
ratio mass spectrometry  
 
Establish:  13C6 phenylalanine in mitochondrial and myofibrillar fractions. 
 
Rate (°C/min):              10°C/min          1.0°C/min        20°C/min 
 
Temp (°C):        110°C          235°C                       245°C                      280  
 
Time (min):        1.0’                        3.0’                           1.0’                        10.0’                                
  
    
• Column: Agilent technologies DB 1701 (length 30 m, I.D. 0.25 mm, film 1µm). 
• RT: 33-34 min (run standard prior to every run. RT may change as column ages). 
 
Inlet method 
Base Temp:   On 
Base Temp:   250°C 
Mode:    Splitless 
Split flow (ml/min):  50 
Splitless time (min):  1 
Surge pressure:  Off 
Surge pressure (kPa):  3 
Surge duration (min):  0 
Constant purge:  On 
Stop purge at (min):  0 
 
Autosampler method 
Sample volume:  1 ul 
Air volume:   0.5 ul 
Injection delay:  2 s 
Pullout delay:   1 s 
Injection speed:  100 ul/s 
Pull-ups pumps:  5 
Pull-ups volume:  5 ul 
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Pull-ups delay:  0 s 
Pre-injection washes:  1 
Pre-injection volume:  5 ul 
Post-injection washes: 3 
Post-injection volume: 8 ul 
 
6.1.5  Citrate synthase activity assay 
A citrate synthase (CS) activity assay was used as a measure of the mitochondrial 
content of each fraction. In short, the different fractions obtained from the muscle 
homogenization were re-suspended in the homogenization buffer (described above, minus 
BSA), containing 0.1% Triton-X to solubilize the mitochondrial inner and outer membranes. 
A Bradford assay was performed in order to determine protein yield. An equal amount of 
protein from each fraction was tested for CS activity. Our aim was to achieve a low level of 
CS activity in the sarcoplasmic and mixed muscle fractions and a high level of CS activity in 
the mitochondrial fractions. The protocol for the CS activity assay was as follows; 1mL of 
0.1 M Tris buffer, pH 8.0, heated to 37°C, was added to a cuvette containing 10 µl of 10mM 
DTNB in 0.1M Tris buffer and 2 µl of 30 mM acetyl-CoA in water. To this, a volume of the 
muscle homogenate was added to obtain 12 µg of protein, which was then tapped gently by 
hand to mix. The spectrophotometer (Thermo, Helios Lambda) was zeroed and 10 µl of 50 
mM oxaloacetic acid in 0.1M Tris buffer were added to start the reaction. Absorbance were 
recorded at 412 nm every 30 s for 5 min. The premise of this assay is that the faster the 
absorbance changes the greater the CS activity. CS activity assay was performed on human 
skeletal muscle tissue (vastus lateralis) obtained during pilot testing. 
 
 
 
Chapter 6  200 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.1.6  Western blots 
We tested for the presence of myofibrillar and mitochondrial proteins in each fraction 
using gel electrophoresis. In brief, Bradford assays were used to determine the protein 
concentration of each fraction, after which samples were standardized to 1 mg/ml by dilution 
with Laemmli loading buffer in. Fifteen µg of protein/lane was loaded onto Criterion XT 
Bis–Tris 12% SDS-PAGE gels (Bio-Rad, Hemel Hempstead, UK) for electrophoresis at 200 
V for 60 min. Gels were equilibrated in transfer buffer (25 mM Tris, 192 mM glycine, 10% 
methanol) for 30 min before proteins were electroblotted onto 0.2 lm PVDF membranes (Bio- 
Rad) at 100 V for 30 min. After blocking with 5% low-fat milk in TBS-T (Tris Buffered 
Saline and 0.1% Tween-20; both Sigma-Aldrich, Poole, UK) for 1 h, membranes were 
rotated overnight with primary antibody against the aforementioned targets at a concentration 
Figure 6.2 Citrate synthase activity assay. Change in absorbance of 12µg of mixed and 
sarcoplasmic protein (low activity) and intermyofibrillar and sub-sarcolemmal mitochondrial 
protein (high activity) obtained from human skeletal muscle tissue.  
Time (min)
0 50 100 150 200 250 300
CS
 
ac
tiv
ity
 
(A
bs
o
rb
an
ce
)
0.00
0.05
0.10
0.15
0.20
0.25
0.30 SS MITO 
IMF MITO 
SARC 
MIXED 
Chapter 6  201 
 
 
of 1:2,000 at 4°C. Membranes were washed (3 x 5 min) with TBS-T and incubated for 1 h at 
room temperature with HRP-conjugated anti-rabbit secondary antibody (New England 
Biolabs, UK), before further washing (3 x 5 min) with TBS-T and incubation for 5 min with 
ECL reagents (enhanced chemiluminescence kit, Immunstar; Bio-Rad). Blots were imaged 
visually inspected for the presence of slow myosin heavy chain (MHCI; DSHB A4.951) and 
cytochrome C oxidase (COX; Cell Signalling 4280) protein using the Chemidoc XRS system 
(Bio-Rad, Hemel Hempstead, UK). A positive test would reveal the presence of slow MHC 
isoforms in the myofibrillar fraction but not in the mitochondrial fractions. Likewise, a 
positive test would reveal the presence of COX in the mitochondrial, but not myofibrillar 
fractions. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 Western blot analysis of isolated protein fraction purity. (A) Total slow myosin 
heavy chain protein content in HeLa control (CTRL), sarcoplasmic (SARC), rat myofibrillar 
(MYOR), human myofibrillar (MYOH), intermyofibrillar mitochondria (IMF MITO) fractions; 
(B) Total Cytochrome C Oxidase protein content in SARC, IMF MITO and MYOH fractions. 
NB: For blot (A) IMF MITO was analyzed in triplicate, for blot (B) all fractions were analyzed 
in triplicate. 
 
CTRL   SARC      MYOR R MYOH CTRL  IMF MITO (A) 
14kDa 
200kDa 
SARC IMF MITO MYOH (B) 
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6.2 Method of plasma glucose enrichment 
6.1.1 Reagent preparation  
 
• Methanol 
• Chloroform 
• Distilled water with pH 2 (use HCL, about 4ml 1M HCL in 500ml water) 
• Butaneboronic acid 
• Acetic anhydride 
• Ethylacetate 
• Pyridine 
 
6.1.2 Protocol for deproteinisation and derivitization of samples  
• 150 µL plasma or standard in glass screw-cap tube. 
• + 150 µL of distilled water PH 2. 
• 1 min vortex (plate shaker). 
• +3 mL methanol:chloroform (2.3:1) (500 mL = 348:152). 
• 5 min vortex (plate shaker). 
• 10 min on ice. 
• 15 min centrifugation at 4ºC, 3500 rpm. 
 
Pipette top clear layer into a new glass screw-cap tube (use glass pipette) 
 
• + 2 mL chloroform. 
• + 1 mL distilled water pH 2. 
• 15 min vortex (plate shaker). 
• 15 min centrifugation at 4ºC, 3500 rpm. 
 
Pipette top clear layer into a new glass screw-cap tube (using glass pipette) 
 
• Dry for ~ 3 hours under nitrogen at 40ºC. 
• The above plasma sample or 30 µL standard + 150 µL Butaneboronic acid (10 mg / 
1mL pyridine). 
• 15 min vortex (plate shaker). 
• 30 min incubate at 95ºC. 
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• +150 µL acetic anhydride. 
• 90 min vortex (plate shaker). 
 
Dry under nitrogen at 50ºC (check every 15 min). 
 
Prepare sample for GC-MS  
• +150 µL ethylacetate. 
• 10 min vortex (plate shaker). 
 
Transfer in glass vial to GC-MS 
 
 
6.1.3 Analysis of [U-13C] and 6, 6-[2H2] glucose enrichment by gas chromatography- mass 
spectrometry  
 
Establish:  U-13C and 2H2 glucose in plasma. 
 
Rate (°C/min):              4°C/min          50°C/min         
 
Temp (°C):        135°C          215°C                       250°C                  
 
Time (min):        1.0’                        2.0’                           2.0’                                                       
  
    
• Column: HP-5MS (30m length, 0.25mm I.D., 0.25um film) 
 
Front inlet: Split injection, split ratio: 50:1 
Flow rate: 2ml /min 
Solvent delay: 1.5 min 
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